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Immune system
During cancer development or following infections with pathogens, such as bacteria and viruses, 
the immune system of the human body is activated. This system is designed to act as the body’s 
internal defense against these invaders and cancers. The process from recognizing an infection 
or tumor to its elimination is called the immune response, and is comprised of the innate and the 
adaptive immune response. The innate immune response is the first line of defense, but lacks 
molecular specificity to the invaders. One of its overall effects is to develop a state of inflammation 
to recruit cells of the adaptive immune response. The adaptive immune response provides a 
specific immune reaction against pathogens and tumor cells. The whole process of an immune 
response is very complex as different immune cells have to communicate using cytokines, 
chemokines and direct cell-cell interactions in order to perform their tasks. 
The immune response starts with the recognition of the invading pathogen or tumor material 
by cells of the innate immune system, the leukocytes in our blood stream, which are present at 
or migrate to the infection or tumor site. There they recognize pathogen-associated molecular 
patterns (PAMPs) on the surface of microbial pathogens or viruses by pattern recognition receptors 
(PRRs). PRRs are receptors expressed on the surface of immune cells and can be classified into 
Toll-like receptors (TLRs), C-type lectin receptors, nucleotide-binding domain and leucine-rich 
repeat containing receptors, and retinoic acid-inducible gene-I like receptors (1). Engagement 
of these receptors by PAMPs induces the production of inflammatory cytokines by the immune 
cells. Besides PAMPs, PRRs can also recognize damage-associated molecular patterns 
(DAMPs), which are released during tissue damage and cell death to initiate a noninfectious 
immune response (2). Necrotic tumor cells will express or release DAMPs and can thereby be 
recognized by the PRRs on immune cells.
Phagocytic leukocytes, e.g., neutrophils, macrophages and dendritic cells, are able to take up 
pathogens or tumor material, also called antigens, after recognition via PRRs by a process called 
endocytosis (for small particles, i.e., < 0.5 µm) or phagocytosis (for larger particles) (3). This 
results in killing of the pathogen and can be followed by immune cell proliferation, production of 
cytokines and chemokines and presentation of pathogen- or tumor-specific protein fragments – 
antigen peptides – on the cell surface to other immune cells. The cells that are able to present 
antigen peptides on their surface are called antigen-presenting cells (APCs). This finally results 
in the activation of antigen-specific immune cells of the adaptive immune response and their 
recruitment to the infection or tumor site. 
The adaptive immune system contributes to the immune defense by increasing the specificity 
and focus of the immune response, as it provides molecular recognition of the pathogen. Each 
cell of the adaptive immune system recognizes one specific antigen. It also provides an effective 
response to repeating infections, because the cells that expand during an immune response 
form an immunological memory to the pathogen. This results in a faster adaptive immune reaction 
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against a second invasion of the same pathogen. The adaptive immune response is initiated by 
two classes of antigen-specific immune cells: the T lymphocytes (T cells) and B lymphocytes 
(B cells). Both are present in a naive state in the lymph nodes, where they differentiate into 
effector cells upon activation (Fig. 1). The T cells are activated when they recognize antigen 
peptides presented on the surface of APCs, which migrate from the infection or tumor site 
to the lymph nodes upon antigen recognition and uptake. These T cells will differentiate into 
helper T cells (CD4+) and cytotoxic T cells (CD8+). The antigen peptides are presented in major 
histocompatibility complexes (MHC) on the surface of APCs. MHCs are divided in MHC class I and 
II. MHC class I is mainly used for the presentation of antigen peptides of endogenous antigens, 
such as viruses, which lead to the activation of CD8+ cytotoxic T cells. Almost all cells express 
MHC class I, and this allows the identification of infected cells by the activated CD8+ cytotoxic T 
cells, which subsequently can induce apoptosis. MHC class II is exclusively expressed in APCs 
and mainly presents endo/phagocytosed (exogenous) antigens, resulting in the differentiation 
of CD4+ helper T cells into two types of T cells: T helper 1 (Th1) and T helper 2 (Th2) cells. Th1 
cells mediate cellular immunity by activating a phagocyte-mediated immune response against the 
infection, whereas Th2 cells are responsible for humoral immunity by inducing antibody secretion 
by B cells (4). Thus, these helper T cells will activate other immune cells, such as B cells, to get 
a proper immune response against the antigen. B cells are able to phagocytose antigens via the 
B cell receptor and present the antigen peptides in MHC class II to helper T cells, which in turn 
activate B cells upon recognition. Activated B cells will differentiate into plasma cells, which are 
able to secrete antibodies in the blood stream that bind and mark pathogens for clearance or 
destruction. 
^ Fig. 1: Activation of the adaptive immune response. An antigen presenting cell (APC) of the innate immune 
response traffics to the lymph node, where it presents antigen peptides to T cells. Presentation of peptides in MHC class I 
results in the differentiation of naive CD8+ T cells into CD8+ cytotoxic T cells. The complex of MHC class II and an antigen 
peptide lead to the differentiation of CD4+ T cells into T helper 1 (Th1) and T helper 2 (Th2) cells. The activated CD4+ T cell 
can activate a B cell that presents a peptide of the same antigen in MHC class II. Activated B cells will differentiated into 
plasma cells, which secrete antibodies against the antigen.  
10
Chapter 1
1
Dendritic cells and antigen cross-presentation
Dendritic cells are APCs at the interplay between the innate and the adaptive immune response. 
Normally, phagocytosed antigens are degraded into antigen peptides and presented in MHC 
class II to CD4+ helper T cells. However, to initiate CD8+ T cell responses against tumor cells as 
well as intracellular pathogens (e.g., viruses) that not directly infect dendritic cells, dendritic cells 
are capable to present peptides derived from endo/phagocytosed antigens not only in MHC 
class II, but also in MHC class I. This process is called cross-presentation, and is necessary to 
activate CD8+ naive cytotoxic T cells for generating antiviral and antitumor responses.
Mechanistically, cross-presentation can occur via two different pathways: the vacuolar and 
the cytosolic pathway (5–7). For presentation via the vacuolar pathway, antigen proteins are 
degraded in the lumen of endosomes or phagosomes by the activation of lysosomal proteases. 
This generates the antigen peptides and their loading onto MHC class I molecules also occurs 
within the endo/phagosome. In the cytosolic pathway, antigen translocates from the lumen 
of endosomes or phagosomes into the cytosol, where it is processed by the proteasome. 
Proteasome-generated peptides are then transported into the endoplasmic reticulum (ER) or 
back into the endo/phagosome by the transporter associated with antigen processing 1 (TAP1) 
and TAP2 for loading onto MHC class I.
Antigen transport to the cytosol is thought to mediated by the translocon Sec61, a member of 
the ER-associated degradation (ERAD) pathway which is found on phagosomes (8, 9). However, 
the role of Sec61 as translocon for cross-presentation is still a matter of debate and the results 
obtained from experiments with RNA silencing or inhibition of Sec61 are controversial (10–14). In 
any case, a specific protein channel such as Sec61 cannot be the only mechanism of antigen 
translocation, because the pore size of Sec61 is too small for the transport of functional folded 
proteins with co-factors (15–17) and nucleic acids, ingested by dendritic cells, can also reach the 
cytosol (18). 
NADPH oxidase NOX2
The NADPH oxidase complex NOX2 is necessary for a proper CD8+ killer T cell response against 
tumor cells (19). NOX2 is expressed by all phagocytes of the immune system, and consists of the 
two transmembrane subunits gp91phox and p22phox, the three cytosolic subunits p40phox, p47phox 
and p67phox, and the small GTPase Rac1 or Rac2 (Fig. 2). The membrane protein gp91phox is highly 
glycosylated and locates as a heterodimer with p22phox – called flavocytochrome b558 – at recycling 
endosomes (20) or at lysosome-related organelles (21, 22) in inactive cells. During phagocytosis, 
the heterodimer is transported to the plasma membrane and to endo/phagosomal membranes 
through a Rab27a-dependent mechanism, as the fusion between the flavocytochrome b558-
positive lysosome-related organelles and phagosomes is delayed in dendritic cells from Rab27a-
deficient mice (21). Besides Rab27a, the fusion also depends on the soluble N-ethylmaleimide-
sensitive factor (NSF) attachment protein receptor (SNARE) protein VAMP8 (23). The parasite 
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Leishmania is able to avoid immune recognition by cleaving VAMP8, which results in a decreased 
recruitment of gp91phox to the phagosomal membrane. In order to form an active NOX2 complex 
on the phagosomal membrane, cytochrome b558 needs to recruit the cytosolic subunits of NOX2. 
This recruitment is facilitated by the phosphoinositide lipids phosphatidylinositol 3-phosphate 
and phosphatidylinositol (3,4)-bisphosphate (24–26). The activated NOX2 complex will oxidize 
cytosolic NADPH and reduce molecular oxygen to generate superoxide anion within the 
phagosomal lumen (Fig. 2). 
 
^ Fig. 2: Assembly of NOX2 complex upon activation. In unstimulated cells, the highly glycosylated membrane 
protein gp91phox forms a heterodimer with p22phox. The cytosolic subunits p40phox, p47phox and p67phox and the small GTPase 
Rac1 or Rac2 (Rac1/2) are expressed in the cytosol. Upon activation by phagocytosis of an antigen, the cytosolic subunits 
and Rac1/2 move to the membrane-bound heterodimer to form an active NOX2 complex. This complex oxidizes cytosolic 
NADPH into NADP+ and H+, which results in the reduction of molecular oxygen to superoxide anion within the phagosomal 
lumen. 
Superoxide anion can readily convert into other molecular species of reactive oxygen species 
(ROS), such as hydrogen peroxide by reacting spontaneously with protons in acidic environments 
or catalyzed by the enzyme superoxide dismutase. This results in a higher phagosomal pH, which 
is observed in neutrophils and dendritic cells but not in macrophages (19, 27). In neutrophils, this 
ROS production, called the oxidative burst, is short (minutes) and transient, resulting in high ROS 
levels within a short time to kill the phagocytosed pathogens (28). In macrophages, the ROS 
production in the phagosomal lumen is less pronounced and, besides responsible for killing, 
ROS can act as second messengers and have a role in redox signaling (29). Dendritic cells 
show a prolonged production of ROS, although the peak level of ROS is 20-times lower than 
in neutrophils (30). This lower peak concentration of ROS may not suffi ce to kill the ingested 
pathogen (30), although this is controversial (31). However, anti-microbial activity is not the only 
host defense function of NOX2-derived ROS (Fig. 3). ROS can modulate the immune system to 
help create a favorable environment for an effective immune response by participation in pro- and 
anti-infl ammatory signaling effects (32). It is also reported that ROS have intracellular effects by 
inhibition of phosphatases, activation of kinases, modulation of calcium signaling and activation 
of transcription factors (24) as well as extracellular effects, as NOX2-generated ROS promote the 
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recruitment of neutrophils to the infection site (33). Furthermore, it is suggested that ROS have a 
role in autophagy (discussed later) and antigen (cross-)presentation, as a key role for the NOX2-
produced ROS is to create a less-degradative endo/phagosomal environment by slowing endo/
phagosome maturation (34, 35). This serves to prevent excessive degradation of the antigen 
proteins and thereby favors the antigen (cross-)presenting capacity of dendritic cells (19).
^ Fig. 3: Effects of NOX2-generated ROS in immunity. The ROS produced by NOX2 have different roles in 
immune cells. ROS function as antimicrobial agent, but also participate in immune modulation, intracellular signaling, 
chemo-attraction, induction of autophagy and antigen cross-presentation. 
Endosome and phagosome maturation
During endocytosis or phagocytosis, an early endo/phagosome is formed. This early endo/
phagosome will undergo maturation towards a late endo/phagosome, which fi nally fuses with 
a lysosome to degrade the internalized antigen. Endosome and phagosome maturation are 
mechanistically reminiscent, although there are differences in terms of the uptake machinery, 
downstream signaling and antigen processing mechanisms. During both endosome and 
phagosome maturation, the protein composition of the endo/phagosome and the endo/
phagosomal membrane changes and the lumen acidifi es to get its degradative capacity (3). 
Rab5, a member of the Rab GTPase family, is present on the early endo/phagosome and is 
required for the transition into the Rab7-positive late endo/phagosome (36). Rab5 activity results 
in the recruitment of VPS34, which generates phosphatidylinositol 3-phosphate on the endo/
13
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phagosomal membrane. This leads to the recruitment and activation of markers that drive endo/
phagosome maturation, such as EEA1 which in turn binds to Rab5 providing a positive-feedback 
loop (37). Rab5 promotes recruitment of Rab7 for the transition to a late endo/phagosome. Rab7 
associates with the effector protein RILP, which links late endo/phagosomes to dynein-dynactin 
to mediate movement over microtubules to lysosomes (38, 39). Late endosomes fuse with 
lysosomes through the action of the SNARE proteins syntaxin-7, syntaxin-8, VAMP7 and VAMP8 
(40–44).
SNARE activity in dendritic cells
SNAREs mediate the fusion between vesicles and organelles within the cell (45–47). Each 
SNARE protein contains at least one natively unstructured domain called the SNARE-motif which 
is necessary for membrane fusion. To drive membrane fusion, cognate SNAREs present in 
both membranes engage and form a tight alpha-helical coiled-coil SNARE complex. A SNARE 
complex consists of four SNARE motifs that can be categorized according to the central residues 
within the bundle to Q-SNAREs (glutamine) and R-SNAREs (arginine). A SNARE complex consists 
of three Q-SNAREs (Qa, Qb and Qc-SNARE) and one R-SNARE (46, 47). Different SNAREs are 
found on early and late endo/phagosomes and lysosomes, and many have a role in dendritic 
cell function. For instance, it is found that syntaxin-11, syntaxin-3, Vti1a and VAMP2 are up-
regulated upon activation of TLRs, where syntaxin-3 is needed for secretion of cytokines (48). 
The SNAREs Sec22b together with syntaxin-4 might influence cross-presentation, as they are 
involved in antigen translocation from the endo/phagosomal lumen into the cytosol (17), although 
the results obtained with dendritic cells from Sec22b knockout mice are controversial (49, 50). 
VAMP8, which inhibits phagocytosis in dendritic cells (51), is also involved in cross-presentation 
as it is responsible for the recruitment of gp91phox to the phagosome (23). 
Reactive oxygen species and antigen presentation
ROS produced by NOX2 in the endo/phagosomal lumen after endo/phagocytosis of antigens lead 
to changes in the endo/phagosomal properties. It results in alkalinization of the endo/phagosomal 
lumen, lower activation or inactivation of lysosomal proteases, and modification of the molecular 
structure of antigens. All these are reported to modulate antigen presentation (Fig. 4).
As discussed above, the conversion of superoxide anion into hydrogen peroxide by dismutasis 
consumes protons within the endo/phagosomal lumen. This counteracts the import of protons by 
the vacuolar ATPase (V-ATPase) and causes a reduced acidification or even an alkalinization of the 
endo/phagosomal lumen. This alkalinization of the lumen depends on NOX2, as dendritic cells 
lacking gp91phox have a lower endo/phagosomal pH (19, 34). It results in reduced degradation of 
antigen by lowering the activity of lysosomal proteases with acidic pH optima, and is proposed to 
thereby promote efficient antigen cross-presentation (19, 52). In line with this, dendritic cells from 
chronic granulomatous disease (CGD) patients, which have a mutation in one of the subunits of 
NOX2, show a lower endosomal and phagosomal pH and impaired cross-presentation (52). 
14
Chapter 1
1
ROS can oxidize amino acids, such as cysteine residues which form disulfide bonds upon 
oxidation. If this happens within the active site of an enzyme, it can change the activity of the 
enzyme, as shown for the V-ATPase (53, 54). In a similar fashion, ROS can inactivate serine and 
cysteine proteases by modifying the catalytic center of these proteases (55, 56). The oxidative 
environment in the phagosomal lumen caused by NOX2-produced ROS thereby results in 
modification and inhibition of the cysteine cathepsins B, L and S. This oxidative inhibition controls 
the proteolysis activity in the phagosome and can alter the antigen peptides produced for 
presentation in MHC class I and II (57, 58).
^ Fig. 4: Effects of NOX2 activity after phagocytosis of antigens by dendritic cells. The production of ROS by 
NOX2 has effects on autophagy by inducing assembly of the autophagy proteins ATG5, ATG12 and ATG16 or by oxidation of 
ATG4. This results in recruitment and binding of LC3 to the phagosomal membrane. NOX2 activity also influences the cross-
presentation capacity of dendritic cells by three mechanisms. The first effect of ROS is alkalinization of the phagosomal 
lumen, which inactivates proteases with acidic pH optima and thereby inhibits antigen degradation. The second effect is 
the modification of antigens to inhibit their translocation over the phagosomal membrane. Modified antigens can also result 
in the alteration of proteolytic activity, which can also be reduced by oxidative inactivation of cathepsins. Altered proteolysis, 
the third effect, changes the antigen degradation and thereby can promote antigen cross-presentation.
NOX2-produced ROS can also oxidize antigens directly within endo/phagosomal lumens, by e.g., 
inducing disulfide bonds. This can influence the susceptibility of antigen proteins to proteolytic 
degradation and might influence antigen processing and presentation. A recent study showed 
that efficient cross-presentation of antigens containing disulfide bonds requires the activity of the 
gamma-interferon-inducible lysosomal thiol reductase (GILT) (59). GILT, localized in phagosomes 
and lysosomes in APCs (60, 61), facilitates the unfolding of antigens in an acidic environment 
15
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by reduction of the disulfide bonds. Unfolded antigen in the phagosomal lumen is then able to 
translocate to the cytoplasm via a mechanism that involves the chaperone heat shock protein 90 
(Hsp90) (62). Since ROS can induce an oxidative and alkaline environment, NOX2 can counteract 
the activity of GILT affecting efficient cross-presentation of disulfide-rich antigens.
Finally, ROS can affect antigen processing by promoting autophagy, as discussed in the next 
section.
Autophagy
Autophagy is a process used by the cell to maintain cellular homeostasis. It degrades unnecessary, 
damaged or misfolded cellular components in the cell. Multiple forms of autophagy have been 
described, but the best understood is a process called macro-autophagy. In macro-autophagy, 
the cargo destined for degradation is first enclosed by LC3-containing phagophores in a double-
membraned vesicle called an autophagosome. This autophagosome subsequently fuses with a 
lysosome to form an autolysosome (63). The metabolic enzymes within the lysosome degrade 
both the autophagic cargo and the inner membrane of the autophagosome. Autophagy can be 
required for cross-presentation of exogenous soluble antigens by dendritic cells (64). However, 
antigen cross-presentation can also occur independently of autophagy, depending on the exact 
endocytic route (64). In starving cells, which contain high levels of mitochondrial ROS, a cysteine 
residue within the catalytic site of the ATG4 cysteine protease can become oxidatively modified. 
This modified ATG4 promotes lipidation of the autophagy marker LC3, which in turn triggers the 
formation of autophagosomes and activation of autophagy-mediated degradation (Fig. 4) (65). 
Whether NOX2-produced ROS also promote autophagy of endosomes and phagosomes via 
oxidative modifications of ATG4 is still unknown.
Autophagy is increasingly well understood to act as a defense system against intracellular 
pathogens. For instance, when the pathogen Streptococcus pyogenes escapes from the 
phagosomal lumen, autophagy is induced and the microbes are enclosed in LC3-positive 
autophagosomes (66). Such recruitment of LC3-positive phagophores to cytoplasm-invading 
pathogens is mediated by ubiquitination of the pathogen followed by recruitment of the adapter 
protein p62 (67).
Other forms of autophagy have also been related to antigen processing. PRR signaling during 
phagocytosis can result in formation of so-called LC3-associated phagosomes (LAPosomes). 
These differ from conventional macro-autophagosomes, because they contain only a single 
membrane and LC3 is directly recruited to the phagosome-enclosed membrane (68). NOX2-
mediated ROS production during phagocytosis is required for the recruitment of LC3 to 
phagosomes (68–71). LC3 recruitment to phagosomes is mediated by the autophagy proteins 
ATG3, ATG4 and ATG7 and ROS-induced assembly of a complex composed of the autophagy 
proteins ATG5, ATG12 and ATG16 (68–71). LC3-promoted phagocytosis has been reported to 
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both promote and delay phagosomal maturation. First, the recruitment of LC3 was shown to 
promote fusion with lysosomes, which leads to phagosomal acidification and antigen degradation 
(68–70). However, contradicting results indicate that LC3-associated phagocytosis can also result 
in delayed phagosomal maturation, as it reduces recruitment of the lysosomal markers LAMP2 
and Rab7 (71). This delayed maturation is proposed to promote the preservation of antigen 
peptides for presentation on MHC class II (71).
Scope of this thesis
In this thesis, we examined the role of NOX2-induced ROS in promoting cytolytic T cell activation. 
We studied the mechanisms of NOX2 recruitment to and removal from the antigen-containing 
compartment, as well as the mechanisms of NOX2-mediated antigen translocation into the 
cytosol.
We first addressed the mechanisms of the recruitment of NOX2 to the phagosomal membrane. 
Although it is well understood how endo/phagosomal NOX2-produced ROS affect the proteolytic 
degradation of antigen proteins, the mechanisms by which gp91phox, the integral membrane 
component of NOX2, reaches the antigen-containing compartment were not known. gp91phox 
traffics from recycling endosomes or lysosomal organelles to the phagosome in a SNARE-
dependent manner (20–23). In chapter 2, we provide an overview of all SNAREs that are involved 
in fusion events during phagosome and endosome maturation. We found that of the 38 SNARE 
proteins present in human, 30 have been described to locate at endosomes and phagosomes 
where they mediate trafficking to other endosomes, lysosomes, the plasma membrane, the Golgi 
apparatus and autophagosomes.
In chapter 3, we identified the SNAREs that are involved in gp91phox trafficking to the phagosomal 
membrane. We also investigated the source compartment of gp91phox in unstimulated cells. We 
found that, during phagocytosis, gp91phox is recruited to the phagosomal membrane from the 
plasma membrane together with the phagocytosed antigen. The production of ROS results in auto-
oxidation of gp91phox and triggers the removal of plasma membrane-originated gp91phox. In order 
to maintain sustained ROS production, gp91phox is replenished from lysosomal compartments to 
the phagosomal membrane. This trafficking is mediated by the formation of a SNARE complex 
composed of VAMP8, SNAP23 and syntaxin-7. 
In chapter 4 the mechanisms mediating the removal of oxidized gp91phox from the phagosomal 
membrane are investigated. We found that oxidation of gp91phox can be inhibited with a ROS 
scavenger. Moreover, we found that gp91phox gets ubiquitinated by ROS, and is finally removed 
from the phagosome via a mechanism involving the autophagy-related proteins p62 and ATG12. 
This activation of autophagy-related proteins results in the recruitment of LC3 to the phagosomal 
membrane. Furthermore, super-resolution STED microscopy data supports a mechanism 
by which the oxidized gp91phox is selectively removed from phagosomal membranes in an 
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autophagy-related mechanism. Here, the ESCRT-III protein CHMP1B is involved in the emanation 
of membrane structures containing gp91phox from the phagosomal membrane.
In chapter 5, we studied how NOX2 promotes the translocation of antigen into the cytosol. 
Although it is well understood how NOX2-produced ROS inhibit the degradation of antigen 
proteins by lysosomal proteases, it was unknown how it promoted the translocation of antigen. 
We found that ROS produced by NOX2 trigger the oxidation of lipids of the endosomal membrane. 
This results in membrane disruption and thereby the antigen can translocate into the cytosol and 
become accessible for proteasomal degradation. This eventually promotes the cross-presentation 
to CD8+ cytotoxic T cells. 
In chapter 6, we further investigated the involvement of VAMP8 in NOX2-mediated antigen 
translocation to the cytosol. We found that VAMP8-mediated NOX2 recruitment to endo/
phagosomes promotes lipid peroxidation of endosomal and phagosomal membranes. Thereby, 
VAMP8 mediates the translocation of antigen from the endosomal and phagosomal lumens into 
the cytosol promoting antigen cross-presentation. We also assessed whether VAMP8 would be 
involved in other trafficking pathways necessary for antigen cross-presentation. However, our 
data showed that the recruitment of MHC class I and TAP, two protein complexes with known 
roles in antigen cross-presentation (8, 22), were not changed upon knockdown of VAMP8 in 
dendritic cells.
In chapter 7 the results of this thesis are discussed and related to findings in literature. A personal 
view of the major open questions in the fields of NOX2 and antigen presentation is provided and 
the most important directions for future research are discussed. Finally, the findings from this 
thesis are recapitulated in a new model explaining how NOX2 and autophagy could promote both 
the cytosolic and vacuolar pathway of antigen cross-presentation.
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Abstract
The soluble N-ethylmaleimide sensitive factor attachment protein receptor (SNARE) protein family 
is of vital importance for organelle communication. The complexing of cognate SNARE members 
present in both the donor and target organellar membranes drives the membrane fusion required 
for intracellular transport. In the endocytic route, SNARE proteins mediate trafficking between 
endosomes and phagosomes with other endosomes, lysosomes, the Golgi apparatus, the 
plasma membrane, and the endoplasmic reticulum. The goal of this review is to provide an 
overview of the SNAREs involved in endosomal and phagosomal trafficking. Of the 38 SNAREs 
present in humans, 30 have been identified at endosomes and/or phagosomes. Many of these 
SNAREs are targeted by viruses and intracellular pathogens, which thereby reroute intracellular 
transport for gaining access to nutrients, preventing their degradation, and avoiding their detection 
by the immune system. A fascinating picture is emerging of a complex transport network with 
multiple SNAREs being involved in consecutive trafficking routes.
Introduction
Eukaryotic cells rely on the ingestion of foreign material by endocytosis and phagocytosis, as this 
is required for the uptake of nutrients, the clearance of infections, and the removal of apoptotic 
and necrotic cells from the body (1). Solutes and small particles (<1 µm sized) are taken up by 
a process called endocytosis, whereas larger particles (>1 µm), such as microbial pathogens 
or tumor cells, are ingested by phagocytosis. There are many pathways for endocytosis and 
phagocytosis that depend on the cell type and the receptors engaged, and differ in the uptake 
machinery, downstream signalling, and processing of the ingested material within the cell (1). 
Endocytosis often (but not always) relies on specific cage proteins, most notably clathrin and 
caveolin, whereas phagocytosis is dependent on the formation of the F-actin cytoskeleton for 
particle engulfment (2). Moreover, phagocytosis can be accompanied by fusion of vesicles at 
the plasma membrane site of uptake, and this allows growing of the nascent phagosome and 
serves to compensate for the loss of plasma membrane surface area. After uptake, endosomes 
and phagosomes undergo a transition process called maturation, where early endosomes and 
phagosomes first convert into late endo/phagosomes and then into acidic lysosomes for the 
degradation of the ingested cargo (1, 3–5). The maturation of endosomes and phagosomes 
is mechanistically similar (4, 6) and driven by vesicular transport between early and late endo/
phagosomes, lysosomes, the plasma membrane, the Golgi apparatus, and recycling endosomes. 
Recycling endosomes are dynamic and heterogeneous compartments that function as a sorting 
station, where proteins and lipids are recycled back to the plasma membrane or routed to late 
endosomes and eventually to lysosomes for degradation (3, 7). In addition to this degradation of 
internalized material, both early and late endosomes have important roles in the biogenesis and 
recycling of specialised secretory granules and vesicles, such as synaptic vesicles in neurons (3, 
8, 9). Moreover, both late endosomes and lysosomes can fuse with autophagosomes, leading 
to the formation of amphisomes and autolysosomes, respectively, and this is necessary for the 
degradation of autophagosomal cargo (10–12). Finally, the endoplasmic reticulum (ER) and the 
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ER-Golgi intermediate compartment (ERGIC) might contribute to phagosome formation via direct 
vesicular trafficking between ER/ERGIC and (nascent) phagosomes (13–16), although this is 
controversial (17–19). 
Stx1A
Stx1B
HPC-1
P35B
×
×
Q
a
288
288
Stx2 Epimorphin × 288
Stx3
Stx4 NY-REN-31
×
×
289
297
Stx5 × 355
Stx7
Stx11
×
×
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287
Stx12 Stx13 × 276
Stx16
Stx17
×
×
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302
Stx18 GIG9 335
Stx19 Stx9 - 294
TSNARE1 Stx20 - 513
GosR1
GosR2
Gos28, GS28
Membrin, GS27
×
-
250
212
Sec20 Bcl2, Trg8, Bnip1, Nip1 - 228
Vti1A
Vti1B
Vti-rp2
Vti-rp1
×
×
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232
Bet1 p18 - 118
Bet1L
Stx6
Gs15, Hspc197 -
×
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Stx8 × 236
Stx10
Use1 Slt1, p31, D12
×
×
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SNAP23 Syndet × 211
Q
b
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c
SNAP25 × 206
SNAP29 Ubisnap × 258
SNAP47 SVAP1 - 464
Sec22b Ers24 × 215
VAMP1 Synaptobrevin-1 × 118
VAMP2 Synaptobrevin-2 × 116
VAMP3 Cellubrevin × 100
VAMP4 × 141
VAMP5 Myobrevin - 116
VAMP7 TI-VAMP × 220
VAMP8 Endobrevin × 100
Q
b
c
Ykt6 × 198
R
1
SNARE Aliases
2
E/P
3
Domain organization
Qc-motif
Qb-motif
R-motif
Longin
Habc
TMH
Qa-motif
Lipidation
×
^ Table 1: Domain topology of human SNAREs. 1 Missing in the table are amisyn (STXB6), tomosyn-1 (STXBP5), and 
tomosyn-2 (STXBP5L) that all contain an R-SNARE motif, but are considered incapable of fusing membranes (26, 338, 
339). 2 An × indicates that the SNARE has been reported to locate at endosomes and/or phagosomes as discussed in this 
review. 3 Domain topology of the SNAREs showing the Qa-SNARE motif (red), Qb-motif (dark green), Qc-motif (light green), 
R-motif (blue), transmembrane helix (TMH; brown), Habc-domain (purple), Longin domain (cyan), and lipidation sites (pink). 
The number of residues is indicated.
24
Chapter 2
2
The identity of organelles is determined by the presence of specific Rab-GTPases, soluble NSF 
attachment protein receptor (SNARE) proteins, and phosphoinositide lipids (1, 3–5, 20). Rab-
GTPases, SNAREs and phosphoinositides interact with large multi-subunit tethering complexes, 
such as the homotypic fusion and vacuole protein sorting (HOPS) and class C core vacuole/
endosome tethering (CORVET) complexes, that bridge opposing membranes (9, 20–25). SNARE 
proteins are the central catalysts of intracellular membrane fusion and are involved in nearly all 
organellar trafficking steps, except mitochondrial fusion (26, 27). The human SNARE family 
consists of 38 known members (Table 1) and is conserved from yeast (Table 2). The fusion of 
membranes starts with the complexing of cognate sets of SNARE proteins present in both the 
target and acceptor membranes. Together, these contribute four different SNARE-motifs to a so-
called trans-SNARE-complex (Fig. 1). This complex ‘zippers up’ from the N- to the C-terminal end 
of the SNARE-motifs forming a four α-helical coiled-coil bundle called a cis-SNARE-complex. This 
trans to cis conformation change brings the two opposing fusing membranes in close apposition 
and provides sufficient energy to drive membrane fusion (28). SNARE proteins are classified 
according to the central residue in their SNARE-motifs into R- (from arginine) and Q- (glutamine) 
SNAREs. A SNARE-complex requires one R-SNARE and three Q-SNARE-motifs, called Qa-, 
Qb- and Qc-SNAREs (Fig. 2). Although members of the SNARE family often have overlapping 
functions and are involved in multiple organellar trafficking pathways, SNARE proteins contribute 
to the specificity of organellar trafficking as they preferentially complex with their cognate binding 
partners and different trafficking steps are catalyzed by specific sets of SNARE proteins (26, 27, 
Yeast Human
1
Identity
2
E-value
3
Pep12p Stx2 31% 8 × 10
-14
Sed5p Stx5 32% 7 × 10
-33
Sso1p Stx1A 29% 1 × 10
-22
Sso2p Stx1A 30% 4 × 10
-25
Tlg2p Stx16 26% 5 × 10
-17
Ufe1p Stx18 27% 2.4 × 10
-1
Vam3p Stx7 27% 1 × 10
-7
Bos1p GosR2 25%
Gos1p GosR1 26% 8 × 10
-18
Sec20p Sec20 16% 2 × 10
-4
Vti1p Vti1A 32% 4 × 10
-25
Sec9p SNAP23 28% 1 × 10
-6
Spo20p SNAP23 23% 3.8 × 10
-1
Bet1p Bet1 24% 5 × 10
-7
Sft1p Bet1 27% 4 × 10
-4
Syx8p Stx8 28% 4
Tlg1p Stx10 24% 3.2 × 10
-1
Use1p Use1 24% 1 × 10
-3
Vam7p Stx6 27% 2 × 10
-1
Nyv1p VAMP1 28% 9 × 10
-8
Sec22p Sec22b 38% 4 × 10
-48
Snc1p VAMP2 38% 6 × 10
-14
Snc2p VAMP2 36% 2 × 10
-12
Ykt6p Ykt6 47% 2 × 10
-62
Q
a
Q
b
Q
b
c
Q
c
R
4.7 × 10
-2
< Table 2: Yeast SNAREs with closest human 
SNARE orthologs.
1 Closest human SNARE ortholog predicted by 
protein sequence alignment with PSI-BLAST.
2 Percentage protein sequence identity. A higher 
value indicates stronger homology.
3 Expect value from BLAST. A lower value indicates 
stronger homology.
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2^ Fig. 1: Scheme of membrane fusion by SNARE complexes. Cognate R- (blue), Qa- (red), Qb- (dark green), and Qc- (light green) SNARE proteins engage with the N-terminal ends of their SNARE-motifs, and form an α-helical coiled-coil 
SNARE-helix. A single SNARE complex suffi ces for membrane fusion (344), although multiple complexes may result in faster 
fusion dynamics (345). In the scheme, the R-SNARE is present in the upper and the Q-SNAREs in the lower compartment, 
but this does not necessarily have to be the case and other distributions can also lead to membrane fusion (326). 
29–31). After completion of membrane fusion, the individual SNARE molecules are released from 
the cis-SNARE complex by the triple-A ATPase N-ethylmaleimide sensitive factor (NSF) (reviews: 
(32, 33)). NSF is recruited to the cis-SNARE complex by the adaptor soluble NSF-attachment 
protein α (αSNAP), although in endosomal traffi cking this function can also be performed by its 
homolog γSNAP (34).
A B C D E
^ Fig. 2: Structures of SNARE proteins. A) Crystal structure of the neuronal SNARE complex consisting of VAMP2 
(R-SNARE; blue), Stx1A (Qa-SNARE; red) and SNAP25 (Qbc-SNARE; Qb-motif: dark green; Qc-motif: light green) (protein 
database (PDB) accession number 3IPD (346)). Brown: transmembrane helices. Pink: palmitoylation of SNAP25. Not shown 
is the N-terminal Habc-domain of Stx1 (see panels C–D). The shaded gray area depicts the position of the membrane. B) 
Crystal structure of an endosomal SNARE complex consisting of VAMP4 (R; blue), Stx12 (Qa; red), Vti1a (Qb; dark green) 
and Stx6 (Qc; light green) (PDB accession number 2NPS (326)). Not shown are the N-terminal regulatory domain of VAMP4 
and the N-terminal Habc-domains of Stx12, Vti1a and Stx6. C) Crystal structure of Stx1A with its Habc-domain (purple) 
interacting with its Qa-SNARE-motif (red; PDB accession number 4JEH (347)). D) Crystal structure of the Habc-domain 
of Vti1b (Qb; purple) which does not interact with its SNARE-motif (121) (PDB accession number 2QYW (182)). E) Crystal 
structure of VAMP7 (R) with its longin domain (cyan) interacting with the N-terminal end of its SNARE motif (blue; PDB 
accession number 4B93 (348)).
The goal of this review is to provide an in-depth overview of the mammalian SNAREs involved 
in endosomal and phagosomal transport. From numerous studies employing subcellular 
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fractionation combined with western blot or proteomics analysis, as well as from microscopy of 
immunolabeled or overexpressed SNARE proteins, by far most of the members of the SNARE 
family have currently been identified at endosomes and/or phagosomes (30 out of 38; Table 
1). Many of these SNAREs are targeted by viruses and intracellular pathogens, which thereby 
actively delay endo/phagosomal maturation or reroute intracellular trafficking to gain access to 
nutrients, avoid their degradation in lysosomes, and avert recognition by the immune system (1, 
5, 35–38). Moreover, mutations in genes coding for SNAREs or their regulating proteins can lead 
to disease (30, 39–41). In the next sections, we discuss the roles of each SNARE identified at 
endosomal and phagosomal membranes, and their roles in disease. 
Qa-SNAREs
Stx1A and Stx1B
The Qa-SNARE syntaxin-1 (Stx1) is one of the most studied SNARE proteins, as it forms the 
plasmalemmal Q-SNARE complex together with synaptosomal-associated protein 25 (SNAP25) 
(Qbc) for the release of neurotransmitter-containing synaptic vesicles, mainly by complexing 
with vesicle-associated membrane protein 2 (VAMP2; R) (26, 27, 42, 43). It is present in two 
84% identical isoforms from gene duplication, Stx1A and Stx1B, that have a similar function in 
neurotransmitter release. Because of compensation by Stx1B, Stx1A knockout mice develop 
normally with only mild neurological disorders caused by impaired synaptic plasticity (44). 
In contrast, Stx1A cannot sufficiently compensate for lack of Stx1B, as Stx1B knockout mice 
die within several weeks from neurological disorders (44, 45). Stx1A also has secretory roles 
outside the neurological system, for instance in secretion of the hormone glucagon-like peptide 
1 from intestinal enteroendocrine L cells (46). Both Stx1 isoforms have the hallmark topology of 
the syntaxin sub-family of SNAREs, and contain a short N-terminal regulatory peptide followed 
by a regulatory Habc-domain connected to the SNARE-motif via a linker and a C-terminal 
transmembrane helix (Table 1). The Habc-domain can fold back onto the SNARE-motif and this 
prevents its engagement in a SNARE complex, thereby auto-inhibiting membrane fusion (Fig. 2) 
(47). Regulation of Stx1 is well-understood, and is mediated by binding to numerous regulatory 
proteins, including the Sec1/Munc18-like (S/M) protein syntaxin-binding protein 1 (STXBP1; 
Munc18a), complexin, and the calcium-sensor synaptotagmin-1, as reviewed elsewhere (42, 43). 
Like all other exocytic SNAREs (see below), Stx1A and/or B are found at endosomes (48), and, 
at least in a Drosophila macrophage cell line, the single fly isoform of Stx1 has been found by 
proteomics at phagosomes (49). The functional roles of endosomal and phagosomal Stx1 are 
unclear, and it might play a role in the transport of Stx1 to the plasma membranes or in the 
routing of unneeded Stx1 to lysosomes for degradation. At the plasma membrane, Stx1 and 
other SNAREs are not randomly distributed, but are clustered in discrete sub-micrometer sized 
membrane domains that have well-understood roles in vesicle tethering, defining the sites of 
secretion, and regulating membrane fusion (review: (50)). Similarly, endocytic trafficking of Stx1 
might also be facilitated by its localization in membrane domains, as super-resolution microscopy 
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revealed clustering of Stx1 in endosomal membranes (51). 
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Vti1a
GosR1
Stx17
Stx16
Stx12
Stx11
Stx7
Stx5
Stx4
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SNARE type
Qa
Qb
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Qbc
R
=
=
=
=
=
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^ Table 3: SNAREs identified at early and late phagosomes by quantitative proteomics.
For each quantitative proteomics study and for each SNARE, all conditions were compared to the condition with the 
maximum abundance. The intensity of the colour indicates the relative abundance of the SNAREs at early and late 
phagosomes. The ‘Change’ indicates whether most studies report that a SNARE is present at higher (↑), lower (↓), or similar 
(=) levels at late (>60 min after uptake) compared to early (<30 min) phagosomes. 
[1] Reference (19); phagosomes with IgG-opsonized 0.8 µm-sized latex beads for 10–30 min (early) and 60–120 min (late) 
purified from RAW264.7 macrophages.
[2] Reference (341); endosomes with 100 nm-sized latex beads for 15 min (early) and 60 min (late) purified from J774 
macrophages.
[3] Reference (342); phagosomes with 0.8 µm-sized latex beads for 15 min (early) and 60 min (late) purified from J774 
macrophages.
[4] Reference (323); phagosomes with 0.8 µm-sized latex beads for 30 min (early) and 270 min (late) from J774 macrophages.
[5–11] Reference (343); phagosomes with 0.8 µm-sized latex beads for 30 min (early) and 180 min (late) from mouse bone-
marrow derived macrophages. Beads were coated with avidin alone [5], or with avidin coupled to the apoptotic marker 
calreticulin [6], complement cleavage fragment iC3b [7], Fc-antibody region [8], lipopolysaccharide [9], mannan [10], or 
posphatidylserine [11].
Stx2
The exocytic Qa-SNARE Stx2 is required for epithelial morphogenesis and Stx2 knock-out mice 
are male sterile due to defective spermatogenesis (52). Although Stx2 predominantly locates 
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at the cell membrane, it is also present at intracellular compartments (53), including early/
recycling endosomes (54) and phagosomes (by proteomics (Table 3) and western blot (55)). 
Most quantitative proteomics studies report a decreased phagosomal presence of Stx2 at later 
time points after antigen uptake (>60 min) compared to earlier time points (<30 min; Table 3). Like 
Stx1, it is unknown whether Stx2 has endosomal and/or phagosomal trafficking roles or is merely 
a bystander that is taken up during invagination of the plasma membrane. 
Stx3
The Qa-SNARE Stx3 is essential (56) and its abolishment leads to defects in secretion (53, 57) 
and endosomal trafficking (58). Stx3 is present at the plasma membrane (53, 55, 59–61) and at 
various intracellular compartments (54, 60, 62–64). Stx3 locates at phagosomes, as shown by 
western blot, microscopy (16, 55), and proteomics ((65–67) and Table 3). Stx3 can interact with 
various R-SNAREs, including VAMP3 for fusion events at the plasma membrane and VAMP8 for 
intracellular fusion events (62). Plasmalemmal and intracellular pools of Stx3 also interact with 
VAMP7, and this facilitates the secretion and biogenesis of lysosomes and lysosome-related 
organelles (58, 68, 69). In epithelial cells, Stx3 regulates apical secretion by forming a Q-SNARE 
acceptor complex with SNAP23 (Qbc) (70–72), where it cycles via Rab11a-recycling endosomes 
(73) in a manner regulated by mono-ubiquitination of Stx3 (63). In addition, Stx3 is regulated by 
interactions of its Habc-domain with the S/M-protein Munc-18b (STXBP2) (74) and with the ERM 
protein ezrin (64). Endocytic trafficking of Stx3 is targeted by human cytomegalovirus (HCMV), as 
plasmalemmal Stx3 is required for virus assembly (58) and its downregulation by viral micro-RNAs 
likely aids in immune evasion (75).
Stx4
The essential Qa-SNARE Stx4 is highly studied as it is required for many other exocytic pathways 
(59, 60, 62, 72, 76, 77), such as insulin-stimulated delivery of the glucose transporter GLUT4 to 
the plasma membrane in adipocytes (74). Moreover, Stx4 is the basolateral counterpart of the 
apical Stx3 in epithelial cells (70). Although most Stx4 localizes at the plasma membrane (53, 59, 
77–79), intracellular pools of Stx4 are reported in various cell types (54, 80–82). Stx4 is found 
at early and recycling endosomes (83) and at phagosomes (16, 55, 84, 85), with quantitative 
proteomics revealing a decreased presence of Stx4 at phagosomes over time of uptake (Table 
3). Stx4 is clustered at the plasma membrane site of phagocytosis where it mediates the polarized 
delivery of VAMP3 (R) positive early/recycling endosomes to facilitate phagosome formation (86). 
Except for exocytosis, other trafficking roles of Stx4 are unknown, and although it was proposed 
to mediate trafficking from the ERGIC to phagosomes by pairing with Sec22b (R) (16), direct 
evidence for this is lacking.
Endocytic trafficking of Stx4 is regulated by interactions with the GTP-bound form of the early 
endosomal small GTPase Rab5 (35) and with the S/M-protein Vps45, which in turn interacts with 
the Rab5 effector rabenosyn-5 (87). Stx4 is further regulated by interactions with the S/M-protein 
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Munc18c (STXBP3) (74, 88), the F-actin cytoskeleton (83, 89, 90), the coiled-coil protein α-taxilin 
(81), and the calcium-sensor synaptotagmin-7 (91). Stx4 is targeted by mycobacterial parasites that 
retain Stx4 at their intracellular habitat (35, 92). This prolonged presence of Stx4 at mycobacterial 
phagosomes promotes fusion with early endosomes and results in a maturation arrest that allows 
the intracellular pathogen to avert its degradation (92). Moreover, Stx4 is essential for the release 
of hepatitis C virus (HCV) via exocytosis of multivesicular bodies, and HCV-infected cells possess 
increased levels of Stx4 and reduced levels of α-taxilin (81).
Stx5
The essential (56) Qa-SNARE Stx5 has well-understood roles in ER-Golgi trafficking (93). Stx5 
is present in two isoforms that arise from two alternative starting methionines (94). Whereas the 
short isoform of Stx5 predominantly localizes at the Golgi apparatus (95–97), the long isoform 
contains an ER-retention signal and is mainly located at the ER (94, 98, 99). Stx5 is responsible 
for both antero- and retrograde intra-Golgi transport by pairing with GosR2 (Qb), Bet1 (Qc), and 
Sec22b (R) or GosR1 (Qb), Bet1L (Qc), and Ykt6 (R), respectively (26, 93). The latter Stx5–
GosR1–Bet1L–Ykt6 SNARE complex also mediates retrograde trafficking from early/recycling 
endosomes to the Golgi complex (100, 101), although this trafficking may also be mediated by 
a Stx6–Stx16–Vti1a–VAMP4 SNARE complex (102). Stx5 has been found at phagosomes by 
proteomics (reference (66) and Table 3), where, given the role of Stx5 in Golgi trafficking, it seems 
possible that it mediates trafficking from phagosomes to the trans-Golgi network for recycling of 
Golgi components. The N-terminus of Stx5 binds to the S/M-protein Sly1 and interacts with the 
conserved oligomeric Golgi (COG) complex, a multi-subunit tethering complex that regulates 
retrograde Golgi transport (93, 103). In addition to its role in Golgi trafficking, Stx5 is required for 
formation of lipid droplets, which are storage compartments of excess fats, together with SNAP23 
(Qbc) and VAMP4 (R) (104). 
Stx5 plays a role in infectious disease as it is recruited to the cytoplasmic viral assembly 
compartment of HCMV where it promotes the efficient production of infectious virus (105). 
Moreover, retrograde trafficking to the trans-Golgi by Stx5 is required for adeno-associated virus 
transduction (106). Finally, Stx5 is recruited to vacuoles containing the intracellular pathogen 
Leishmania and is essential for the development of this compartment (97).
Stx7
The Qa-SNARE Stx7 mainly locates at late endosomes and lysosomes (54, 107–110), but is also 
found at early and recycling endosomes (54, 96, 111, 112) and the plasma membrane (96, 113). 
In addition, Stx7 locates at phagosomes as found by imaging (108, 114), western blot (84), and 
proteomics (49, 65, 66, 85, 115). Although Stx7 can be recruited to phagosomes in multiple 
phases (19), several studies showed a rapid increase in phagosomal Stx7 over time after uptake 
((108, 114) and Table 3). Stx7 mediates homotypic fusion of late endosomes by forming a complex 
with Vti1b (Qb), Stx8 (Qc) and VAMP8 (R) (107, 116, 117) and the structure of this SNARE-bundle 
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has been solved by x-ray crystallography (118) (Fig. 2). The Stx7–Vti1b–Stx8 SNARE complex with 
VAMP7 (R) instead of VAMP8 mediates fusion of late endosomes with lysosomes and homotypic 
fusion of lysosomes (117, 119). Stx7 also mediates fusion of lysosomes with phagosomes (110, 
114) and plays a role in trafficking from the trans-Golgi network to endosomes (120).
Stx7 is involved in the selection of cargo proteins for vesicular transport by direct interactions, as 
shown for the chloride channel cystic fibrosis transmembrane conductance regulator (CFTR) in 
epithelial cells (111), and by indirect interactions via the epsin N-terminal homology domain protein 
EpsinR, which is a cargo adaptor involved in Golgi-endosome transport (120). The regulation of 
the activity and subcellular localization of Stx7 are well-characterized. Similar to Stx1 and Stx4, 
the Habc-domain of Stx7 can prevent SNARE complex formation by folding back on its SNARE 
region (121). Cycling of Stx7 between endosomes and the plasma membrane is regulated by a 
dileucine-based internalisation motif located at its cytoplasmic domain (96). Stx7 is also regulated 
by various post-translational modifications: Stx7 is palmitoylated on a cysteine at the cytoplasmic 
face of the transmembrane domain, and this is important for its internalisation at the plasma 
membrane (113). Stx7 can be phosphorylated by the kinase colony-stimulating factor 1 (CSF1) 
and this phosphorylation promotes formation of the Stx7–Vti1b–Stx8–VAMP8 SNARE complex 
(122). This complex is stabilized by interactions with the calcium-sensor protein unc-13 homolog D 
(Munc13-4; UNC13D) (123), which locates together with Stx7 at lysosomes and lysosome-related 
organelles (124).
Stx7 further interacts with the HOPS and CORVET tethering complexes (125) and with the 
positive regulator of these complexes UV radiation resistance-associated gene (UVRAG) (126). 
These interactions are hijacked by various negative strand RNA viruses, such as influenza A and 
vesicular stomatitis virus (VSV), that thereby facilitate viral entry and propagation by promoting 
assembly of the Stx7–Vti1b–Stx8 SNARE complex and recruitment of VAMP8 endosomes to 
virus-containing endosomes (126). Stx7-mediated trafficking pathways are also targeted by the 
intracellular pathogen Helicobacter pylori, resulting in the formation of an hybrid late endosomal-
lysosomal vacuole supporting bacterial survival (127). 
Stx11
The Qa-SNARE Stx11 lacks the typical C-terminal transmembrane domain present in most other 
SNAREs (Table 1), but, similar to Ykt6 (and possibly Stx19), it is anchored to membranes by lipids 
covalently attached to cysteines located near its C-terminus (128, 129). Stx11 is located at the 
plasma membrane, early/recycling endosomes, late endosomes, lysosomes, and the trans-Golgi 
network (128–131), and has been identified at mostly early phagosomes by proteomics (Table 3). 
Stx11 is strongly expressed by immune cells (132) and genetic mutations of Stx11 are the cause 
of the autosomal recessive disorder familial hemophagocytic lymphohistiocytosis type-4 (FHL-4). 
FHL-4 patients (and Stx11 knockout mice) display immune dysregulation and high blood levels 
of inflammatory cytokines (30). These symptoms are caused by secretory defects, as Stx11 is 
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required for exocytosis in many immune cells, including cytolytic T cells, natural killer (NK) cells, 
and platelets (131, 133–135). Exocytosis is mediated by formation of a Stx11–SNAP23–VAMP8 
complex and this is regulated by binding to the S/M-protein Munc18b (134, 135). Stx11 also has 
intracellular trafficking roles, as it regulates transport from late endosomes to lysosomes (128). 
Here, Stx11 can act as a non-fusogenic SNARE that interacts with Vti1b (Qb), but does not result 
in membrane fusion. This negatively regulates the availability of Vti1b to pair with other SNAREs 
(128). In line with such a role for Stx11 as a negative regulator of membrane fusion, silencing of 
Stx11 in macrophages led to increased phagocytosis and TNFα secretion while overexpression 
resulted in the opposite effect (130), although this was not observed in a later study (133). 
Stx12
Stx12 (called Stx13 in rat) is located at early and recycling endosomes and cycles via the plasma 
membrane (48, 54, 107, 108, 110, 112), although it is also found at the Golgi apparatus (54) 
and autophagophores (the precursors of autophagosomes) (136). Super-resolution stimulated 
emission depletion (STED) microscopy revealed that Stx12 can organize in membrane domains 
at endosomal membranes (51). Stx12 also locates at phagosomes (65, 66, 84, 85, 108, 114, 
115, 137), and, although one study showed that Stx12 was rapidly cleared from phagosomes 
after uptake (108), most studies report no or only a slow clearance of Stx12 from phagosomes 
((84, 114, 137) and Table 3). Stx12 has well-characterized, but apparently non-essential (87, 138), 
trafficking roles. It mediates the homotypic fusion of early endosomes by complexing with Vti1a 
(Qb), Stx6 (Qc) and VAMP4 (R) (48, 139–141). The complexing of Stx12 with Vti1a is also involved 
in homotypic fusion of autophagophores to form autophagosomes (136). In addition, Stx12 
mediates transport from early and recycling endosomes to the plasma membrane, in a manner 
regulated by the protein hepatocyte growth factor-regulated tyrosine kinase substrate Hgs (also 
called Hrs) (140, 142). Finally, Stx12 has cell-type specific roles in the recycling and biogenesis 
of secretory compartments, such as neurotransmitter vesicles and melanosomes (143, 144). 
Endosomal localization and activity of Stx12 is regulated by interactions with adapter protein 3 
(AP3) (144), early endosomal antigen 1 (EEA1) (139, 141), and, at least in Caenorhabditis elegans, 
with the S/M-protein Vps45 (87). 
Stx16
The Qa-SNARE Stx16 locates at the Golgi apparatus (54, 145–147) and in membrane domains 
(51) at recycling endosomes (48, 145). Stx16 has also been detected at phagosomes by 
proteomics ((66) and Table 3), but it does not seem to be enriched here (148). Although Stx16 
is required for structural integrity of the Golgi apparatus (149), its role is apparently not essential 
as Stx16 knockout mice display only minor phenotypic abnormalities (56, 150). Stx16 mediates 
retrograde trafficking from late endosomes to the Golgi by Rab9-dependent complexing with 
Vti1a (Qb), Stx10 (Qc) and VAMP3 (R) (102, 151). In contrast, Rab6A and Rab11-dependent (102, 
151) transport from early/recycling endosomes to the Golgi apparatus is mediated by complexing 
of Stx16 with Vti1a (Qb), Stx6 (Qc) and VAMP3 or VAMP4 (R) (100–102, 146, 152, 153). Endosome 
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to Golgi transport is further regulated by interactions of Stx16 with the tethering protein Golgi-
associated retrograde transport protein (GARP) (147), the putative tethering protein GCC185 (151), 
and the S/M-protein Vps45 (87, 154). Finally, at least in Drosophila, Stx16 interacts with the S/M-
protein Vps33, a component of the HOPS and CORVET tethering complexes (155). 
Stx17
The C-terminal region of the Qa-SNARE Stx17 consists of two relatively short hydrophobic 
domains and a glycine zipper that can form a hairpin-type structure for insertion of free (non-
membrane bound) Stx17 into membranes (26). Although Stx17 plays a role in ER-Golgi transport 
and knockdown of Stx17 causes fragmentation of the Golgi complex (11, 156), it is especially 
well-studied in autophagy. Stx17 is required for the degradation of autophagosomal cargo (11, 
157–159) and its insertion in autophagosomes allows for the fusion with lysosomes (reviews: (12, 
160–162)). Several proteomics studies identified Stx17 at phagosomes (Table 3), and, although still 
unclear, the insertion of Stx17 in phagosomal membranes might be important for the degradation 
of phagosomal cargo by autophagy-related processes. Insertion of Stx17 in autophagosomal 
membranes requires lysosome-associated membrane protein 2 (LAMP2) (163) and this insertion 
is regulated by the N-terminal regulatory domain of Stx17 (164). Autophagosome-lysosome fusion 
is the result of a SNARE complex composed of Stx17, SNAP29 (Qbc) and VAMP8 (R) (11, 165). 
The Stx17–SNAP29 Q-SNARE acceptor complex is stabilized on autophagosomes by binding 
of Stx17 to the Beclin-1-associated autophagy-related key regulator ATG14 (166), although this 
interaction may also play a role already upstream in autophagosome formation (159, 167). In 
Drosophila, Stx17 interacts with the HOPS tethering complex which, in addition to endosomal 
maturation, regulates the fusion of lysosomes with autophagosomes (168). Enterovirus A71 
exploits this pathway to facilitate its replication, as the non-structural viral protein 2BC promotes 
autolysosome formation by interacting with Stx17 and SNAP29 (169). In contrast, the intracellular 
pathogen Legionella suppresses this pathway by secreting a serine protease that cleaves Stx17, 
and thereby prevents its degradation by autophagy (170). 
Stx18
Stx18 is an essential Qa-SNARE (56) with well-known roles in ER transport, but western blot 
and microscopy revealed that it also locates at phagosomes (15). Although controversial (17–
19), Stx18 is proposed to promote phagocytosis by mediating fusion of ER-derived vesicles to 
nascent phagosomes (13–16, 171) by complexing with Use1 (Qc) and/or a plasmalemmal Qa-
SNARE (which would result in a complex with two Qa-SNAREs) (15, 172). The availability of Stx18 
for phagocytosis is proposed to be negatively regulated by the R-SNARE Sec22b, which might 
sequester Stx18 by forming a non-fusogenic SNARE complex (172).
Qb-SNAREs
GosR1
The Qb-SNARE GosR1 mediates retrograde trafficking from early and recycling endosomes to 
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the trans-Golgi network by complexing with Stx5 (Qa), Bet1L (Qc) and Ykt6 (R) (100). GosR1 
potentially could have a similar role in phagosome to Golgi transport, as it is found on phagosomes 
by proteomics ((49) and Table 3).
Vti1a
The Qb-SNARE Vti1a, which is weakly homologous to Vti1b (28% sequence identity), locates at 
the Golgi network (173, 174) and endosomes (48). Vti1a also locates at phagosomes (65, 66, 175), 
with quantitative proteomics showing a decreased phagosomal presence over time of uptake 
(Table 3). Although Vti1a knockout mice are viable (176), they show behavioural, metabolic and 
growth defects (56). Vti1a not only plays a role in Golgi trafficking, with depletion of Vti1a resulting 
in a disruption of the ribbon structure of the Golgi apparatus (149), but can also act as a negative 
regulator of phagocytosis (175). Vti1a mediates retrograde trafficking from late endosomes to the 
trans-Golgi network by complexing with Stx16 (Qa), Stx10 (Qc), and VAMP3 (R) and trafficking 
from early/recycling endosomes with Stx16, Stx6 (Qc), and VAMP4 (R) (102, 151, 174, 177). 
Assembly of this latter Vti1a–Stx16–Stx6–VAMP4 SNARE complex is mediated by the GARP 
tethering complex (147). The intracellular pathogen Coxiella burnetii hijacks retrograde endosome-
Golgi trafficking by actively recruiting Vti1a to its vacuolar habitat thereby facilitating the interaction 
with endosomes (178). In addition to retrograde endosome-Golgi trafficking, Vti1a also mediates 
anterograde trafficking (173) by complexing with VAMP7 (R) (179) and autophagosome formation 
by pairing with Stx12 (Qa) (136). Finally, neurons and neuroendocrine cells express a splice variant 
of Vti1a, called Vti1a-β, that contains an insertion of seven amino acids next to its SNARE-motif 
(180). This isoform mediates homotypic fusion of early endosomes (with Stx12, Stx6, and VAMP4) 
(48) and is involved in the recycling of neurotransmitter vesicles (143, 174, 180, 181). 
Vti1b
The Qb-SNARE Vti1b localizes at the Golgi apparatus, late endosomes, lysosomes (48, 54, 109, 
110, 128, 174, 182, 183), and less at early endosomes (111, 182). Vti1b is also found at phagosomes 
(65, 66, 175) where, opposite to Vti1a, it becomes more abundant during phagosomal maturation 
((114) and Table 3). Although Vti1b-deficient mice are viable and fertile, they are smaller than wild-
type mice and display minor trafficking defects such as delayed lysosomal degradation (184). In 
contrast, mice lacking both Vti1a and Vti1b (but not the single knockouts) display severe neuronal 
defects, suggesting that these Qb-SNAREs can substitute for each other (176). Vti1b mediates 
fusion of late endosomes with other endosomes and lysosomes by complexing with Stx7 (Qa), 
Stx8 (Qc), and VAMP7 or VAMP8 (R) (116, 117). These SNARE complexes with Stx6 (Qc) instead 
of Stx8 can mediate biogenesis of lysosome-related organelles, such as melanosomes (185). 
Vti1b also has roles in Golgi-endosome trafficking (with Stx7, Stx6, and VAMP3 (R)) (86, 186) and 
is required for the fusion of autophagosomes with lysosomes (187) that mediates degradation of 
intracellular pathogens (188). Finally, Vti1b is proposed to have a non-fusogenic tethering role, as it 
promotes release of cytolytic granules from cytolytic T lymphocytes at the immune synapse (189) 
by linking cytolytic granules to endosomes (190). This non-fusogenic role might explain how Vti1b 
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could act as a negative regulator of phagocytosis (similar to Vti1a, VAMP8 and Sec22b) (175), as 
it would allow to sequester other SNAREs by forming non-fusogenic complexes.
Vti1b contains an N-terminal Habc-domain which, in contrast to some Qa-SNAREs, cannot 
interact with its own SNARE-motif (121), but regulates its localization at late endosomes and the 
trans-Golgi network by binding to the clathrin adapter EpsinR (182, 191). The subcellular localization 
of Vti1b further depends on Stx6 (192), whereas Vti1b in turn affects the stability of Stx8 (184). 
The endocytic trafficking role of Vti1b with Stx7 is regulated by binding to UVRAG and viruses, 
such as influenza A and VSV, use this pathway for their escape from endosomes (126). Like Vti1a, 
the bacterial-driven recruitment of Vti1b to intracellular vacuoles containing the pathogen Coxiella 
burnetii has been shown to promote bacterial survival and proliferation (178). 
Qc-SNAREs
Stx6
The Qc-SNARE Stx6 mainly localizes at the Golgi apparatus (96, 112, 147, 193–197), but also at 
early and recycling endosomes, the plasma membrane, and secretory vesicles, and it plays a role 
in trafficking between these compartments and from these compartments to lysosomes (48, 53, 
54, 96, 192, 194, 197–199). Stx6 is detected by proteomics on phagosomes (66), where most 
quantitative studies report a lower presence of Stx6 at late phagosomes (>60 min after uptake) 
compared to earlier timepoints (<30 min; Table 3). However, Stx6 is best understood in both 
retrograde and anterograde Golgi-endosome trafficking (86, 186, 196, 200) and depletion of Stx6 
results in a disruption of the Golgi ribbon structure (149). For retrograde trafficking, Stx6 forms a 
SNARE-complex with Stx16 (Qa), Vti1a (Qb), and VAMP4 (R) (102, 146, 177, 201). 
Stx6 is important for endosomal trafficking of cholesterol, and Stx6 senses cholesterol levels 
by direct binding (202) at the interface between endosomes and the trans-Golgi network 
(200). The altered cellular cholesterol levels in Niemann–Pick type C1 (NPC1) syndrome cause 
a redistribution of Stx6 from the Golgi to early/recycling endosomes (153, 200). Stx6 is also 
involved in the transport of lipids to the plasma membrane (195), where it cycles by means of a 
tyrosine-based internalization motif located between its Habc-domain and SNARE-motif (96). In 
addition to lipid trafficking, Stx6 mediates homotypic fusion of early/recycling endosomes (with 
Vti1a, VAMP4, and Stx16 or Stx12 (Qa)) (48, 141, 174) as well as the fusion of endo/phagosomes 
with autophagosomes (with Vti1b (Qb) and VAMP3 (R)) for clearance of intracellular pathogens 
(188). Finally, in many cell types, Stx6 is found at specialized secretory granules (143, 174) where 
it can be involved in their biogenesis, as shown for melanosomes (185). 
The regulation of Stx6 in retrograde endosome-Golgi trafficking in well-understood and is 
mediated by binding of its Habc-domain, which does not interact with its SNARE-motif (203), 
to the S/M-protein Vps45 (154, 193), the COG complex (204), and the Stx6 Habc-interacting 
protein of 164 kDa (SHIP164) (147). Following binding of SHIP164 to Stx6, it can interact with the 
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GARP tethering complex (205), and this promotes the assembly of the Stx6–Stx16–Vti1a–VAMP4 
SNARE complex (147). Anterograde Golgi-to-endosome transport is regulated by interactions of 
Stx6 with the mammalian E3 ubiquitin ligase family members MARCH-II and MARCH-III (206), 
whereas its endocytic trafficking roles are regulated by direct interactions with the Rab5-effector 
EEA1 (141, 198). Stx6 is targeted by the intracellular pathogen Mycobacterium tuberculosis that 
promotes its proliferation by preventing Stx6 recruitment to pathogen-containing phagosomes 
(137). In contrast, the intracellular pathogens Salmonella and Chlamydia promote Stx6 recruitment 
to their intracellular vacuoles and this aids their survival (78, 207). 
Stx8
The Qc-SNARE Stx8 localizes at early and recycling endosomes (54, 96, 112, 208, 209), late 
endosomes, lysosomes (54, 96, 109, 110, 112, 113, 183), and the trans-Golgi network (112). Stx8 
is also detected at phagosomes (65, 66, 85, 115, 137), with most quantitative studies showing 
an increased phagosomal presence of Stx8 over time after uptake ((114) and Table 3). Although 
Stx8 is non-essential and knockout mice show no significant abnormalities (56), its endocytic 
trafficking functions are well studied. SNARE complex formation of Stx8, Stx7 (Qa), and Vti1b 
(Qc) with VAMP8 (R) mediates homotypic fusion of late endosomes (116, 117), whereas the same 
SNARE complex with VAMP7 (R) mediates fusion between late endosomes and lysosomes (117). 
The formation of these SNARE complexes and late endosomal localization of Stx8 are regulated 
by interactions of Stx8 with the SNARE-associated protein SNAPIN (183). The late endosomal 
localisation of Stx8 is further mediated by interactions of its Habc-domain, which does not bind-
back on the SNARE-motif (121), with EpsinR (120) and UVRAG (126), and by a dileucine motif of 
Stx8 (210). Another dileucine motif mediates internalization of Stx8 at the plasma membrane (96, 
209). Stx8 is stabilized by Vti1b (184) and is palmitoylated, although this does not seem to be 
important for its trafficking in contrast to Stx7 (113). Stx8 mediates trafficking of several key cargo 
molecules by direct interactions, as shown for the internalization of the K+ channel TASK-1 (209), 
surface-delivery of the Cl- channel CFTR (111, 208), and surface-delivery of the nerve growth 
factor receptor TrkA (211). Finally, endosomal trafficking of Stx8 is targeted by several pathogens. 
Mycobacterium delays Stx8 recruitment to its intracellular habitat, which could promote pathogen 
survival by blocking acquisition of lysosomal constituents (137). Moreover, VSV and other viruses 
promote their cellular entry by rerouting trafficking of Stx8 with Stx7, Vti1b and VAMP8 (126). 
Stx10
Stx10 is a Qc-SNARE which is structurally closely homologous to Stx6 (61% sequence identity) 
(212). Stx10 is not much studied because it is absent in mouse (but present in humans), but is 
believed to be involved in retrograde transport from endosomes to the trans-Golgi network (102, 
151). Whereas Stx6 mediates transport from early/recycling endosomes to the Golgi apparatus 
(see above), Stx10 mediates transport from late endosomes by pairing with Stx16 (Qa), Vti1a (Qb), 
and VAMP3 (R) (102, 151). This retrograde trafficking by Stx10 depends on the small GTPase 
Rab9 (151). Stx10 is not found at phagosomes by proteomics, but most of these studies are 
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conducted with mouse cells that do not have Stx10. Stx10 locates at intracellular vacuoles 
bearing the intracellular pathogen Chlamydia trachomatis, and this is required for the creation and 
maintenance of these vacuoles (213).
Use1
The Qc-SNARE Use1 locates at the ER and Golgi apparatus and is involved in trafficking to 
lysosomes, presumably by complexing with VAMP7 (R) (214). By microscopy and western blot, 
Use1 was found to locate at phagosomes (15). Although controversial (17–19), Use1 is proposed 
to mediate transport from the ER to phagosomes by complexing with Stx18 (Qa) and these 
Q-SNAREs might be negatively regulated by forming a non-fusogenic complex with Sec22b (R) 
(15, 172).
Qbc-SNAREs
SNAP23
The essential (215) Qbc-SNARE SNAP23 is best known for its role in plasma membrane 
trafficking. SNAP23 mediates exocytosis in many cell types (59, 60, 71, 86, 88, 91, 216–218), 
for instance in neurons where it mediates the post-synaptic surface delivery of the glutamate 
receptor at dendritic spines (219). The Qb- and Qc-SNARE motifs of SNAP23 are connected by a 
linker region containing five palmitoylated cysteines (220) that anchor it at the plasma membrane, 
recycling and late endosomes, and the trans-Golgi network (53, 54, 59–61, 79, 129, 217, 221, 
222). SNAP23 is also found at phagosomes (16, 65, 66, 84, 114, 223, 224) and, although it might 
be recruited at several stages during phagosomal maturation (19), most quantitative proteomics 
show an overall decrease of phagosomal SNAP23 following uptake (Table 3). Although best-
understood for its role in plasma membrane trafficking, SNAP23 also catalyses endosomal fusion 
events (129, 222), such as for the biogenesis of lysosome-relate organelles (e.g., melanosomes) 
(68). The intracellular trafficking roles of SNAP23 are characterized for phagosomes, where 
SNAP23 is responsible for the recruitment of several proteins with key roles in phagosomal 
maturation from recycling endosomes (223) and lysosomes (84, 114, 225): the V-ATPase (84), 
MHC class I (223), and the NADPH oxidase NOX2 (with Stx7 (Qa) and VAMP8 (R)) (84, 114, 225).
The subcellular localization of SNAP23 is regulated by phosphorylation by the serine IkB kinase 
(IKK)-β (223, 226), and this promotes SNARE complex formation and membrane fusion (221, 
223, 226, 227). In cancer cells, SNAP23 can also be phosphorylated by pyruvate kinase type M2 
(PKM2), a metabolic enzyme (227), but whether this occurs in healthy cells is unknown. SNAP23 
is further regulated by interactions with the calcium-sensor synaptotagmin-7 (91) and the Sec6 
and Sec8 subunits of the exocyst complex (218). 
SNAP25
The Qbc-SNARE SNAP25 is anchored by four palmitoylated cysteines (one less than SNAP23) 
(220, 228) at the plasma membrane, early/recycling endosomes, and the trans-Golgi network (48, 
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218, 220, 228–231). Although SNAP25 is expressed by non-neuronal cells (218), it is best known 
for its role in neurotransmitter release from neurons and neuroendocrine cells by complexing with 
Stx1 (Qa) and VAMP2 (R) (26, 27, 42, 43, 219). These SNAREs can also mediate the subsequent 
recycling of synaptic vesicles, thereby directly coupling exocytosis with endocytosis (232, 233). 
Another role of SNAP25 is the homotypic fusion of early endosomes by complexing with Stx12 
(Qa) and VAMP2 regulated by Hgs in a calcium-dependent manner (140, 142). SNAP25 has been 
detected at phagosomes from macrophages and from Drosophila melanogaster (49, 65), but its 
functional roles here are unclear. Finally, SNAP25 may have a role in autophagy as its upregulation 
in cancer promotes autophagy-mediated tumor progression (234). 
Endocytic trafficking of SNAP25 is regulated by phosphorylation within its Qc-SNARE motif by 
the serine kinase protein kinase C (PKC) (235). Trafficking of SNAP25 is further regulated by ADP-
ribosylation factor 6 (ARF6) (229) and interactions with the Sec6 and Sec8 subunits of the exocyst 
complex (218). The protein cytoplasmic LEK1 (cytLEK1) regulates endosomal transport by linking 
SNAP25-positive early/recycling endosomal vesicles to the microtubule network (231). 
SNAP29
Loss of the Qbc-SNARE SNAP29 results in CEDNIK syndrome (cerebral dysgenesis, neuropathy, 
ichthyosis and keratoderma), characterized by a wide range of symptoms, including severe 
psychomotor retardation and generalized ichthyosis (39, 40). In mice, SNAP29 might even be 
essential, as no homozygous knockout mice for SNAP29 were obtained (56). In contrast to 
SNAP23 and SNAP25, the linker between the Qb- and Qc-SNARE motifs of SNAP29 contains no 
palmitoylation sites. This lack of palmitoylation makes SNAP29 a cytosolic protein, although it can 
locate at the plasma membrane, early/recycling endosomes, and other organelles by interacting 
with other (membrane-anchored) SNAREs (54, 236–238) such as Stx6 (Qc) (194). Proteomics 
studies identified SNAP29 at phagosomes ((49, 85) and Table 3), where it can be recruited at 
multiple stages following phagocytosis (19). 
Although SNAP29 might be involved in Golgi trafficking and cells from CEDNIK patients have 
a disrupted Golgi morphology (39), it is best characterized in endocytic trafficking. SNAP29 
mediates recycling of transferrin and integrins from recycling endosomes (39) and the fusion 
of these compartments with phagosomes (236). The endocytic role of SNAP29 is regulated by 
interactions with EH-domain containing protein 1 (EHD1), the subunit α-adaptin of AP-2, and  the 
small GTPase Rab3A (237, 238). In addition, SNAP29 mediates the fusion of autophagosomes 
with lysosomes by complexing with Stx17 (Qa) and VAMP8 (R) (11, 165, 166) or VAMP7 (R) 
(157) in a manner dependent on O-GlcNAcylation of SNAP29 (165). This pathway is blocked by 
human parainfluenza virus type 3 (HPIV-3), which thereby prevents its lysosomal degradation and 
promotes virus replication (239). In contrast, enterovirus A71 facilitates its replication by promoting 
this pathway, and binding of the viral protein 2BC to SNAP29 and Stx17 promotes fusion of 
autophagosomes with lysosomes (169).
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R-SNAREs
Sec22b
The non-essential (56) R-SNARE Sec22b plays a role in ER-Golgi trafficking and mainly locates 
at the ER, the ERGIC and cis-Golgi compartments (16, 240), but it is also found at phagosomes 
((14–16, 66, 67, 115, 223) and Table 3). Although controversial (241, 242), Sec22b might regulate 
trafficking from the ERGIC to phagosomes in dendritic cells (16, 243, 244). Sec22b might also be 
responsible for transport from the ER to phagosomes by complexing with Stx18 (Qa) and Use1 
(Qc) (14, 15), although this is also debated (17–19). This route is used by intracellular parasites, 
such as Leishmania, Toxoplasma, and Legionella, that redirect Sec22b-mediated transport from the 
ER to parasite-containing phagosomes to promote their survival (16, 36).
In addition to the controversial roles in ER/ERGIC-phagosome trafficking, Sec22b locates at 
autophagosomes where it performs two functions. First, Sec22b coordinates the recruitment of 
autophagic secretory cargo, such as IL-1β, by interaction with the cargo receptor TRIM16. Second, 
Sec22b mediates the fusion of autophagosomes with the plasma membrane by complexing with 
Stx3 or Stx4 (Qa) and SNAP23 or SNAP29 (Qbc) (158). Moreover, Sec22b has been shown 
to form non-fusogenic SNARE complexes, for instance with Stx1 (Qa) for tethering of the ER 
to the plasma membrane (240). Such non-fusogenic SNARE complex formation might explain 
how Sec22b sequester other SNAREs (such as Stx18 (Qa)) and thereby negatively regulates 
phagocytosis (172), although this is also controversial (16, 65). Finally, Sec22b trafficking is 
regulated by its N-terminal longin domain (26), which can interact with its SNARE-motif to prevent 
complex formation (similar to VAMP7 and Ykt6) (245).
VAMP1
The R-SNAREs VAMP1 and VAMP2 are highly homologous (78% sequence identity), locate 
both at secretory vesicles and endosomes (246, 247), and both mediate neuronal secretion by 
complexing with Stx1 (Qa) and SNAP25 (Qbc) (26, 27, 42, 43, 247). Despite this high structural 
and functional similarity, VAMP1 and VAMP2 are expressed in discrete but partially overlapping 
areas of the brain (248, 249) and have unique trafficking functions, as VAMP1 (but not VAMP2) 
mediates TNFα-induced surface trafficking of the transient receptor potential (TRP) A1 and V1 
channels in trigeminal ganglion neurons (247). Mice carrying a VAMP1 null mutation display 
the so-called lethal-wasting (lew) phenotype, characterized by severe neurological defects and 
premature death (250). 
VAMP2
VAMP2 is the main R-SNARE for neuronal secretion by complexing with Stx1 (Qa) and SNAP25 
(Qbc) (26, 27, 42, 43) and is also involved in the subsequent recycling of synaptic vesicles (232, 
251). VAMP2 knockout mice die immediately after birth, because of absence of neurotransmitter 
release from neurons (which do not contain compensatory VAMP3) (252). Although VAMP2 is 
predominantly expressed in neurons and neuroendocrine cells, it also mediates exocytosis 
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in non-neuronal cell types (216, 218, 253, 254), mainly by complexing with Stx4 (Qa) and 
SNAP23 (Qbc) (216, 218, 225, 253–256). In addition, VAMP2 facilitates the membrane growth 
for phagocytosis by mediating local fusion of endosomes with the plasma membrane at the 
site of uptake (257). Besides being located at secretory vesicles, VAMP2 also locates at the 
plasma membrane (62, 258), early/recycling endosomes (48, 259), and lysosomes (109). VAMP2 
is organized in membrane domains of early endosomes (51) and mediates homotypic fusion 
of these compartments by complexing with Stx12 (Qa) and SNAP25 (140). VAMP2 does not 
contain a regulatory N-terminally domain, but reaches secretory granules by trafficking signals 
located within its SNARE-motif (259). These signals likely interact with the cargo adaptor protein 
AP3 and the endocytic clathrin adaptor CALM/PICALM, which are known to mediate intracellular 
sorting of VAMP2 (258, 260). Interaction with AP3 is required for trafficking to synaptic vesicles 
(260), whereas interaction with CALM/PICALM is necessary for VAMP2 retrieval from the plasma 
membrane (258). 
VAMP3
The R-SNARE VAMP3 is structurally and functionally closely related to VAMP2 (63% sequence 
identity), but is ubiquitously expressed. VAMP3 mainly locates at early and recycling endosomes 
and regulates transport to other endosomes, autophagosomes, the Golgi apparatus, and 
the plasma membrane (59, 62, 72, 86, 197, 218, 223, 258, 261–266). VAMP3 also locates at 
phagosomes (66, 148, 223, 267) with quantitative immunofluorescence microscopy showing that 
VAMP3 is more abundant at early (<30 min after uptake) compared to late (>60 min) phagosomes 
(148), although this is opposite to the findings from most quantitative proteomics studies (Table 
3). VAMP3 mediates exocytosis mainly by complexing with Stx4 (Qa) and SNAP23 (Qbc) (59, 62, 
72, 76, 86, 217, 268–270). In addition, trafficking from early/recycling endosomes to the Golgi 
apparatus is mediated by complexing of VAMP3 with Stx16 (Qa), Vti1a (Qb), and Stx6 or Stx10 
(Qc) (102, 151, 196), whereas trafficking in the reverse direction is mediated by complexing with 
Stx7 (Qa), Vti1b (Qb), and Stx6 (7, 86, 186). VAMP3 has also been described to mediate fusion 
between autophagosomes and multivesicular bodies to generate autophagosomal vacuoles 
called amphisomes (271), and this may play a role in the degradation of pathogen-containing 
endo/phagosomes (188). 
Endocytic trafficking of VAMP3 is required for many cellular processes, including the recycling 
of the transferrin receptor (263, 264), insulin-stimulated trafficking of GLUT4 (272), the recycling 
of integrins in migrating cells (273, 274), and fibrinogen uptake by platelets (274). Nevertheless, 
VAMP3 knockout mice have no (275) or only a very mild phenotype (56) and this is probably 
caused by compensation by other R-SNAREs, as shown for VAMP3 in phagocytosis. Here, 
VAMP3 mediates ARF6-dependent fusion of recycling/early endosomes with the plasma 
membrane at the site of phagocytosis by complexing with Stx4 (86, 276, 277), but ablation of 
VAMP3 does not affect phagocytosis (148, 275, 278). Since phagocytosis is blocked by tetanus 
neurotoxin (257), which cleaves and inactivates both VAMP2 and VAMP3, it is suggested that 
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VAMP2 can compensate for VAMP3. Compensation in the reverse direction (i.e., VAMP3 for 
VAMP2) has been shown in chromaffin cells, where VAMP2 knockout cells have no secretory 
defect due to full compensation by VAMP3 (252).
Like VAMP2, VAMP3 contains no N-terminal regulatory domain, but its subcellular sorting is 
mediated by signals located within its SNARE-motif (259). Retrieval of VAMP3 from the plasma 
membrane is governed by interactions with the endocytic clathrin adaptor CALM/PICALM (258), 
and, at least in Drosophila, trafficking of VAMP3 to early/recycling endosomes is regulated by 
ubiquitination (262). Endosomal sorting of VAMP3 is further regulated by two enzymes involved 
in phosphoinositide metabolism: phosphatidylinositol 4-kinase IIa (PI4K2A), which regulates its 
pairing with Vti1a (Qb) (269), and the phosphoinositide lipid 3-phosphatase myotubularin-related 
protein 4 (MTMR4) (279). Finally, VAMP3 is involved in the formation and maintenance of vacuoles 
supporting survival of several intracellular pathogens (6, 178, 280), as for example VAMP3-positive 
vesicles are selectively recruited to the infection sites of Salmonella typhimurium and Trypanosoma 
cruzi to facilitate their survival (281, 282).
VAMP4
The R-SNARE VAMP4 predominantly locates at the Golgi apparatus (54, 102, 147, 177, 201, 
283, 284), but is also present at the plasma membrane, in membrane domains of early/recycling 
endosomes (48, 51, 54, 102, 177, 201), and at lysosome-related secretory compartments such 
as synaptic vesicles from neurons (143, 201) and cytolytic granules in NK cells (285). Moreover, 
VAMP4 has been found at phagosomes by proteomics ((65, 66) and Table 3), and western blot 
experiments revealed that VAMP4 is recruited to phagosomes in consecutive phases following 
uptake (19). VAMP4 functions in retrograde trafficking from early and recycling endosomes to the 
trans-Golgi network by complexing with Stx16 (Qa), Vti1a (Qb), and Stx6 (Qc) (102, 177) and loss 
of VAMP4 results in disruption of the ribbon structure of the Golgi (149). VAMP4 also participates 
in anterograde transport from the Golgi to endosomes (201), which is important for distributing 
cholesterol at the Golgi-endosome interface by pairing with Stx6 (153, 200). Moreover, VAMP4 
plays a role in the homeostasis of other lipids as well, because it is involved in the formation 
of lipid droplets, storage compartments of excess lipids, together with Stx5 (Qa) and SNAP23 
(Qbc) (104). Other endocytic functions of VAMP4 are the clathrin-independent bulk endocytosis in 
neurons (286) and the homotypic fusion of early endosomes by forming a SNARE complex with 
Stx12 (Qa), Vti1a, and Stx6 (48).
The well-conserved N-terminal domain of VAMP4 contains a di-leucine motif and an acidic 
cluster that regulate its localization to the trans-Golgi network by interacting with the cargo adaptor 
protein AP1 (26, 283) and the GARP complex (147). The N-terminal domain also regulates 
clathrin-dependent endocytosis of VAMP4 (177). Endosomal trafficking of VAMP4 is hijacked by 
the intracellular pathogen Legionella pneumophila. This pathogen expresses three proteins that 
resemble Q-SNAREs and form a SNARE-like complex with VAMP4 (38), which results in fusion 
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of VAMP4-containing vesicles with the pathogen-containing vacuoles, and thereby it enables 
growth of these vacuoles promoting proliferation of the pathogen (38). 
VAMP7
The R-SNARE VAMP7, also known as tetanus neurotoxin-insensitive VAMP (TI-VAMP) (review: 
(69)), mainly locates at late endosomes and lysosomes (54, 72, 91, 110, 117, 187, 197, 271, 282, 
284, 287–291), although it is also found at the plasma membrane (61), early endosomes (144), 
and autophagosomes (187, 290, 292). VAMP7 is detected already at the nascent cup (288) 
of phagosomes (66, 85, 115) and its phagosomal presence increases in time following uptake 
(Table 3). VAMP7 knockout mice only have a mild behavioral phenotype (293), possibly related 
to a reduced neurite outgrowth (294). By complexing with Stx7 (Qa), Vti1b (Qb), and Stx8 (Qc), 
VAMP7 mediates fusion of late endosomes with lysosomes and homotypic fusion of lysosomes 
(117, 119) and is proposed to mediate fusion of lysosomes with phagosomes (110). VAMP7 is 
also involved in Golgi to late endosome trafficking (289), the biogenesis of lysosome-related 
secretory compartments, such as melanosomes (8, 68), the formation of autophagophores (the 
precursors of autophagosomes) (292), and the fusion of autophagosomes with lysosomes (187, 
271). However, these roles of VAMP7 in late endosomal and lysosomal trafficking were recently 
questioned and it was argued that VAMP7 primarily acts as a SNARE for exocytosis of lysosomes 
and lysosome-related secretory compartments (69). Indeed, a role for VAMP7 in exocytosis has 
been reported for many cell types, mainly by complexing with plasmalemmal Stx3 or Stx4 (Qa) 
and SNAP23 (Qbc) (61, 71, 72, 79, 197, 256, 284, 285, 290, 295). This exocytic role of VAMP7 
is important for efficient uptake of some phagocytic cargoes (288), because VAMP7-mediated 
fusion of vesicles with the plasma membrane at the site of phagocytosis can promote phagosome 
formation (288, 296), although VAMP7 has also been reported to act as a negative regulator of 
phagocytosis (148).
The regulation of VAMP7 is well understood. Like Ykt6 (R) and Sec22b (R), VAMP7 contains an 
N-terminal longin domain that can bind back on its SNARE-motif and thereby prevents formation 
of a SNARE complex (Fig. 2) (287, 297). This closed conformation of VAMP7 is stabilized by 
interactions with the guanine exchange factor (GEF) ankyrin repeat domain-containing protein 27 
(VARP), a GEF for Rab21 which interacts with the retromer complex and regulates the endosomal 
localization of VAMP7 (reviews: (69, 298)). VARP also interacts with GolginA4 and the kinesin 1 
Kif5A (299), and this promotes the directed movement of VAMP7 vesicles from the cell center 
to the cell periphery (282, 290, 299). In contrast, the adaptor protein 2 (AP2) binding protein Hrb 
(HIV Rev-binding protein) only binds to the longin domain in an open conformation of VAMP7, 
thereby allowing for specific recycling of cis-SNARE complexes by clathrin-mediated endocytosis 
(291, 300). Hrb binding to VAMP7 plays an additional role in autophagosome formation (292). The 
longin domain of VAMP7 also binds to AP3 and this binding is responsible for targeting VAMP7 
from early and recycling endosomes to late endosomes and lysosomes (287, 301). Other proteins 
regulating VAMP7 are Stx12 (Qa), with loss of Stx12 resulting in mislocalization of VAMP7 to 
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lysosomes (144), and the calcium-binding protein synaptotagmin-7 (91). 
VAMP7 plays a role in the pathogenesis of at least two intracellular pathogens. First, Coxiella 
burnetii promotes its survival and proliferation by actively recruiting VAMP7 to bacteria-containing 
phagosomes (178). Second, VAMP7 is required for efficient host cell infection by Trypanosoma cruzi, 
and VAMP7-positive lysosomes are recruited to the infection site at the plasma membrane (282).
VAMP8
VAMP8 locates at early/recycling endosomes (48, 111, 218, 223, 258, 266, 302), late endosomes, 
lysosomes (11, 107, 109, 110, 187, 266, 303), the plasma membrane, the trans-Golgi network 
(258, 304), and phagosomes (65–67, 85, 114, 148, 223, 267). Quantitative imaging (114) and 
most quantitative proteomics studies (Table 3) revealed an increased presence of VAMP8 
following phagosome maturation, although the phagosomal recruitment of VAMP8 can occur in 
multiple phases after uptake (19). VAMP8 is best understood as a general SNARE for regulating 
exocytosis of the exocrine system, and VAMP8 knockout mice have secretory defects in exocrine 
tissues (255, 305–308). VAMP8 mediates exocytosis mainly by interacting with plasmalemmal 
Stx4 (Qa) and SNAP23 (Qbc) (76), and this is for instance required for granule secretion from 
mast cells (79, 123, 307–309) and platelets (76, 310, 311). Moreover, the secretory role of VAMP8 
is required for host defence to Entamoeba histolytica as it mediates the intestinal mucin secretion 
triggered by this pathogen (312). In addition to these secretory roles, VAMP8 mediates fusion 
between early/recycling endosomes, late endosomes and lysosomes (with Stx7 (Qa), Vti1b 
(Qb), and Stx8 (Qc)) (107, 116–118, 304) and is responsible for biogenesis of lysosome-related 
secretory compartments such as melanosomes (with Stx7, Vti1b, and Stx6 (Qc)) (185). VAMP8 
also mediates the trafficking from lysosomes to phagosomes (110, 114), although some studies 
show that it might actually act as a negative regulator of phagocytosis (148, 313). Finally, VAMP8 
is involved in autophagosomal fusion by complexing with Stx17 (Qa) and SNAP29 (Qbc) (11, 165, 
187). 
Although VAMP8 contains no N-terminal regulatory domain, its function is regulated by binding to 
the calcium-sensor Munc13-4 (124), the lipid phosphatidylinositol 3-phosphate [PI(3)P] (314), the 
endocytic clathrin adaptor CALM/PICALM (258), the human trypanolytic factor APOL1 (41), and the 
small GTPase Rab17 (303). Rab17 stabilizes VAMP8 at late endosomes (303), whereas Munc13-4 
stabilizes the Stx7–Vti1b–Stx8–VAMP8 SNARE complex to promote homotypic endosome fusion 
and exocytosis (123). Mutations in APOL1 that affect binding to VAMP8 are the cause of kidney 
disease (41). The phagocytic activity of VAMP8 is regulated by caspase-dependent cleavage of 
VAMP8 in its SNARE-motif (313). This pathway is hijacked by the intracellular pathogen Leishmania, 
which averts its detection by the immune system by cleaving VAMP8 with a bacteria-produced 
protease and thereby blocks NOX2 recruitment to the phagosome (267). On the other hand, 
VAMP8 can also facilitate pathogen invasion, as Salmonella typhimurium-generated PI(3)P promotes 
the recruitment of VAMP8 to the bacterial invasion site to allow pathogen uptake (314). Moreover, 
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VAMP8 selectively traffics to at least a subset of vacuoles containing Coxiella burnetii, suggesting a 
role in the survival of this intracellular pathogen (178). 
Ykt6
The R-SNARE Ykt6 does not contain a transmembrane domain, but is attached to the membrane 
by prenylation and palmitoylation of cysteine residues at its C-terminus (26, 315, 316). The 
reversible palmitoylation allows Ykt6 to actively cycle on and off membranes (317) and therefore 
Ykt6 is present as both a free cytosolic pool and a membrane-associated pool at the Golgi 
apparatus (316, 318), late endosomes, and lysosomes (315). Ykt6 has also been identified at 
phagosomes by proteomics ((66) and Table 3), although it could not be detected by western 
blot (16, 223). Like VAMP7 (R), Ykt6 contains an N-terminal longin domain (26) that can adopt a 
closed conformation to prevent SNARE complexing (316). In case Ykt6 is only prenylated but not 
tethered to membranes by palmitoylation, the prenyl moiety stabilizes this closed conformation 
of Ykt6, thereby inactivating the soluble form of Ykt6 (317). Ykt6 mediates retrograde transport 
from early/recycling endosomes to the trans-Golgi network by complexing with Stx5 (Qa), GosR1 
(Qb) and Bet1L (Qc) (100) and it has secretory roles (270, 319) such as exosome production and 
release (320, 321).
Discussion and conclusion
To date, a vast majority of the human members of the SNARE protein family (30 out of 38) have 
been identified at endosomes and/or phagosomes (Table 1), and, given the increased sensitivity 
of detection methods, we expect that more SNAREs will be found at these organelles in the 
future. Although its localization at endo/phagosomes does not automatically mean that a SNARE 
has active trafficking roles, and it could be merely present as a cargo molecule en route to its target 
organelle, almost all 30 SNAREs have currently been assigned functions in endosomal and/
or phagosomal trafficking. In fact, most SNAREs are not implied in a single transport route, but 
function in multiple and frequently consecutive pathways between endo/phagosomes with other 
endosomes, lysosomes, the plasma membrane, autophagosomes, the Golgi apparatus, the ER 
and the ERGIC (Fig. 3). Moreover, the functions of many of these SNARE proteins overlap and 
there are often no well-definable single sets of SNAREs mediating a certain endo/phagosomal 
transport route.
At first glance, it does not seem surprising that by far most SNAREs participate in multiple 
endosomal and/or phagosomal trafficking routes. Many other membrane trafficking components 
are involved in multiple and overlapping trafficking steps as well, such as phosphoinositides, 
Rab-GTPases, and cage proteins (23, 322–324). Although SNARE proteins contribute to the 
identity of organellar membranes (26, 27, 29), the specificity of organellar trafficking requires the 
combined presence of SNAREs and several other components, thus the synergistic recognition 
of specific SNAREs, Rab-GTPases, cage proteins, tethering complexes, and phosphoinositides, 
in a process called coincidence detection (20, 325). This coincidence detection is facilitated by
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^ Fig. 3: Schematic summary of SNAREs with known functions in endosomal and phagosomal transport. 
Red: Qa-SNAREs; dark green: Qb-SNAREs; light green: Qc-SNAREs; intermediate green: Qbc-SNAREs; blue: R-SNAREs. 
Early: early and/or recycling endosome or phagosome; late: late endosome or phagosome; TGN: trans-Golgi network; ER: 
endoplasmic reticulum; ERGIC: ER-Golgi intermediate compartment. Note that for clarity, the scheme is simplified and 
early and recycling endosomes are not distinguished, many cell-specific routes are not included (e.g., for biogenesis of 
specialized secretory compartments), and endosomes and phagosomes are not distinguished.
direct interactions between SNAREs with phosphoinositides, adapter proteins, the cytoskeleton, 
multi-subunit tethering complexes, and Rab-GTPases (9, 21–24, 35, 238, 303). As described in 
this review, these interactions are important for the specific trafficking roles of SNAREs, as they 
allow control over the selection of cargo, the formation of trafficking vesicles, and the tethering 
and docking of these vesicles to the target organelles. Moreover, coincidence detection is an 
efficient way to increase the number of different trafficking routes with only a limited number of 
components, i.e., 38 SNAREs, about 70 Rab-GTPases, and 7 phosphoinositides. Nevertheless, 
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the requirement for coincidence detection for organellar identity was put to question in a recent 
study employing microinjection of artificial liposomes carrying reconstituted Stx12 (Qa), Vti1a (Qb), 
Stx6 (Qc), and VAMP4 (R) in mammalian cell lines (31). These liposomes specifically fused to 
early endosomes within the cells, demonstrating that, at least for early endosomes, SNAREs 
alone suffice for organellar targeting (31). This finding raises the question how these SNAREs can 
have other trafficking roles as described in this review (e.g., endosome-Golgi, endosome-plasma 
membrane trafficking).
Perhaps the answer to the question how SNAREs can be involved in multiple trafficking pathways 
lies in the trafficking of the SNARE proteins themselves. Most SNAREs are stably membrane-
anchored by their C-terminal transmembrane domain and rely on intracellular membrane transport 
for reaching their subcellular location. There are, in principle, two ways by which a SNARE protein 
can reach its target organelle (Fig. 4): (i) by the action of other SNAREs (i.e., the cargo SNARE 
being transported by other R- and Q-SNAREs), and (ii) by its direct complexing with SNAREs 
that are already present at the target membrane (i.e., the cargo SNARE trafficking itself) followed 
by disassembly of the SNARE-complex by NSF with α-SNAP. There is evidence in literature 
supporting both mechanisms. First, for example, VAMP8 (R) does not directly mediate exocytosis 
of cytolytic granules from CD8+ killer T cells, but rather is responsible for bringing Stx11 (Qa) from 
recycling endosomes to the immunological synapse which in turn mediates lytic granule release 
by complexing with VAMP2 (R) on the granules (254, 302). Second, in macrophages, VAMP3 
(R) transports TNFα from the Golgi apparatus to early/recycling endosomes by complexing with 
endosomal Stx7 (Qa), Vti1b (Qb), and Stx6 (Qc), but is also involved in the subsequent exocytosis 
of TNFα by pairing with plasmalemmal Stx4 (Qa) and SNAP23 (Qbc) (7, 86, 186). Thus, SNAREs 
can reach their target organelles both by being transported by other SNAREs and by actively 
engaging in their own trafficking. The first mechanism could offer a larger control over particulate 
trafficking pathways, but requires the recycling of the delivered SNAREs, which is not needed in 
the second mechanism (Fig. 4). Moreover, the second mechanism would not only explain the 
involvement of SNAREs in multiple consecutive trafficking routes, but also their large promiscuity. 
At least in vitro, most, if not all, combinations of Qa–Qb–Qc–R SNAREs can form fusogenic 
SNARE complexes (48), and, likely because of this promiscuity, SNARE knockout often results 
in no or relatively mild phenotypes (44, 138, 176, 184, 275, 293). Thus, a paradigm that emerges 
from this review is that the involvement of SNAREs in multiple trafficking routes is likely also 
important for transport of the SNAREs themselves.
The functional distribution of SNARE proteins over organellar membranes is still another open 
and important topic. In exocytosis, it is well-established that the secretory vesicles and granules 
carry the R-SNARE (e.g., VAMP2 in synaptic vesicles) which interacts with a Q-SNARE complex 
at the plasma membrane (e.g., Stx1 (Qa) and SNAP25 (Qbc)). However, the functional SNARE 
distribution over the donor and target membranes for other intracellular transport routes is still 
unknown. Many (if not all) organellar membranes contain both R- and Q-SNAREs. This is especially
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apparent in homotypic fusion between the same types of organelles, such as endosomes, 
because in this case both membrane compositions are identical and contain the same sets of 
SNARE proteins. In vitro, Stx12 (Qa), Vti1a (Qb), Stx6 (Qc), and VAMP4 (R) can fuse liposomes 
with five out of seven possible combinations of distributions of these SNAREs over the donor 
and acceptor membranes (326), demonstrating that the functional topology of SNARE proteins 
does not necessarily have to be the R-SNARE on the donor membrane vs. the Q-SNAREs on the 
target membrane. One indication that the functional topology may be different comes from the 
finding that most Q-SNAREs contain N-terminal regulatory domains, whereas these are absent 
in many R-SNAREs (Table 1). For instance, a late endosomal Q-SNARE acceptor complex of 
Stx7 (Qa), Vti1b (Qb) and Stx8 (Qc) would contain 3 Habc-domains (116, 117), while the cognate 
R-SNARE VAMP8 does not have an N-terminal regulatory domain. Because of these reasons, 
it seems reasonable to hypothesize that inter-organellar transport routes might be mediated by 
different SNARE distributions than the canonical R- vs. Q-SNARE distribution (for instance R–Qa 
with Qb–Qc). This hypothesis could be tested by classical in vitro lipid dequenching experiments 
with artificial liposomes and purified organelles (28, 110), combined with the in vivo visualization 
of SNARE-complexes in live cells by Förster resonance energy transfer coupled to fluorescence 
lifetime imaging microscopy (FRET-FLIM) (62). 
Although the spatial control of membrane trafficking is increasingly well understood, it is still largely 
unknown how inter-organellar fusion events are regulated temporally. Cellular homeostasis requires 
not only the spatial regulation of membrane trafficking, but also the coordination of membrane 
fusion and fission rates for maintaining organellar integrity. In addition, many cell types actively 
need to respond to external stimuli, and this often requires a dynamic rerouting of intracellular 
trafficking. One still underinvestigated possibility is that intracellular membrane fusion events are 
regulated by calcium (327), similar to neuronal exocytosis (26, 27, 42, 43). Evidence supporting 
< Fig. 4: Two possibilities for delivering a SNARE protein 
to its target organelle. A) Possibility 1: R-SNARE protein x 
(cyan) is delivered to its target organelle by the complexing of 
R-SNARE protein y (blue) with acceptor Q-SNAREs (green). 
R-SNARE protein y can be either present in the vesicular (A1) 
or target (A2) membrane. Although this results in correct 
localization of cargo R-SNARE x, the delivering R-SNARE y is 
‘mis-localized’ during this process and needs to be recycled. 
B) Possibility 2: R-SNARE x delivers itself at the target organelle 
by direct complexing with acceptor Q-SNAREs present on the 
target membrane. After NSF/α-SNAP-mediated disassembly 
of the SNARE-complex, R-SNARE x becomes available for 
subsequent trafficking functions on the target organelle.
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a role for calcium in endosome-endosome and endosome-lysosome trafficking comes from in 
vitro fusion experiments with purified endosomes (328, 329) and experiments with membrane-
permeable calcium chelators (141). Moreover, ablation of the lysosomal calcium channel transient 
receptor potential protein mucolipin (TRPML1) results in enlarged endo/lysosomes and trafficking 
defects in the late endocytic pathway (330). Finally, several calcium-sensing proteins bind to 
endocytic SNAREs, for instance calmodulin (binds to Stx12 (Qa) and VAMP2 (R)) (141, 331), 
synaptotagmin-7 (binds to Stx4 (Qa) and SNAP23 (Qbc)) (91), and Hgs (calcium-dependent 
binding to SNAP25 (Qbc) and Stx12) (140, 142). The role of calcium in intracellular trafficking could 
be addressed by using intracellular calcium chelators, combined with FRET-FLIM to monitor the 
occurrence and conformations of SNARE complexes in live cells (62, 332–335).
Overexpression of the SNAREs Vti1a (Qb), Vti1b (Qb) (175), Sec22b (R) (172), VAMP7 (R) or VAMP8 
(R) (148) has been shown to result in a decreased phagocytosis efficiency, whereas gene ablation 
of Vti1a, Vti1b (175), Sec22b (172), Stx11 (Qa) (130) or VAMP8 (148) resulted in the opposite 
effect. Although non-physiological effects cannot be excluded, these findings suggest that Stx11, 
Vti1a, Vti1b, Sec22b, VAMP7, and VAMP8 might act as negative regulators of phagocytosis (130, 
148, 172, 175, 313). Such inhibition of phagocytosis could be caused by the complexing of the 
inhibitory SNARE with other SNAREs involved in phagocytosis. By such a competitive inhibition, 
the inhibitory SNARE reduces the availability of the other SNARE proteins, as has been shown for 
Sec22b which blocks phagocytosis by sequestering Stx18 (Qa) (172). There are in principle two 
mechanisms by which an inhibitory SNARE could sequester other SNAREs. First, it might form a 
non-fusogenic SNARE complex (that does not result in membrane fusion), and such complexes 
have been shown to negatively regulate membrane fusion for Stx6 (Qc) and Stx2 (Qa) (336, 337). 
Moreover, Sec22b and Vti1b have been shown to tether organelles by forming non-fusogenic trans-
SNARE complexes (190, 240). In fact, non-fusogenic inhibitory SNAREs are exploited by various 
intracellular pathogens, such as Legionella and Chlamydia, which thereby reroute the membrane 
trafficking within the host cell to facilitate pathogen survival (37, 38). Non-fusogenic complexes are 
also the mechanism of SNARE regulation by amisyn, tomosyn-1 and tomosyn-2, which are soluble 
proteins that contain R-SNARE motifs and act as negative regulators of SNAREs (338, 339). 
Second, SNAREs may inhibit phagocytosis by sequestering other SNAREs to transport routes 
elsewhere in the cell (i.e., by forming a fusogenic complex). As described above, most SNAREs are 
engaged in multiple transport routes and these could well interfere with each other. Such interfering 
transport is described for SNAP23 (Qbc) in adipocytes, whose exocytic function in insulin-
stimulated translocation of GLUT4 to the plasma membrane (253) competes with its intracellular 
function in lipid droplet formation (104), and this might contribute to the development of diabetes 
type 2 (340). Thus, it seems a possibility that SNAREs can negatively affect phagocytosis (and 
other intracellular trafficking) by sequestering essential SNAREs to other transport routes within the 
cell. The presence of non-fusogenic SNARE complexes and post-fusion cis-SNARE complexes 
could be distinguished by FRET-FLIM, as this allows resolving different SNARE conformations with 
simultaneous visualization of the subcellular localization of these SNARE complexes (62, 332–335).
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As summarized in this review, about two decades of research have led to the identification of 
many members of the SNARE protein family on endosomes and phagosomes (Fig. 3). For most of 
these SNAREs, binding factors that regulate membrane tethering, docking and fusion have been 
characterized, and we now have a general mechanistic understanding of how many SNARE-
mediated trafficking routes are regulated. As explained above, a key challenge for the near future 
will be to integrate this knowledge in order to answer one of the key questions in cell biology: 
how a relatively small family of SNARE proteins can have specific regulatory functions in so many 
distinct, and often cell type specific, trafficking functions. This question is important, given the 
central role of SNAREs in virtually all cellular processes, including cellular homeostasis, migration, 
growth, and nutrient uptake. Moreover, SNARE proteins are crucial for organism development and 
maintenance as well as for immune function, because pathogens and apoptotic/necrotic cells 
are cleared by SNARE-dependent processes. Many intracellular pathogenic microorganisms 
and viruses subvert endo/phagosomal transport routes by targeting members of the SNARE 
protein family, and this has now been described for Stx3, Stx4, Stx6, Stx7, Stx8, Vti1a, Vti1b, 
VAMP3, VAMP4 and VAMP8. A better understanding of the molecular mechanisms underlying 
SNARE-mediated membrane trafficking in the endosomal and phagosomal pathways will aid in 
the development of new approaches to combat these pathogens. Interfering with such SNARE 
functions could well be a viable therapeutic strategy, as the Botulinum neurotoxins (Botox), which 
target the neuronal SNAREs, are now widely used in the clinic for treatment of muscle spasms. 
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List of abbreviations
AP1, 2, 3  adapter protein 1, 2, 3
ARF6  ADP-ribosylation factor 6
CFTR  cystic fibrosis transmembrane conductance regulator 
COG  conserved oligomeric Golgi 
CORVET class C core vacuole/endosome tethering
EEA1  early endosomal antigen 1
ER  endoplasmic reticulum
ERGIC  ER-Golgi intermediate compartment
ESCRT  endosomal sorting complex required for transport
FRET  Förster resonance energy transfer
FLIM  Fluorescence lifetime imaging microscopy
GARP  Golgi-associated retrograde transport protein 
GEF  guanine exchange factor
HCMV  human cytomegalovirus
HCV  hepatitis C virus
HOPS  homotypic fusion and vacuole protein sorting 
IMPC  International Mouse Phenotyping Consortium
LAMP2  lysosome associated membrane protein 2
MHC   major histocompatibility complex
MTMR4  myotubularin-related protein 4
NPC1  Niemann–Pick type C1 
NSF  N-ethylmaleimide sensitive factor
SHIP164  Stx6 Habc-interacting protein of 164 kDa 
αSNAP   soluble NSF-attachment protein α
SNAP23, 25, 29 synaptosomal-associated protein 23, 25, 29
SNARE  soluble-N-ethylmaleimide-sensitive-factor accessory-protein receptor
STED  Stimulated emission depletion
Stx1  syntaxin-1 (Stx2, etc.)
TAP  transporter associated with antigen processing 
TRP  transient receptor potential
Tyrp1  tyrosinase-related protein 1
UVRAG  UV radiation resistance-associated gene
VAMP1  vesicle-associated membrane protein 1 (VAMP2, 3, etc.)
VARP  ankyrin repeat domain-containing protein 27
VSV  vesicular stomatitis virus
Vti1a, 1b  vesicle transport through interaction with t-SNAREs homologue 1a, 1b
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Abstract
In dendritic cells, the NADPH oxidase 2 complex (NOX2) is recruited to the phagosomal membrane 
during antigen uptake. NOX2 produces reactive oxygen species (ROS) in the lumen of the 
phagosome that kill ingested pathogens, delay antigen breakdown and alter the peptide repertoire 
for presentation to T cells. How the integral membrane component of NOX2, cytochrome b558 
(which comprises CYBB and CYBA), traffics to phagosomes is incompletely understood. In this 
study, we show in dendritic cells derived from human blood-isolated monocytes that cytochrome 
b558 is initially recruited to the phagosome from the plasma membrane during phagosome 
formation. Cytochrome b558 also traffics from a lysosomal pool to phagosomes and this is 
required to replenish oxidatively damaged NOX2. We identified syntaxin-7, SNAP23 and VAMP8 
as the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins 
mediating this process. Our data describe a key mechanism of how dendritic cells sustain ROS 
production after antigen uptake that is required to initiate T cell responses.
Introduction
Phagocytosis is an essential process by which immune cells clear microbial pathogens as well 
as apoptotic and necrotic (tumor) cells. Both the plasma membrane and intracellular vesicles 
contribute to phagosome formation, as intracellular vesicles fuse with the plasma membrane at 
the cup of the nascent phagosome (1–3). The protein and lipid compositions of phagosomes 
progressively change during phagosome formation and during the subsequent maturation steps, 
when early phagosomes convert into late phagosomes and then into lysosomes (1–3). A key player 
in the processing of ingested pathogens by phagocytes of the immune system is the NADPH 
oxidase NOX2 complex. NOX2 consists of the three cytosolic proteins: p47phox (NCF1), p40phox 
(NCF4) and p67phox (NCF2), and the two integral membrane proteins p22phox (CYBA) and gp91phox 
(CYBB), which together are called cytochrome b558 (4–6). Cytochrome b558 traffics in complex, and 
p22phox and gp91phox need to form a stable heterodimer before exit from the endoplasmic reticulum 
(6–8). NOX2 produces reactive oxygen species (ROS) that facilitate the killing of the ingested 
pathogen by neutrophils (4, 9) and dendritic cells (10). In dendritic cells, NOX2 also modulates the 
antigenic repetoire for presentation to both CD4+ and CD8+ T cells (4, 10–18). NOX2 localizes to 
the plasma membrane, to early and recycling endosomes, and to antigen-containing endosomes 
and phagosomes (4, 6, 7, 19). In macrophages and dendritic cells, cytochrome b558 is recruited 
to phagosomes from vesicles of a recycling endosomal and lysosomal nature (7, 12, 20). How 
these vesicles are delivered to the phagosome is a field of intense study, and although several 
players in this process have been identified, such as the small GTPase Rab27a (12) and the Ca2+-
sensing protein synaptotagmin-11 (21), many questions remain. One key open question is which 
soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins catalyze 
the delivery of vesicles containing cytochrome b558 to phagosomes.
SNARE proteins drive all intracellular membrane fusion reactions in eukaryotic cells (except 
mitochondrial fusion). Cognate SNAREs present in the donor and acceptor membranes engage 
and assemble into a four-α-helix coiled-coil bundle. Each helix of this bundle is contributed by a 
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different SNARE-motif belonging to separate subfamilies – termed Qa-, Qb-, Qc- and R-SNAREs, 
respectively (22, 23). The SNAREs that catalyze the membrane fusion events underlying 
phagosome formation and maturation are not well characterized. In the mouse RAW264.7 
macrophage cell line, one study has shown a clear switch from syntaxin (Stx)12 to Stx7 (both Qa) 
during uptake of sheep red blood cells (24). There, Stx12 readily disappeared within 10 min after 
phagosome formation, and this was accompanied by an increase in the levels of Stx7. This result 
suggests a role for Stx12 in early, and Stx7 in late, phagosomal fusion events, in accordance with 
their described roles in endosomal maturation (24–33). For Stx7, this agrees well with several 
quantitative proteomics studies in which Stx7 increases in late (>60 min after uptake) compared 
to early (<30 min) phagosomes for different cell types and phagocytic cargoes (34–36). An 
exclusive role for Stx12 in early phagosomal fusion events is much less clear, as Stx12 can be 
detected on late phagosomes by proteomic analyses (37–40) and western blotting (41, 42). In 
addition to Stx7 and Stx12, proteomics studies have identified dozens of other SNARE proteins 
present on phagosomes (34–40), but the roles of all these SNAREs remain largely unexplored. 
The recruitment of some SNAREs, including VAMP8 (R-SNARE) and SNAP23 (both Qb and Qc 
motifs), can even occur in several phases during phagosome maturation (34). All these findings 
indicate a complex cascade of phagosomal fusion events, with many different SNAREs involved 
at multiple trafficking steps during phagosomal maturation.
Recently, it has been shown that phagosomal recruitment of cytochrome b558 is mediated by the 
R-SNARE VAMP8 (also called endobrevin), and that the intraphagosomal pathogen Leishmania 
suppresses an immune response by selectively cleaving VAMP8 in order to block NOX2 assembly 
(20). In this study, we have identified the Q-SNAREs mediating cytochrome b558 recruitment to 
phagosomes containing zymosan (particles derived from Saccharomyces cerevisiae) in dendritic cells 
derived from human blood-isolated monocytes. Through a combination of immunofluorescence 
microscopy, flow cytometry and siRNA knockdown, we demonstrate that gp91phox has already 
been recruited from the plasma membrane to the phagocytic cup, sometime during formation of 
the phagosome. Concurrently, gp91phox traffics to phagosomes from an intracellular pool residing 
in LAMP1-positive compartments. This serves to replenish oxidatively damaged NOX2 at the 
phagosome. The phagosomal recruitment of gp91phox depends on the SNARE proteins VAMP8, 
SNAP23 and Stx7 that can interact with each other and form a stable complex. siRNA-mediated 
knockdown of these SNAREs results in reduced recruitment of gp91phox to the phagosome and 
impairs ROS production. Our findings contribute to our understanding of how dendritic cells are 
able to sustain the production of ROS for hours after antigen uptake, which is required for antigen 
processing and presentation (11–17).
Results
Gp91phox is recruited to phagosomes from the plasma membrane and from late endosomes/lysosomes
In immune cells, gp91phox is present on the plasma membrane and in intracellular compartments 
(4, 6, 7, 19). Activation by immune stimuli can result in enrichment of gp91phox on the plasma 
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membrane (4, 19), raising the possibility that gp91phox is recruited to nascent phagosomes from 
the plasma membrane. In order to determine the source of phagosomal gp91phox in dendritic 
cells, we first determined which fraction of gp91phox resided on the plasma membrane. Dendritic 
cells were derived from monocytes from blood of healthy volunteers and incubated with zymosan 
particles for 60 min. The presence of gp91phox on the plasma membrane was measured by flow 
cytometry using an antibody recognizing an extracellular epitope and no permeabilization. This 
value was compared to that for the total cellular pool of gp91phox with permeabilization (Fig. 1A). 
Around 10% of the total level of gp91phox was present on the plasma membrane in resting dendritic 
cells, and this percentage increased to approximately 22% after zymosan stimulation (Fig. 1A). 
However, we observed a small (~15%) but significant decrease in total cellular levels of gp91phox 
upon zymosan stimulation (Fig. 1A-B), suggesting that gp91phox is degraded following zymosan 
uptake. The decrease of cellular gp91phox could be inhibited by addition of α-tocopherol, a radical 
scavenger, during zymosan uptake (Fig. 1B), indicating that the degradation was due to oxidation 
of gp91phox. 
We then investigated whether gp91phox is recruited to the phagosome from the plasma membrane 
during the formation of the phagocytic cup. By pre-incubating the cells with an antibody against 
gp91phox before zymosan addition, we determined whether plasma membrane gp91phox is taken 
up together with the zymosan particles during phagocytosis. Most phagosomes were positive for 
gp91phox that had originated from the plasma membrane at 15 min after uptake, which is the earliest 
time point at which we obtained a sufficient number of phagosomes for analysis (Fig. 1C, surface-
recruited). We compared this to the total pool of gp91phox on phagosomes, which we visualized by 
immunostaining in the presence of a detergent (Fig. 1C, total). To quantify the presence of gp91phox 
on phagosomes, phagosomal membranes were first selected based on morphology (Fig. S1A). 
Then, we calculated the mean fluorescence intensity of the gp91phox signal at the phagosomal 
membrane and normalized this by division over the mean fluorescence of the imaged area of the 
cell to correct for differences in staining efficiencies and varying expression levels among cells 
and donors. These normalized intensity values allow estimation of phagosomal enrichment for 
gp91phox in an unbiased manner. Normalized intensity values above 1 indicate enrichment on the 
phagosomal membrane, whereas values below 1 indicate reduction. The phagosomal enrichment 
was calculated as the percentage of phagosomes with normalized intensity values above 1. 
Interestingly, the signal of plasma membrane-originated gp91phox gradually decreased over time 
after uptake, whereas the signal of total gp91phox on the phagosomes remained stable (Fig. 1D). 
This decrease of plasma membrane-originated gp91phox signal was caused by sequestration 
of antibody-labeled gp91phox from the phagosomes and not by degradation or dissociation of 
the antibody, as experiments with a control antibody (directed against the zymosan particles) 
showed no decrease in signal (Fig. 1E; Fig. S1B). To test whether gp91phox was replenished at the 
membrane from intracellular compartments, the same preincubation experiment was performed 
with dendritic cells transfected with siRNA against VAMP8 (VAMP8 siRNA; 85% knockdown 
efficiency; Fig. 1F). VAMP8 has been shown to mediate gp91phox recruitment to phagosomes in 
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murine dendritic cells derived from bone marrow (20). After 60 min of incubation with zymosan, the 
phagosomal enrichment of plasma membrane-originated gp91phox was equal for cells expressing 
non-targeting and VAMP8 siRNA (Fig. 1G). However, the total level of gp91phox on phagosomes 
was only increased in non-targeting siRNA samples and not with VAMP8 siRNA (Fig. 1G). These 
results not only confi rm that VAMP8 mediates the recruitment of gp91phox to phagosomes (20), but 
also support the conclusions that gp91phox is initially recruited to phagosomes from the plasma
^ Fig. 1: Recruitment of gp91phox to phagosomes from the plasma membrane and replenishment of oxidized 
gp91phox from intracellular pools. A) Representative fl ow cytometry histograms (left) and mean fl uorescence intensity 
bar graphs (right) of dendritic cells stained for surface gp91phox (without detergent) or total gp91phox (with detergent) in the 
presence or absence of zymosan. Gp91phox levels were normalized to those in permeabilized untreated cells (n=6 donors; 
one-way ANOVA with Tukey’s test). B) Total cellular levels of gp91phox following zymosan stimulation both in the presence 
and absence of α-tocopherol (α-Toc; n=3 donors; two-way ANOVA with Bonferroni’s test). C) Confocal images of dendritic 
cells that had been pre-incubated with an antibody against gp91phox (recruited to the surface; green in merged image) 
or with immunostaining against total gp91phox (total) after 15, 30, 60 and 120 min of stimulation with zymosan (magenta). 
Yellow arrowheads, gp91phox-positive phagosomes. BF, bright fi eld. Scale bars: 10 µm. D) Quantifi cation of the phagosomal 
enrichment of gp91phox from panel C (n=3 donors; two-way ANOVA with Bonferroni’s test). E) Comparison of surface-
enriched gp91phox (from panel D) with the presence of a control antibody directed against the zymosan particles (normalized 
to values at t=15 min; n=3 donors; two-way ANOVA with Bonferroni’s test; representative images are shown in Fig. S1B). 
F) Representative western blots and quantifi cation of siRNA-mediated knockdown of VAMP8 relative to that with a non-
targeting control siRNA (NT) (n=9 donors; two-sided paired Student’s t-test). KD, knockdown; GAPDH, loading control. G) 
Quantifi cation of phagosomal enrichment of surface-recruited and total gp91phox after 60 min zymosan uptake upon siRNA 
knockdown of VAMP8 (KD) by immunofl uorescence analysis (individual donors shown; two-way ANOVA with Bonferroni’s 
test). Results show means ± S.E.M.
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membrane and that there is a subsequent turnover of gp91phox through replenishment from 
intracellular compartments. 
Cytochrome b558 is known to be recruited to phagosomes from vesicles of an endosomal/
lysosomal nature (7, 12, 20, 21), and we tested whether gp91phox was replenished from these 
compartments in our dendritic cells. Gp91phox clearly overlapped with the late endosomal/
lysosomal marker LAMP1 in unstimulated cells (Fig. 2A), similar to that reported previously for 
murine dendritic cells and human islet cells (12, 43). However, LAMP1 seemed largely absent from 
gp91phox-positive phagosomes, indicating that LAMP1 and gp91phox localization might be mutually 
exclusive (Fig. 2A). We calculated Pearson correlation coefficients in order to quantify the overlap 
of LAMP1 with gp91phox (Fig. 2B). Phagosomes were, again, first selected based on morphology 
and then the Pearson correlation coefficients of LAMP1 with gp91phox were calculated (Fig. S1A). 
These were compared with the Pearson correlation coefficients calculated for entire cells in the 
absence of zymosan. We used Pearson correlation coefficients rather than Mander’s overlap 
coefficients as Pearson correlation coefficients are not influenced by changes in signal intensity 
(44, 45). Interestingly, the Pearson coefficient for LAMP1 with gp91phox dropped from ~0.7 in cells 
without zymosan to ~0.3 with zymosan. To further investigate the distribution of gp91phox and 
LAMP1 on phagosomes, we performed timecourse pulse-chase experiments. Dendritic cells 
were pulsed with zymosan at 4ºC (at which zymosan will bind to the cells, but is not taken up) and 
subsequently washed and chased at 37ºC (a temperature at which phagocytosis occurs). We 
observed a transition over time with the content of gp91phox on phagosomes gradually decreasing 
and phagosomal LAMP1 gradually increasing, and this transition occurred via an intermediate 
phase at which the phagosomes were positive for both proteins (Fig. 2C-D). We could not detect 
a pool of gp91phox at the Golgi network (Fig. 2E-F), indicating that gp91phox was not recruited to 
phagosomes from the Golgi. These results indicate that gp91phox traffics from LAMP1-rich late 
endosomes/lysosomes to phagosomes containing no or low levels of LAMP1. 
For complete assembly and activity of NOX2, not only does cytochrome b558 needs to be present 
on the phagosome but also the 3-phosphoinositide lipids phosphatidylinositol (3,4)-bisphosphate 
[PI(3,4)P2] and/or phosphatidylinositol (3)-phosphate [PI(3)P], which interact with p47phox and 
p40phox, respectively, two cytosolic subunits of NOX2 (5, 46–48). We tested for the presence 
of these phosphoinositide lipids on phagosomes by transfecting our dendritic cells with GFP 
fused to the PH-domain of TAPP2 (also known as PLEKHA2) or to the PX-domain of p40phox, 
which specifically recognize PI(3,4)P2 and PI(3)P, respectively (46, 49, 50). We also tested for the 
presence of late endosomal/lysosomal phosphatidylinositol (3,5)-bisphosphate [PI(3,5)P2] using 
the N-terminal sequence of MCOLN1 fused to GFP (50, 51). After pulsing the transfected cells 
with zymosan, we immunolabeled the cells for gp91phox and LAMP1. PI(3,4)P2 and PI(3)P were 
mostly present on gp91phox-enriched phagosomes, but to a less extent or not present on LAMP1-
enriched phagosomes (Fig. 2G-H). In contrast, PI(3,5)P2 was present on phagosomes containing 
gp91phox or LAMP1. These results show that phagosomes containing gp91phox also contain the
67
oXiDiZeD PHaGosomal noX2 ComPleX is rePlenisHeD From lYsosomes
3
^ Fig. 2: Gp91phox traffi cs from LAMP1-rich compartments to phagosomes containing 3-phosphoinositides. 
A) Confocal images of unstimulated and zymosan-pulsed dendritic cells immunostained for gp91phox (green in merge) 
and LAMP1 (magenta). Red arrowheads, cellular compartments positive for gp91phox and LAMP1; yellow arrowheads, 
LAMP1-positive phagosomes; pink arrowheads, gp91phox-positive phagosomes. BF, bright fi eld. Scale bar: 5 µm. B) 
Pearson correlation coeffi cients between gp91phox and LAMP1 channels from A (individual donors shown; two-sided 
unpaired Student’s t-test). C) Confocal images of dendritic cells with a pulse of zymosan at 4ºC and chased for 15, 30, 
60 or 120 min at 37ºC that were immunostained for gp91phox (green in merge) and LAMP1 (magenta). Yellow arrowheads, 
LAMP1-positive phagosomes; pink arrowheads, gp91phox-positive phagosomes; cyan arrowheads, gp91phox and LAMP1 
double positive phagosomes. Scale bar: 10 µm. D) Quantifi cation of the phagosomal enrichment of gp91phox and LAMP1 
shown in panel C. E) As panel A, but cells were stained for gp91phox (green) and TGN38 (magenta). Scale bar: 10 µm. F) 
Pearson correlation coeffi cients between gp91phox and TGN38 channels from E (individual donors shown). G) Confocal 
images of dendritic cells that had been transfected with the GFP-tagged PH-domain of TAPP2 [binds to PI(3,4)P2; cyan in 
merges], the PX-domain of p40phox [PI(3)P] or the N-terminus of MCOLN1 [PI(3,5)P2] immunostained for gp91phox (yellow) 
and LAMP1 (magenta). Pink arrowheads, phagosomes positive for both the described phosphoinositide (PI) and gp91phox; 
yellow arrowheads, phagosomes positive for both the described phosphoinositide and LAMP1. Scale bar: 10 µm. H) 
Quantifi cation of phagosomal enrichment of gp91phox or LAMP1 on phosphoinositide-positive phagosomes from panel G 
(n=3 donors; one-way ANOVA with Tukey’s test). Results show means ± S.E.M.
3-phosphoinositides required for NOX2 activity. Taken together, our data show a turnover of 
NOX2 on phagosomes in which gp91phox is initially recruited from the plasma membrane during 
formation of the nascent phagosome and, later, oxidatively damaged gp91phox (see Fig. 1B) is 
replenished from LAMP1-positive compartments of lysosomal nature. Our data further show 
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that LAMP1-enriched phagosomes do not contain high levels of gp91phox, nor do they contain 
suffi cient levels of the 3-phosphoinositide species required for NOX2 activity.
Gp91phox colocalizes with Stx7, Stx8, SNAP23, Vti1b and VAMP8 on phagosomes
Next, we addressed the question of which SNAREs mediate the phagosomal recruitment of 
gp91phox from late endosomal/lysosomal compartments. We focused on the potential roles of the 
Q-SNARE proteins SNAP23, Vti1b (Qb), Stx7, Stx8 (Qc) and Stx12 in phagosomal cytochrome 
b558 recruitment. We selected these Q-SNAREs for three reasons. First, these SNAREs interact 
with VAMP8 (25, 42, 52–55), which is the R-SNARE involved in phagosomal recruitment of 
cytochrome b558 (20). Second, a recent study with phagosomes purifi ed from human dendritic cells 
(i.e., the cell type studied here) identifi ed the Q-SNAREs Stx7, Stx8 and Stx12 on phagosomes 
(40). The presence of SNAP23, Stx7, Stx12 and Vti1b on phagosomes has been confi rmed by 
immunofl uorescence, cellular fractionation and overexpression of tagged fusion proteins (24, 41, 
42, 56–58). Third, levels of cytochrome b558 on phagosomes correlate with phagosomal SNAP23 
in a macrophage cell line (42), and gp91phox traffi cking and ROS production could be inhibited
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by targeting SNAP23 in primary human neutrophils (59), suggesting a role for this SNARE in the 
phagosomal recruitment of NOX2 in dendritic cells. We started by investigating the localization 
of gp91phox relative to that of VAMP8 and to the aforementioned candidate Q-SNARE proteins. 
As a negative control, we also immunolabeled cells for the ER and Golgi SNARE Stx5 (Qa) 
(60, 61). The colocalization of gp91phox with SNAP23, Stx7, VAMP8, Vti1b and Stx8 could be 
clearly observed, both in unstimulated cells and on zymosan-containing phagosomes (Fig. 
3A; Fig. S2A). To quantify this colocalization, we performed three unbiased analyses. First, we 
calculated Pearson correlation coefficients between the channels of interest on the phagosomal 
membrane (Fig. S1A). These Pearson correlation coefficients were compared with the Pearson 
correlation coefficients calculated for entire cells in the absence of zymosan. As a positive control 
for the maximum overlap observable in our samples, we immunolabeled cells with a primary 
antibody against gp91phox and a combination of secondary antibodies labeled with two different 
fluorophores. The maximum Pearson coefficient observable in our samples calculated with our 
positive control was 0.92 (Fig. 3B; Fig. S2B). In contrast to our previous observations with LAMP1 
(Fig. 2B), the Pearson correlation coefficients measured for the SNARE proteins with gp91phox 
were similar between the absence and presence of zymosan (Fig. 3B; Fig. S2B). Pearson 
coefficients were between 0.5 and 0.7 for gp91phox with Vti1b, Stx7, VAMP8, Stx8, SNAP23 and 
Stx12 regardless of the presence of zymosan. Colocalization of Stx5 gave a Pearson correlation 
coefficient below 0.5. The differences in Pearson correlation coefficients for gp91phox with Vti1b, 
Stx7, VAMP8, Stx8 and SNAP23 were all found to be statistically significant compared to gp91phox 
with Stx5 (Fig. 3C). Furthermore, the Pearson correlation coefficients for gp91phox with Vti1b and 
VAMP8 were also significantly higher than the Pearson correlation coefficients for gp91phox with 
SNAP23, Stx7 and Stx12. Thus, although we did observe some localization of Stx5 at gp91phox-
positive phagosomes, the localization of Vti1b, Stx7, VAMP8, Stx8, SNAP23 and Stx12 at these 
phagosomal membranes was more prevalent. 
For the second analysis, we correlated the average fluorescence intensity of each of the SNAREs 
at the phagosomal membranes with that of gp91phox for all individual phagosomes and normalized 
these by dividing them by the mean fluorescence of the imaged area of the cell (Fig. S1A). We 
< Fig. 3: Gp91phox colocalizes with SNAREs on the phagosomal membrane. A) Confocal images of dendritic 
cells stimulated with zymosan particles for 60 min and immunostained for gp91phox (green in merge) together with Vti1b, 
Stx7, VAMP8, Stx8, SNAP23, Stx12 or Stx5 (magenta). Yellow arrowheads, phagosomes positive for both gp91phox and the 
indicated SNARE. BF, bright field. Scale bar: 5 µm. B) Pearson correlation coefficients for colocalization of gp91phox with the 
indicated SNAREs for zymosan-containing phagosomes (from panel A) and for unstimulated cells (w/o zymosan; Fig S2A). 
Colocalization of gp91phox immunostained with both Alexa Fluor 488 and 568-labeled secondary antibodies is shown as a 
positive control (individual donors shown). C) Significance levels (one-way ANOVA with Tukey’s test) from panel B. Black 
text, zymosan-pulsed samples; red text, unstimulated samples. ns, not significant. D) Normalized staining intensity values 
of phagosomal gp91phox as a function of normalized intensity values of the indicated SNAREs for individual phagosomes 
(log2 scale; phagosomes pooled from >3 donors are shown; solid lines, linear regression with 95% confidence intervals; 
β, regression coefficients; R2, R-squared values). E) Quantification of the phagosomal enrichment for gp91phox and/or the 
indicated SNAREs (from panel D, with normalized intensity values >1). F) Phagosomal enrichment of gp91phox and the 
indicated SNAREs following stimulation with zymosan (n=6 donors for gp91phox; n=3 donors for the SNAREs). Results show 
means ± S.E.M. 
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then performed linear regression analysis. Our positive control of gp91phox immunostaining with 
two differently labeled secondary antibodies showed almost perfect positive correlation (Fig. 3D; 
β = 0.95; R2 = 0.96). The correlations of most of the SNAREs with gp91phox were in reasonable 
agreement with the Pearson correlation coefficients. We observed correlation with the SNAREs 
Vti1b (β = 0.59; R2 = 0.39), Stx7 (β = 0.35; R2 = 0.17), VAMP8 (β = 0.38; R2 = 0.35), Stx12 (β = 
0.46; R2 = 0.26) and Stx8 (β = 0.52; R2 = 0.29; Fig. 3D; Fig. S3). No or only weak correlation was 
observed with Stx5 (β = 0.06; R2 = 0.05). Interestingly, SNAP23 showed the strongest correlation 
with gp91phox of all SNAREs tested (β = 0.80; R2 = 0.57), supporting the possibility that cytochrome 
b558 delivery to phagosomes is mediated by SNAP23 as suggested previously (42, 59).
For the third analysis, we calculated the phagosomal enrichment factors (Fig. S1A). Note that this 
analysis only provides a rough estimate for the enrichment of proteins on phagosomes as the 
fluorescence on the phagosomal membrane is divided over the average fluorescence over the 
imaged cell area. We calculated the enrichment factors for phagosomes containing both gp91phox 
and the SNARE (double positive), and for phagosomes containing only one of these proteins (Fig. 
3E). The results of this analysis were in reasonable agreement with those from the Pearson and 
regression analyses, with the overlap with gp91phox higher for Vti1b, Stx7, VAMP8, Stx8, SNAP23 
and Stx12 than for Stx5. We also used phagosomal enrichment factors to quantify the kinetics 
of gp91phox and SNARE recruitment to phagosomes (Fig. 3F). As we expected based on the 
phagosomal recruitment of gp91phox from the plasma membrane shown by our data (Fig. 1C-D) 
and on the pulse-chase time-course experiments with LAMP1 (Fig. 2C-D), gp91phox was already 
enriched in the majority of the phagosomes within 15 min after stimulation (the earliest time 
point at which we obtained a sufficient number of phagosomes for analysis). The phagosomal 
enrichment of gp91phox was stable or increased somewhat up to 60 min after uptake and 
decreased afterwards. Similarly, SNAP23 and Vti1b remained present at comparable levels over 
the entire 2 hours timecourse of the experiment. The phagosomal enrichment of Stx7, VAMP8 and 
> Fig. 4: siRNA knockdown of Stx7, SNAP23 and VAMP8 reduces phagosomal recruitment of cytochrome 
b558 and ROS production. A) Representative western blots and quantifications of siRNA knockdown (KD) for Stx7 (51% 
knockdown efficiency), Stx12 (56%), SNAP23 (67%) and gp91phox (92%) relative to levels with a non-targeting siRNA control 
(NT). GAPDH, loading control (n=8 donors; two-sided paired Student’s t-test). B) Confocal images of dendritic cells pulsed 
with Alexa Fluor 633-conjugated zymosan particles (magenta in merge) and then immunolabeled for gp91phox (green) with 
knockdown of VAMP8, Stx7, Stx12 or SNAP23. Yellow arrowheads, phagosomes enriched for gp91phox; red arrowheads, 
phagosomes negative for gp91phox. BF, bright field. Scale bar: 10 µm. C) Quantification of the phagosomal enrichment of 
gp91phox from panel B (individual donors shown; one-way ANOVA with Dunnett’s test; representative confocal images of 
gp91phox KD are shown in panel F). ns, not significant. D) Quantification of the phagosomal enrichment of EEA1 and LAMP1 
(individual donors shown; representative confocal images are shown in Fig. S4B). E) Quantification of the enrichment 
of gp91phox and p67phox to zymosan-containing phagosomes in dendritic cells with knockdown of gp91phox or Stx7 (n=3 
donors; one-way ANOVA with Tukey’s test). F) Representative confocal images for data presented in E. Yellow arrowheads, 
phagosomes enriched for gp91phox (green) and p67phox (magenta); red arrowheads, phagosomes negative for gp91phox and 
p67phox. BF, bright field. Scale bar: 10 µm. G) Confocal images of zymosan-pulsed dendritic cells with VAMP8, Stx7, Stx12 
or SNAP23 knockdown. Zymosan particles were labeled with ROS-sensitive OxyBURST that becomes fluorescent upon 
oxidation (shown in rainbow lookup table). Scale bar: 10 µm. H) Intraphagosomal ROS production calculated from the 
fluorescence intensities shown in panel G (normalized to those with non-targeting siRNA; one-way ANOVA with Dunnett’s 
test; individual donors shown). Results show mean ± S.E.M. 
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Stx8 gradually increased over time, indicating that these SNAREs were recruited from intracellular 
compartments to the phagosome. In contrast, the phagosomal enrichment of Stx12 decreased 
over time, indicating that it was removed from the phagosomal membrane.
 
siRNA knockdown of Stx7, SNAP23 and VAMP8 decreases phagosomal NOX2 complex recruitment and activity
In order to investigate which SNAREs are involved in the phagosomal recruitment of gp91phox from 
lysosomal compartments, we performed siRNA-mediated silencing of Stx7, Stx12 and SNAP23 
(Fig. 4A; average knockdown effi ciencies of 51% for Stx7, 56% for Stx12 and 67% for SNAP23). 
As a positive control, we also transfected dendritic cells with siRNA against gp91phox (92% 
knockdown effi ciency; Fig. 4A), and against VAMP8 (85% knockdown effi ciency; Fig. 1F), which 
is the R-SNARE required for phagosomal recruitment of gp91phox (Fig. 1G) (20). We were unable 
to obtain substantial knockdown (< 25%) of Vti1b and Stx8 in dendritic cells. In unstimulated cells, 
we did not see any obvious rearrangement of gp91phox upon knockdown of the SNAREs, and it 
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still located to the plasma membrane and intracellular pools (Fig. S4A); however, due to the limited 
resolution of our microscope, we cannot exclude that (part of) the intracellular pool of gp91phox 
mislocated to other intracellular compartments upon SNARE knockdown. For each condition, we 
evaluated the enrichment of gp91phox to the phagosome 60 min after uptake of zymosan particles 
labeled with Alexa Fluor 633. Each condition was compared to a non-targeting siRNA-transfected 
condition (Fig. 4B). Compared to results with the non-targeting siRNA, we observed significant 
loss of phagosomal gp91phox recruitment upon knockdown of VAMP8, Stx7 and SNAP23 (Fig. 
4C). In contrast, we did not observe loss of gp91phox recruitment upon Stx12 knockdown (Fig. 4C). 
The phagosomal enrichment of LAMP1 and of the early endosomal marker EEA1 were unaffected 
upon VAMP8, Stx7 and SNAP23 knockdown (Fig. 4D; Fig. S4B), indicating that the reduced 
phagosomal recruitment of gp91phox was not due to a general maturation defect. These results 
support a role for SNAP23 and Stx7 (but not Stx12) in the recruitment of gp91phox to phagosomes. 
For the complete assembly of NOX2, the cytosolic subunits p47phox, p40phox and p67phox need 
to bind to gp91phox (4–6). Indeed, recruitment of p67phox to phagosomes was reduced upon 
knockdown of gp91phox (Fig. 4E–F), confirming that gp91phox is required for NOX2 assembly. In 
line with this, knockdown of Stx7 (i.e., one of the SNAREs required for phagosomal recruitment 
of gp91phox) resulted in decreased recruitment of both gp91phox and p67phox to phagosomes 
(Fig. 4E–F). To further investigate the potential roles of SNAREs in the assembly of functional 
NOX2, we measured the effects of SNARE knockdown on phagosomal ROS production. 
We measured intraphagosomal ROS with the ROS probe OxyBURST Green H2DCFDA 
(2’,7’-dichlorodihydrofluorescein diacetate), which we covalently coupled to zymosan particles. 
Oxidation of the non-fluorescent H2DCF by ROS results in the formation of the highly fluorescent 
dichlorofluorescein, thereby providing a direct means for detecting ROS in phagosomes of 
dendritic cells by confocal microscopy (62, 63) (Fig. 4G). Upon knockdown of VAMP8, Stx7 
and SNAP23, the OxyBURST fluorescence was decreased compared to that with the non-
targeting siRNA (Fig. 4H). We did not observe a significant decrease in ROS production upon 
Stx12 knockdown (Fig. 4H). These findings further support the involvement of Stx7, SNAP23 and 
VAMP8 in gp91phox recruitment to the phagosome.
These SNAREs could function in membrane trafficking steps upstream of the recruitment of 
gp91phox to the phagosome. However, as VAMP8, Stx7 and SNAP23 are all located at the 
phagosomal membrane, it is also conceivable that they directly mediate the delivery of gp91phox
to phagosomes, with VAMP8 (R-SNARE) complexing with Stx7 (Qa) and SNAP23 (Qb and Qc). A 
SNARE complex comprising VAMP8, Stx7 and SNAP23 has not been described in the literature 
and we next determined whether these SNAREs can form a complex.
SNAP23, Stx7 and VAMP8 can form a SNARE complex
VAMP8 is well-known to complex with Stx7 (25, 31, 52, 64) and with SNAP23 (65, 66). The 
interaction of Stx7 with SNAP23 has not been described, but Stx7 can be immunoprecipitated 
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with overexpressed SNAP23 in J774 macrophages (42). To investigate whether Stx7 complexes 
with endogenous SNAP23 in dendritic cells, dendritic cell lysates were incubated with antibodies 
against Stx7, and the immunoprecipitates were subjected to western blot analysis for SNAP23 
(Fig. 5A). We observed the presence of SNAP23 in the immunoprecipitates, and this presence 
increased >10-fold when we blocked NSF-mediated SNARE disassembly with N-ethylmaleimide 
(NEM). The presence of zymosan increased the interaction of SNAP23 with Stx7, but not 
signifi cantly. This experiment demonstrates that SNAP23 interacts with Stx7 in vivo; we then 
addressed whether these two SNAREs could form a ternary SNARE complex with VAMP8. We 
combined recombinantly expressed (in Escherichia coli ) and purifi ed full-length SNAP23, Stx7 and 
VAMP8 in a stoichiometric ratio. After overnight incubation, this mixture was subjected to SDS-
PAGE. A four-helix bundle SNARE complex is very stable and cannot be denatured by SDS at 
room temperature, but it does disassemble upon heating the sample to 95ºC. We observed clear 
SNARE complex formation (i.e. multiple bands running at high molecular masses) provided that 
all three SNARE proteins were present, whereas no complexes could be observed with binary 
mixtures of only two of the SNARE proteins present (Fig. 5B). This experiment demonstrates that 
SNAP23, VAMP8 and Stx7 are capable of forming a SNARE complex in vitro. 
^ Fig. 5: Complex formation of Stx7, SNAP23 and VAMP8. A) Immunoprecipitation (IP) of Stx7 (α-Stx7) from 
zymosan-pulsed dendritic cells with or without NEM and probed for SNAP23 (α-SNAP23). Shown are a representative 
western blot and quantifi cation of the band intensities normalized to control conditions (without zymosan and NEM) (mean 
± S.E.M. of fi ve donors; one-way ANOVA with Tukey’s test). WCL, whole-cell lysate. First lane shows only antibody in buffer 
without lysate. B) In vitro complex formation of purifi ed full-length VAMP8 (blue arrowhead), SNAP23 (green) and Stx7 (red) 
analyzed by SDS-PAGE and Coomassie staining. Ternary SNARE complexes (multiple bands between ~250 and 37 kDa; 
pink arrowheads) are SDS resistant at 20ºC but disassemble at 95ºC. A representative gel from three experiments is shown.
Discussion
An essential step for the function of NOX2 is the recruitment of its transmembrane component 
cytochrome b558 to phagosomes. In this study, we found that gp91
phox, which traffi cs together 
with p22phox (6–8), is initially internalized together with the zymosan phagocytic cargo from the 
plasma membrane (Fig. 6). During or after formation of the phagosome, an intracellular pool 
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of gp91phox has already been trafficked to phagosomes from LAMP1-rich compartments of 
a late endosomal/lysosomal nature (Fig. 6), as has been reported previously (12, 20). When 
phagosomes convert into LAMP1-rich lysosomes, they contain no or only low levels of gp91phox 
and the 3-phosphoinositides PI(3,4)P2 and PI(3)P required for NOX2 activity. Our data show 
a decrease of cellular levels of gp91phox following zymosan uptake, and this decrease can be 
blocked by the radical scavenger α-tocopherol; the trafficking from intracellular compartments 
is likely to serve to replenish gp91phox affected by oxidative damage. Thus, the turnover of the 
phagosome allows a sustained production of ROS by NOX2 during phagosome maturation. This 
is likely to be of particular importance for dendritic cell function, where, and in contrast to the 
more transient oxidative burst in neutrophils and macrophages, a sustained ROS production is 
essential for antigen processing and presentation (11–17).
We identified a role for Stx7, SNAP23 and VAMP8 in trafficking of cytochrome b558 to the antigen-
containing phagosome. VAMP8 and SNAP23 have been shown previously to be involved in this 
process (20, 42, 59), and our data confirm this. Although SNAP23 has long been considered to 
be a plasma membrane SNARE (22, 65–71), it is increasingly clear that it also has intracellular 
functions in many different cell types (42, 57, 72–79). The localization of SNAP23 to phagosomes 
was only discovered recently, and it was implied to mediate phagosomal recruitment of gp91phox 
and MHC class I (42, 57). Stx7 is widely considered to be a late endosomal SNARE that mediates 
fusion of late endosomes and lysosomes (25, 28, 29, 31, 33). Our findings are in line with this 
given that cytochrome b558 is recruited from intracellular compartments of a lysosomal nature 
to phagosomes. As our data show that SNAP23, Stx7 and VAMP8 all localize to phagosomes 
with gp91phox and that they can form a complex together, it seems plausible that these SNAREs 
directly catalyze the fusion of gp91phox-containing vesicles with phagosomes. However, it could 
also be that these SNAREs catalyze upstream fusion steps needed for cytochrome b558 trafficking 
to the phagosome. Accordingly, we cannot exclude the involvement of other SNAREs, including 
Stx8 and Vti1b, due to insufficient knockdown levels. Finally, it may well be that the trafficking of 
cytochrome b558 differs among cell types or stimuli, especially considering that zymosan results 
in much more pronounced NOX2 activity compared to other immune stimuli (80). Stimulus-
dependent assembly of NOX2 occurs in primary mouse neutrophils, where NOX2 assembles 
within seconds on phagosomes bearing serum-opsonized Staphylococcus aureus, as opposed to 
phagosomes containing immunoglobulin G-bound targets, where the NOX2 complex assembles 
on a tubulovesicular compartment at the base of the emerging phagosome (48).
Possibly, the vesicles trafficking cytochrome b558 to phagosomes also contain late endosomal/
lysosomal cargo molecules such as the V-ATPase and/or lysosomal cathepsin proteases. This 
could be the case since the V-ATPase and LAMP1 are recruited to phagosomes in a SNAP23-
dependent manner, similar to cytochrome b558 in a mouse macrophage cell line (42). In 
macrophages, V-ATPase subunit a3 is recruited from late endosomal/lysosomal compartments 
containing LAMP2 and Stx7, and this occurs early during phagosome formation (81), similar to the 
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^ Fig. 6: Model of phagosomal turnover of gp91phox. (1) During phagosome formation, cytochrome b558 [gp91
phox 
(gp91) and p22phox (p22)] is internalized from the plasma membrane together with zymosan. (2) Cytochrome b558-positive 
phagosomes contain the 3-phosphoinositides required for NOX2 activity – PI(3,4)P2 and/or PI(3)P. (3) NOX2 produces 
ROS, which result in auto-oxidation of cytochrome b558. (4) Phagosomal cytochrome b558 is replenished from an intracellular 
pool residing in LAMP1-rich late endosomes/lysosomes through the action of the SNARE proteins VAMP8, Stx7 and 
SNAP23. p47, p47phox; p67, p67phox; p40, p40phox.
recruitment of gp91phox observed in our study. However, we found that LAMP1 and gp91phox 
do not colocalize on phagosomes, and we did not detect a defect of LAMP1 traffi cking upon 
SNARE knockdown. Moreover, both LAMP1 and the V-ATPase are recruited to phagosomes 
later than gp91phox in human dendritic cells (14), and LAMP1 and cathepsins are recruited 
later than the V-ATPase in murine macrophages (81–83), making it unlikely that cytochrome 
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b558-trafficking vesicles also contain these molecules. Another interesting question is how 
cytochrome b558 trafficking to the phagosomal membrane is regulated. Key proteins for this 
process include the small GTPase Rab27a in murine dendritic cells (12) and the Ca2+-sensor 
synaptotagmin-11 in murine macrophages (21). The recruitment of gp91phox may also be regulated 
by phosphorylation of SNAP23, as it has recently been shown that recruitment of MHC class I 
to phagosomes is promoted by IKK2-dependent phosphorylation of SNAP23 in murine dendritic 
cells (57). Similar to NOX2 (11, 12, 14, 17), the presence of MHC class I at the antigen-containing 
phagosome is important for cross-presentation to cytotoxic T lymphocytes by dendritic cells 
(84, 85). Our findings contribute to the emerging concept that SNAP23 is a key regulator for 
dendritic cell function. Targeting SNAP23 and other SNAREs responsible for phagosomal 
maturation might be a novel strategy to combat autoimmune diseases, infection and cancer. 
 
Material and methods
Cell culture
Primary cultures of human monocyte-derived dendritic cells were generated from peripheral 
blood monocytes (PBMCs) obtained from buffy coats of healthy individuals (informed consent 
obtained and approved by RadboudUMC ethical committee) according to institutional guidelines 
and as described previously (86). Monocytes were differentiated into dendritic cells by culturing 
for 6 days at 37ºC under 5% CO2 in complete RPMI-1640 (Gibco, ThermoFisher) supplemented 
with 10% fetal bovine serum, 2 mM UltraGlutamine (Lonza), 1% Antibiotic-Antimytotic (AA, Gibco, 
ThermoFisher), 300 U/ml IL-4 and 450 U/ml granulocyte-macrophage colony-stimulating factor 
(GM-CSF).
Antibodies
Primary antibodies used were: mouse-IgG1 anti-gp91phox (D162-3, MBL), rabbit serum anti-
SNAP23 (111202, Synaptic Systems), rabbit serum anti-Stx8 (110083, Synaptic Systems), rabbit 
serum anti-Stx7 (110072, Synaptic Systems), mouse-IgG1 anti-Stx7 (sc-514157, Santa Cruz), 
rabbit serum anti-Stx12 (299022, Synaptic Systems), rabbit serum anti-VAMP8 (104302, Synaptic 
Systems), rabbit serum anti-Vti1b (164002, Synaptic Systems), rabbit serum anti-Stx5 (110053, 
Synaptic Systems), rabbit serum anti-LAMP1 (L1418, Sigma), rabbit serum anti-TGN38 (sc-27680, 
Santa Cruz), mouse-IgG1 anti-EEA1 (610456, BD Biosciences), rabbit serum anti-p67phox (07-
002, Merck Millipore), rabbit monoclonal-IgG anti-GAPDH (2118, Cell Signaling Technology), 
mouse-IgG1 anti-FITC (200-602-037, Jackson ImmunoResearch Laboratories) and mouse-
IgG1 isotype control (400102, Biolegend). The following secondary antibodies were used for 
immunofluorescence: goat anti-mouse IgG (H+L) Alexa Fluor 488 or 568-conjugated (A-11029 
and A-11031, ThermoFisher) and goat anti-rabbit IgG (H+L) Alexa Fluor 568 or 647-conjugated 
(A-11036 and A-21245, ThermoFisher) antibodies. For immunoblotting, we used secondary 
antibodies goat anti-rabbit or anti-mouse IgG (H+L) IRDye-800CW-conjugated (926-32211, Li-
Cor) antibodies, and for flow cytometry, goat anti-mouse IgG (H+L) Alexa Fluor 488-conjugated 
antibodies were used.
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siRNA knockdown assays
Dendritic cells were transfected with siRNA (all ThermoFisher) against gp91phox 
(5’-CCGAGUCAAUAAUUCUGAUCCUUAU-3’), syntaxin-7 (mix of 3 siRNAs: 
5’-GCAGCUGUCAAGGGCAGCAGAUUAU-3’, 5’-GGAGUUGCGAUUAUCAGUCUCAUCA-3’, 
5’-GAGAAUCUUCUAUCAGGCAACUUGA-3’), SNAP23 (mix of 3 siRNAs: 
5’-GACACCAACAGAGAUCGUAUUGAUA-3’, 5’-GGAUAAUCUGUCAUCAGAAGAAAUU-3’, 
5’-CAUAGGCAAUGAGAUUGAUGCUCAA-3’), VAMP8 (mix of 3 siRNAs: 5’- 
GAGGAAAUGAUCGUGUGCGGAACCU-3’, 5’-GAGGUGGAGGGAGUUAAGAAUAUUA-3’, 
5’-CGACAUCGCAGAAGGUGGCUCGAAA-3’) or syntaxin-12 (mix of 3 siRNAs: 
5’-GCAACAGUUACAACACUCCACAAAU-3’, 5’-UCACUGAGCAGGAUUUGGAACUUAU-3’, 
5’-ACAGUUACAGCGAGCUGCUUACUAU-3’) or with irrelevant ON-TARGET plus Non-Targeting 
(NT) siRNA#1 (Dharmacon), as described previously (11).
Immunoblotting
Knockdown efficiency was analysed by SDS-PAGE (20 µg/lane; 12% acrylamide). Proteins were 
transferred to PVDF membranes, blocked with 3% milk and 1% BSA in PBS (137 mM NaCl, 
2.7 mM KCl, pH 7.4) and incubated with primary antibodies (1:500 dilution). Protein expression 
was visualized using IRDye-800-labeled secondary antibody (Li-Cor; 1:5,000 dilution). Western 
blots were imaged using the Odyssey CLx Infrared Imaging System (Li-Cor), and processed with 
ImageStudio (Li-Cor).
Microscopy sample preparation
Alexa Fluor 633-labeled zymosan particles were produced by rehydrating 10 mg zymosan (Z4250, 
Sigma) in 900 µL of 0.2 M Na2CO3/NaHCO3 pH 9.0. 50 µL of this suspension was subsequently 
added to a vial containing 220 nmol Alexa Fluor 633 C5-maleimide (A-20342, ThermoFisher). 
Unbound dye was removed by vigorous washing with PBS. 
For microscope sample preparation, 50,000 dendritic cells were plated on 12-mm-diameter 
glass coverslips in the presence of unlabeled or Alexa Fluor 633-labeled zymosan particles in a 
particle-to-cell ratio of 5:1 in serum-free RPMI medium with 1% AA and 2 mM UltraGlutamine, and 
incubated at 37ºC under 5% CO2. For the pulse-chase experiments, cells were incubated for 30 
min with zymosan at 4ºC, subsequently washed and incubated for 15, 30, 60 or 120 min at 37ºC 
under 5% CO2. The cells were washed with PBS and fixed in 4% paraformaldehyde (PFA) in PBS 
for 15 min at room temperature. Cells were permeabilized with 0.1% (v/v) saponin and blocked 
with confocal laser scanning microscopy (CLSM) buffer [PBS, 20 mM glycine and 3% (w/v) 
BSA] for 30 min. For immunostaining, the cells were incubated with primary antibodies (1:200) 
in CLSM with 0.1% saponin for 60 min at room temperature or overnight at 4ºC. Subsequently, 
cells were washed with PBS and incubated with secondary antibodies (1:400) for 60 min at room 
temperature. Cells were embedded in 68% glycerol with DAPI.
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Preincubation with antibodies against gp91phox
Cells on coverslips were incubated with or without anti-gp91phox antibody (1:400) for 30 min at 4ºC. 
Cells were washed and stimulated with Alexa Fluor 633-labeled zymosan particles (5 particles/
cell) at 37ºC under 5% CO2. Subsequently, the cells were fixed, blocked and permeabilized as 
described above. Samples without anti-gp91phox preincubation were stained with anti-gp91phox 
antibody (1:200) in CLSM with 0.1% saponin and incubated overnight. This was followed by 
staining and mounting as described above. For the control antibody experiments, zymosan 
conjugated to FITC (50) was incubated with Alexa Fluor 647-labeled anti-FITC antibody (1:200) 
for 30 min at 4ºC, extensively washed and resuspended in RPMI medium. Cells were incubated 
with these particles and stained with Alexa Fluor 568-labeled secondary antibody as described 
above.
Phosphoinositide transfection 
For colocalisation experiments with phosphoinositides, cells were transfected with plasmids 
(10 pg/cell) encodinh the PH-domain of TAPP2, the PX-domain of p40phox or the N-terminus of 
MCOLN1, as described previously (50). At 7 hours post transfection, cells were stimulated with 
unlabeled zymosan (5 particles/cell) in serum-free RPMI for 60 min at 37ºC, and fixed and stained 
as described before.
Measurement of phagosomal ROS production
Amine-reactive OxyBURST-Green H2DCFDA (3 mg; D-2935, ThermoFisher) was incubated with 
10 mg zymosan for 60 min at room temperature. Subsequently, OxyBURST was activated with 
1.5 M hydroxylamine. Free dye and hydroxylamine were removed with a Nanosep 300K Omega 
filter tube (OD300C34, Pall corporation). Cells on coverslips were cultured with OxyBURST-
zymosan (4 particles/cell) for 60 min at 37ºC under 5% CO2, fixed with 4% PFA and mounted as 
described above.
Microscopy and colocalization analysis
All samples were imaged with a Leica SP8 confocal laser scanning microscope with a 63×1.20 NA 
water immersion objective (Leica HC PL APO 63×/1.20 W CORR CS2). All images were evaluated 
with Fiji (ImageJ 1.49 s). Colocalization and intensity levels were evaluated by first selecting a 
phagosome based on morphology. The areas corresponding to phagosomal membranes were 
then selected, and finally colocalization of proteins was calculated using the Pearson correlation 
coefficient. All images were evaluated independently. At least 25 phagosomes for at least 3 
independent experiments each were analyzed.
Flow cytometry
Cells were cultured with Alexa Fluor 633-labeled zymosan (5 particles/cell) with or without 500 
µM α-tocopherol in serum-free RPMI with 1% AA and 2 mM UltraGlutamine, and incubated for 30, 
60 or 120 min. Cells were then washed with PBS supplemented with 0.5% BSA (in phosphate-
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buffered albumin PBA) and fixed in 4% PFA in PBS for 4 min on ice. Cells were blocked with PBA 
supplemented with 2% human serum, or blocked and permeabilized with 0.5% (v/v) saponin in 
PBA for 10 min on ice. For staining, cells were incubated with anti-gp91phox antibody or isotype 
control (1:200) in PBA with or without 0.5% saponin for 30 min at 4ºC. Subsequently, the cells 
were washed with PBS and incubated with goat-anti-mouse IgG (H+L) Alexa Fluor 488 (1:400) in 
PBA with or without 0.5% saponin for 30 min at 4ºC. After incubation, the fluorescence intensity 
of Alexa Fluor 488 was measured by flow cytometry (excitation, 488 nm; emission, 530/30 nm; 
FACSCaliber, BD Biosciences). 
Immunoprecipitation
Cells were incubated with or without zymosan (50 particles/cell) for 45 min at 37ºC. Cells were 
washed twice with PBS and incubated with or without NEM at a final concentration of 2 mM 
for 15 min at 37ºC. NEM was quenched by washing once with 4 mM DTT.  Cells were lysed in 
immunoprecipitation (IP) buffer (20 mM Tris-HCl pH 7.6, 137 mM NaCl, 1% IGEPAL, 2 mM EDTA). 
Lysates were precleared and incubated with 1 µg of mouse IgG1 anti-Stx7 antibody for 30 min 
on ice, followed by incubation overnight with protein-G-Sepharose at 4ºC. Samples were washed 
with IP buffer, and protein was eluted by boiling in SDS sample buffer. IP samples and 4% of total 
lysates were analyzed by western blotting for SNAP23 and Stx7. 
SNARE complex formation
Fragments of rat full-length VAMP8, rat full-length Stx7 and rat full-length SNAP23 were purified as 
described previously (64, 87). For assembly of the SNARE complexes, 10 mM of the three protein 
fragments was incubated overnight at room temperature. Samples were analyzed by SDS-PAGE 
with colloidal Coomassie Blue (ThermoFisher).
Statistical analysis
Sample sizes represent the number of individual donors or phagosomes as indicated in the 
figures. Data were analyzed using one-way ANOVA (following post-hoc Tukey or Dunnett’s tests), 
two-way ANOVA (following post-hoc Bonferroni’s test), regression analysis or Student’s (un-)
paired two-sided t-tests. A value of P<0.05 was considered statistically significant for all statistical 
analyses (*P <0.05; ** P <0.01; *** P <0.001).
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Supplementary Figures
^ Fig. S1: Calculation of the Pearson correlation coefficients on the phagosomes and the phagosomal 
enrichment factors, and control experiment for phagosomal sequestration of gp91phox. A) Example confocal 
image of a dendritic cell immunostained for gp91phox (green) and VAMP8 (magenta). For the Pearson correlation coefficients, 
the membranes of individual phagosomes were manually selected based on morphology (excluded area masked in red) and 
the correlation between the channels was calculated. For the normalized intensity values (In), the membranes of individual 
phagosomes were also manually selected and the mean fluorescence intensitity (I1) was determined for each phagosome. 
These values were then divided by the mean fluorescence intensity over the entire imaged cell area (I2) to correct for 
different staining efficiencies and expression levels among cells/donors (perimeter of the imaged cell area depicted in 
red). The phagosomal enrichment is defined as the percentage of phagosomes with normalized intensity values > 1. B) 
Representative confocal images of dendritic cells stimulated with zymosan conjugated with FITC (Zym-FITC; blue) and 
labeled with an Alexa Fluor 647-labeled antibody raised against FITC (primary; red). After 60 min of stimulation, cells were 
immunostained with an Alexa Fluor 568-labeled secondary antibody (secondary; green). The images were quantified from 
the Alexa Fluor 568 signal relative to the Alexa Fluor 647 signal (shown in main Fig. 1E). BF, bright field. Insets, magnification 
of zymosan-containing phagosomes. Scale bar: 10 µm.
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^ Fig. S2: Gp91phox colocalizes with SNAREs in resting cells. A) Confocal images of dendritic cells (without 
zymosan) immunostained for gp91phox (green in merge) with Vti1b, Stx7, VAMP8, Stx8, SNAP23, Stx12 or Stx5 (magenta). 
Yellow arrowheads, cellular regions positive for both gp91phox and the indicated SNARE. BF, bright field. See main Fig. 3B–C 
for quantification. Scale bar: 10 µm. B) The mean Pearson correlation coefficients of unstimulated and zymosan-pulsed 
cells of main Fig. 3B.
^ Fig. S3: Regression analysis of normalized intensity values on phagosomes. Similar to Fig. 3D. Normalized 
intensity values of gp91phox as a function of normalized intensity values of the indicated SNAREs for individual phagosomes 
(Log2-scale; solid lines, linear regression with 95% confidence intervals; β, regression coefficients; R2, R-squared values).
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^ Fig. S4: Subcellular localization of gp91phox, EEA1 and LAMP1 after knockdown. A) Representative confocal 
images of dendritic cells with knockdown of gp91phox, VAMP8, Stx7, SNAP23 and Stx12 (without zymosan) immunostained 
for gp91phox. B) Representative confocal images of dendritic cells with knockdown of gp91phox, VAMP8, Stx7, SNAP23 and 
Stx12 stimulated with zymosan and immunostained for EEA1 (green in merge) and LAMP1 (magenta). Yellow arrowheads: 
phagosomes enriched for EEA1; red arrowheads: phagosomes enriched for LAMP1. Scale bars, 10 µm.
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Abstract
After uptake of pathogens and malignant cells, dendritic cells of the immune system rely on 
the sustained production of radical oxygen species (ROS) for antigen presentation. These 
ROS are produced by the NADPH oxidase NOX2. As a result of ROS production, gp91phox, 
the membrane-integrated catalytic subunit of NOX2, suffers from oxidative modifications and 
needs to be constantly replenished from a pool residing in lysosomal compartments. Goal of 
this study is to elucidate the mechanism by which oxidatively modified gp91phox is removed from 
antigen-containing compartments. We found that NOX2 activity results in the recruitment of the 
autophagy-related protein LC3 to phagosomes in human monocyte-derived dendritic cells. Super-
resolution STED microscopy revealed that LC3 was not present at the enclosing membrane of 
the phagosome, but rather located at gp91phox-positive punctuated structures juxtaposed to the 
phagosome. Formation of these punctuated structures was dependent on the autophagy-related 
protein ATG12 and the adapter protein p62 (SQSTM1), which both are required for removal of 
gp91phox from the phagosomal membrane. Furthermore, removal of NOX2 from phagosomes 
was dependent on the ESCRT-III protein CHMP1B, which, opposite to other ESCRT proteins, can 
bulge membrane inwards into the cytosol. Our data support a model where self-oxidized NOX2 is 
removed from phagosomes by the formation of membrane compartments that emanate from the 
phagosomal membrane and are targeted to autophagosomes. This is a new cellular mechanism 
for the degradation of integral membrane proteins and provides a mechanistic explanation for the 
known roles of autophagy in antigen presentation.
Introduction
Recognition and uptake of pathogens by dendritic cells of the immune system trigger activation 
of many processes within the cell. This results in elevated production of radical oxygen species 
(ROS) within the phagosome by the NADPH oxidase NOX2, required for killing of the pathogen 
(1) and for regulation of proteolytic processing for antigen presentation (2–7). However, the 
ROS production will also cause oxidative damage within the dendritic cell, resulting in oxidative 
modifications of lipids and proteins (8, 9). Recently, we showed that ROS production results in 
auto-oxidation of gp91phox, the catalytic membrane component of NOX2, resulting in loss of NOX2 
activity (8). Our data showed that gp91phox initially reaches the phagosome by co-encapsulation 
from the plasma membrane during uptake of the pathogen. Phagosomal gp91phox is subsequently 
replenished from a lysosomal compartment by the interactions of the SNARE proteins VAMP8, 
syntaxin-7 and SNAP23 (8). This replenishment allows to maintain ROS production for prolonged 
times after antigen uptake, which is a requirement for antigen (cross-)presentation (3, 10).
One question that was raised during our recent study (8) is if and via which mechanism oxidatively 
modified NOX2 is removed from the phagosomal membrane. Soluble proteins suffering from 
oxidative damage can be proteolytically degraded by the proteasome or in lysosomes following 
import by lysosomal associated membrane protein 2 (LAMP2) (11). Integral membrane proteins 
can also be degraded in lysosomes, and they are sorted into the lysosomal lumen by two 
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degradation pathways: formation of multivesicular bodies (MVBs) and autophagy. 
First, membrane-associated proteins and lipids can be delivered to lysosomes via the formation 
of MVBs by the endosomal sorting complexes required for transport (ESCRT) machinery (12). 
Ubiquitination of cargo proteins destined for degradation leads to their recognition by and 
recruitment of the ESCRT machinery, which pushes the protein outwards into the lumen of the 
endosomes, thereby resulting in their sorting into intraluminal vesicles (ILVs) within the endosome 
(13). The ESCRT machinery, first found in yeast but conserved in mammalian cells, consists of 
five complexes: ESCRT-0, -I, -II, -III and VPS4 (14, 15). ESCRT-0 initiates the process of MVB 
formation by recognition of phosphatidylinositol-3-phosphate (PI3P) and ubiquitinated proteins 
on the endosomal membrane. ESCRT-0 is followed by recruitment of the ESCRT-I and ESCRT-
II complexes, which both bind ubiquitinated proteins. This in turn leads to the budding of the 
endosomal membrane into the endosomal lumen and recruitment of ESCRT-III, which mediates 
the recruitment of deubiquitination enzymes and ILV formation by membrane scission. Finally, 
activation of the VPS4 complex results in disassembly of ESCRT-III from the endosomal membrane. 
Upon fusion of the MVBs with lysosomes, the ILVs are digested completely by lysosomal 
metabolic enzymes (16). In addition to outward budding, some ESCRT proteins, including the 
ESCRT-III protein CHMP1B, have been shown to be able to pull membranes inwards into the 
cytosol (17–19), but the cellular roles of this tubulation in protein degradation remain unclear.
Second, damaged proteins, membrane structures and even complete organelles can be delivered 
to lysosomes via autophagy. Autophagy is a degradation system used by the cell to maintain cellular 
homeostasis (20, 21). The best understood form of autophagy is macro-autophagy which involves 
the formation of a double-membrane compartment, called an autophagosome, encapsulating 
proteins and organelles (21, 22). For autophagosome formation, ubiquitinated proteins are 
recognized by the adapter protein p62/SQSTM1, which can in turn bind to membrane structures 
carrying the protein LC3, called autophagophores (23–28). Autophagophore formation relies on 
an ubiquitin-like initiation complex consisting of autophagy-related gene (ATG) 5, 6, 12 and 16 
and a conjugation complex consisting of ATG3, 4 and 7 (21, 22). The fusion of autophagophores 
surrounding the autophagosomal cargo completes formation of the autophagosome. Similar to 
MVBs, completed autophagosomes can fuse with lysosomes to form autolysosomes and this 
mediates the degradation of the inner membrane of the phagosome and the autophagosomal 
cargo.  
Autophagosomal proteins can also play a role in the processing of ingested pathogens via a 
mechanism different from macro-autophagy. LC3 can bind to single-membrane phagosomes 
upon phagocytosis of C. albicans, L. monocytogenes, killed yeast (zymosan), or particles coupled 
with Toll-like receptor (TLR) ligands, immunoglobulins or β-glucan, via a process called LC3-
associated phagocytosis (LAP) (29–35). LAP relies on the formation of phosphoinositide 
3-phosphate by the lipid kinase VPS34 and on ROS production by NOX2 (29–36). LAP markedly 
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differs from macro-autophagy, because the LC3-containing phagosomes contain only a single 
membrane compared to the double membranes of autophagosomes. LC3 recruitment to the 
phagosome is shown to promote phagosomal acidification and pathogen digestion by promoting 
fusion with lysosomes (29, 31, 32), although other studies report the opposite where LAP delays 
phagosome maturation to preserve the pathogen for antigen presentation (30, 33). A regulatory 
role for LAP in antigen processing is supported by the findings that the autophagy proteins ATG5 
and ATG7 are not required for phagosomal maturation per se (37), suggesting that LC3 recruitment 
is not direct linked with phagosome maturation and lysosome fusion.
In this study, we identified a novel mechanism for the removal of membrane proteins from 
phagosomes. We found that auto-oxidation of phagosomal gp91phox results in its ubiquitination 
and triggers recruitment of the autophagy-marker LC3 to the phagosome. LC3 recruitment was 
dependent on p62 and ATG12 and knockdown of these autophagy-related proteins impaired 
the removal of gp91phox from phagosomes. These findings demonstrate that an autophagy-
related mechanism is involved in the removal of oxidized gp91phox from the phagosomal 
membrane. Super-resolution STED microscopy showed that LC3 was not directly present at the 
phagosomal membrane, arguing against LAP, but that LC3-positive puncta containing gp91phox 
were closely juxtaposed to the phagosomal membrane, suggesting that autophagosome-
related compartments emanated from the phagosome. Removal of gp91phox from phagosomes 
was dependent on CHMP1B which located to LC3-positive phagosomes. Because CHMP1B 
can bulge membranes inwards into the cytosol (17), our findings support a novel pathway for 
degradation of oxidatively-damaged gp91phox, where the ESCRT machinery pulls membrane from 
phagosomes which are then encapsulated in LC3-positive autophagosomes. 
Results
LC3 is recruited to gp91phox-positive early phagosomes in a ROS-dependent manner
In mouse bone marrow-derived neutrophils, macrophages and dendritic cells and in the murine 
cell line RAW264.7, the recruitment of LC3 to the phagosomal membrane during LAP is mediated 
by NOX2-produced ROS (30–35). To confirm such a role for NOX2 in LC3 recruitment to 
phagosomes in human monocyte-derived dendritic cells, we first performed immunofluorescence 
labeling of gp91phox and LC3 in cells containing phagosomes with the model antigen zymosan, 
a yeast particle. Different time points after uptake were examined to determine the time course 
of recruitment of gp91phox and LC3 following phagocytosis. At 15 min after uptake, 90% of total 
phagosomes were positive for gp91phox (Fig. 1A-B). However, at 2 hours after zymosan uptake 
only 23% of total phagosomes showed gp91phox localization (Fig. 1A-B), similar to our previous 
observations (8). LC3 localization decreased during phagosome maturation in a similar fashion as 
gp91phox, from 25% of the phagosomes positive for LC3 at 15 min to 6% positive phagosomes at 
2 hours after zymosan uptake (Fig. 1A-B). We quantified the amount of single and double positive 
phagosomes, and found that LC3 was nearly always present on NOX2-positive phagosomes 
(Fig. 1B). 
91
ESCRT-III REgulaTES auTophagy In ThE REmoval of oxIdIzEd gp91phox fRom ThE phagoSomE
4
As LC3 dissociates from the phagosomal membrane before fusion with lysosomes (33), we 
investigated whether LC3 would still be present on phagosomes positive for the lysosomal marker 
LAMP1. Our data showed that many, but not all, LAMP1-positive phagosomes contained LC3 
(Fig. 1C-D), suggesting that LC3 is removed gradually from LAMP1-positive phagosomes as we 
previously observed for gp91phox (8). These results indicate that LC3 is recruited to early NOX2-
positive phagosomes and later removed from LAMP1-positive lysosomes. To further verify the 
role of NOX2 in LC3 recruitment (30–35), we silenced NOX2 in dendritic cells by using siRNA 
against gp91phox (Fig. 1E). Knockdown of gp91phox  resulted in a decrease of not only gp91phox 
(Fig. 1F-G), but also of LC3-positive phagosomes (Fig. 1H). Thus, these findings support that 
LC3 recruitment to the phagosomal membrane is dependent on ROS-production by NOX2, as 
previously shown for RAW macrophages and mouse phagocytic cells (30–35).
LC3 overlaps with gp91phox-positive punctuated structures juxtaposed to the phagosomal membrane
In previous studies to LAP, LC3 was shown to be recruited to the single enclosing membrane of 
phagosomes (29–36). However, in contrast to those studies, we did not observe a continuous 
ring of LC3 around the phagosome, but rather observed LC3-positive dense puncta immediately 
surrounding gp91phox-positive phagosomes (Fig. 1I). These puncta contained both LC3 and 
gp91phox, whereas the continuous ring of the phagosomal membrane only contained gp91phox but 
not LC3 (Fig. 1I, yellow arrow heads). To better resolve these punctuated structures, we performed 
3-dimensional super-resolution STED microscopy with an isometric resolution of approximately 
100 nm in all dimensions (38). The LC3 and gp91phox-positive punctuated structures were located 
about 20–100 nm adjacent to the phagosome, but LC3 was not present at the enclosing 
membrane of the phagosome itself (Fig. 1J). The punctuated staining of both LC3 and gp91phox 
juxtaposed to the phagosome suggests vesiculation or tubulation of the phagosomal membrane, 
where membrane structures emanate and/or are pinched off from the phagosome. 
Gp91phox is oxidized by ROS resulting in ubiquitination
We next addressed the question how LC3 is recruited to zymosan-containing phagosomes. We 
and others showed that NOX2-generated ROS can oxidize phagosomal lipids (8) and proteases 
present in the lumen of phagosomes (39, 40). We therefore hypothesized that NOX2-generated 
ROS would also oxidize proteins present at the phagosomal membrane including gp91phox itself. 
In fact, we already showed that the total amount of cellular gp91phox decreases following ROS 
production, and this decrease can be partially blocked with the anti-oxidant α-tocopherol, the 
most active form of vitamin E (8). These findings suggest that ROS production leads to auto-
oxidation of gp91phox which is subsequently degraded by the cell. To test this hypothesis, we 
directly examined oxidative-modifications of NOX2. We performed an assay where we determined 
the oxidative modification of gp91phox by lipid peroxidation products. Here, we used the fatty-acid 
mimic linoleamide alkyne (LAA) which incorporates in cellular membranes and produced reactive 
aldehydes upon oxidation that indiscriminately bind to proteins. These LAA-modified proteins can 
be subsequently detected by SDS-PAGE following bio-orthogonal ligation with Alexa Fluor 647
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< Fig. 1: Recruitment of LC3 to gp91phox-positive puncta emanating from the phagosomal membrane. A) 
Confocal images of dendritic cells stimulated with zymosan particles for 15, 30, 60 and 120 min and stained for gp91phox 
(green in merge) and LC3 (magenta). Yellow arrowheads, gp91phox-positive phagosomes; blue arrowheads, gp91phox and 
LC3 double positive phagosomes; red arrowheads, negative for gp91phox and LC3. BF, bright field. Scale bar: 10 µm B) 
Quantification of A. Percentages are normalized to total amount of phagosomes. Data obtained from 3 different donors. C) 
Confocal images of dendritic cells stimulated with zymosan particles for 60 min and stained for LAMP1 (green in merge) 
and LC3 (magenta). Yellow arrowheads, LAMP1-positive phagosomes; green arrowheads, LC3-positive phagosomes; 
red arrowheads, negative for LAMP1 and LC3. BF, bright field. Scale bar: 10 µm D) Quantification of C. Percentages 
are normalized to total amount of phagosomes. Data obtained from 3 different donors. E) Representative western blot 
and quantification of siRNA knockdown for NOX2 (95% knockdown efficiency; n = 4 donors). NT, non-targeting siRNA 
control. Tubulin (Tub), loading control. F) Same as panel A, but now stimulated for 60 min and with knockdown of NOX2. 
G) Quantification of gp91phox-positive phagosomes of F. Data obtained from 5 different donors. H) Quantification of LC3-
positive phagosomes of F. Data obtained from 4 different donors. I) Two representative confocal images of phagosomes 
positive for gp91phox (green in merge) and LC3 (magenta). The insert shows a single phagosome. Yellow arrowheads, 
gp91phox and LC3 double positive ruffles juxtaposed on the outside of the phagosomal membrane. BF, bright field. Scale 
bars: 10 µm. J) Two representative gp91phox and LC3 double positive phagosomes imaged with super-resolution STED 
microscopy. Plotted in graph are the fluorescence intensity cross-sections indicated by the yellow line. Pink arrowheads, 
positions of maximal LC3 intensities. Green arrowheads, positions of maximal gp91phox intensities. Scale bars: 5 µm. Results 
show mean ± S.E.M.
azide. Cells were incubated with LAA, followed by zymosan stimulation for 60 min. Then, gp91phox 
was immunoprecipitated and the immunoprecipitates were incubated with Alexa Fluor 647 azide. 
LAA-modified gp91phox was detected by in-gel fluorescence of Alexa Fluor 647 and western 
blotting (Fig. 2A). Treatment with the ROS scavenger α-tocopherol showed a reduction of about 
50% of oxidized gp91phox compared to control (Fig. 2A-B). This finding suggests that ROS lead to 
oxidative modifications of the subunit gp91phox of NOX2.
As proteins suffering from oxidative damage can be prone to ubiquitination (41), we investigated 
if ROS production by NOX2 would result in its ubiquitination. We performed immunoprecipitation 
with the FK2-ubiquitin antibody, which recognizes mono- and poly-ubiquitin attached to proteins 
(42). The immunoprecipitates were analyzed by western blotting, using a monoclonal antibody 
against gp91phox. We could demonstrate that mono-ubiquitin binds gp91phox as a specific band 
appeared on western blot (Fig. 2C), although these results are compromised by the presence 
of a less-intense (±7.5% of maximal intensity) a-specific band from the ubiquitin antibody 
appearing at a similar height in the gel. The percentage of mono-ubiquitinated gp91phox after 
stimulation with zymosan and treatment with α-tocopherol was 60% lower than upon zymosan 
treatment alone (Fig. 2D). To examine whether ubiquitination could be involved in the recruitment 
of LC3 to phagosomes, we performed immunofluorescence labeling of ubiquitin and LC3. Our 
data showed that LC3 and ubiquitin co-locate at the punctate structures juxtaposed to the 
phagosomes (Fig. 2E). Ubiquitination can mediate the recruitment of the adaptor protein p62/
SQSTM1, which can lead to autophagic targeting of ubiquitinated proteins and recruitment of LC3-
positive autophagophores (23–28). By immunofluorescence labeling of p62 and LC3, we found 
that p62 located at LC3-containing punctuated compartments juxtaposed to the phagosomes 
(Fig. 2F). These data support a model where oxidatively damaged gp91phox is removed from the 
phagosomal membrane by an autophagy-related mechanism involving ubiquitination and p62-
mediated recruitment of LC3. 
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< Fig. 2: gp91phox is oxidized and mono-ubiquitinated, and removed from the phagosomal membrane in 
an ATG12- and p62-dependent manner. A) Immunoprecipitation (IP) of gp91phox from zymosan-pulsed dendritic cells 
cultured with or without LAA and α-tocopherol (α-Toc). LAA-modified gp91phox was visualized by in-gel fluorescence of 
Alexa Fluor 647 azide; gp91phox was visualized by western blot. B) Quantification of Alexa Fluor 647 fluorescence signal of 
panel A, normalized to the amount of immunoprecipitated gp91phox. The intensity of α-Toc treated cells was normalized to 
control (only stimulated with zymosan). Individual donors are shown. C) IP of ubiquitin (α-Ub) from zymosan-pulsed dendritic 
cells cultured with or without α-Toc and probed for gp91phox. Representative western blot shows gp91phox band at height 
of arrowhead. First lane shows isotype control, last lane shows only antibody in buffer without lysate. D) Quantification of 
the gp91phox band from C. The intensity of α-Toc treated cells was normalized to control (only stimulated with zymosan). E) 
Representative confocal image of phagosomes stained for ubiquitin (green in merge) and LC3 (magenta). Scale bar: 10 
µm. F) Representative confocal image of phagosomes stained for p62 (green in merge) and LC3 (magenta). Scale bar: 10 
µm. G) Representative western blot and quantification of siRNA knockdown for ATG12 (~72% knockdown efficiency; n = 3 
donors). NT, non-targeting siRNA control. Tubulin (Tub), loading control. H) Same as G, but now for p62 (~80% knockdown 
efficiency; n = 4 donors). I) Representative confocal images of dendritic cells with knockdown of NOX2, ATG12 and p62. 
Cells were pre-incubated with an antibody against gp91phox (preincubation; left panel; green in merge) and stimulated with 
zymosan (magenta) or with immunostaining against total gp91phox (total; right panel; green in merge) and LC3 (magenta). 
Yellow arrowheads, gp91phox-positive phagosomes; blue arrowheads, gp91phox and LC3 double positive phagosomes; 
red arrowheads, negative for gp91phox and LC3. BF, bright field. Scale bars: 10 µm. J) Quantification of gp91phox-positive 
phagosomes from panel I. K) Quantification of LC3-positive phagosomes from panel I. Results show mean ± S.E.M. 
Removal of NOX2 from phagosomes depends on autophagy-related proteins ATG12 and p62
As LC3 is recruited to phagosomes and as ubiquitination is involved in the degradation of 
proteins via autophagy, we investigated the role of autophagy-related proteins in the removal of 
ubiquitinated gp91phox from the phagosomal membrane. We performed siRNA knockdown of 
ATG12 (Fig. 2G) and p62 (Fig. 2H) followed by pulse-chase experiments to address the roles of 
these proteins in gp91phox removal from phagosomes. These experiments are based on pulsing 
the cells at 4ºC with an antibody that binds an extracellular epitope of gp91phox, staining all NOX2 
present at the plasma membrane. This was followed by extensive washing and stimulation with 
zymosan particles and a chase for various time points at 37ºC, during which the gp91phox was 
internalized together with the zymosan particles (8). We previously showed that this plasma 
membrane-originated gp91phox is removed from the phagosomal membrane in a ROS-dependent 
manner and replaced by a lysosomal pool of gp91phox (8). Our results showed that whereas 
plasma membrane-derived gp91phox was removed from the phagosomal membrane after 
60 min in the non-targeting siRNA control condition (NT; Fig. 2I-J), this removal was impaired 
upon knockdown of ATG12 or p62 (Fig. 2I-J). In contrast, the total amount of gp91phox-positive 
phagosomes, visualized by immunofluorescence in presence of a detergent, did not change 
upon knockdown compared with NT control (Fig. 2I-J), indicating that ATG12 and p62 knockdown 
did not affect the replenishment of gp91phox from lysosomal compartments. As a negative control, 
we found that the number of gp91phox-positive phagosomes was >60% reduced upon silencing 
of gp91phox itself (Fig. 2I-J). ATG12 or p62 knockdown not only resulted in prolonged presence 
of plasma membrane-derived gp91phox at phagosomes, but also in reduced LC3 recruitment 
to phagosomes (Fig. 2I,K). Thus, our data show that ATG12 and p62 are necessary for the 
recruitment of LC3 and the removal of plasma membrane-derived gp91phox from the phagosomal 
membrane.
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Role of ESCRT-III protein CHMP1B in removal of gp91phox from the phagosomal membrane
In the final set of experiments, we searched for proteins involved in the formation of the LC3-
positive punctuated structures juxtaposed to the phagosomes. A recent study showed that 
CHMP1B, a protein of the ESCRT-III complex, could lead to membrane deformation in the 
reverse direction as other ESCRT proteins (i.e., pulling instead of pushing), which would result in 
tubulation of the phagosomal membrane inwards into the cytosol (17). As our data revealed that 
LC3 overlaps with NOX2-positive punctuated structures located juxtaposed to the phagosome, 
we investigated whether CHMP1B would be involved in formation of these punctuated structures 
from the phagosomal membrane. We first determined the location of CHMP1B relative to the LC3-
positive puncta surrounding zymosan-containing phagosomes. Since we were unable to obtain 
an antibody suitable for immunofluorescence of CHMP1B, we transfected dendritic cells with a 
myc-tagged construct of CHMP1B. We used CHMP4A as control, as, oppositely to CHMP1B, 
this ESCRT-III protein can push the membrane outwards into the lumen of endosomes, resulting 
in the formation of ILVs (17, 43). Myc-tagged fusion constructs have been previously used to study 
the intracellular location of CHMP1B and CHMP4A (44). By immunofluorescence labeling for the 
myc-tags, we observed overlap between LC3 and CHMP1B at the puncta locating adjacent to 
the phagosomal membrane, whereas LC3-positive phagosomes did not contain CHMP4A (Fig. 
3A). 
Next, we siRNA-silenced CHMP1B to test whether its recruitment to phagosomes takes place 
before or after LC3 recruitment and whether CHMP1B would be involved in the removal of gp91phox 
from the phagosomal membrane. We obtained 41% knockdown of CHMP1B by siRNA transfection 
(Fig. 3B). By immunofluorescence, we found that the recruitment of LC3 was not changed upon 
knockdown of CHMP1B (Fig. 3C-D), suggesting that LC3 is recruited to phagosomes prior to 
CHMP1B. The removal of plasma membrane-derived gp91phox was measured by the pulse-
chase experiments with an antibody recognizing the extracellular domain of gp91phox. Our results 
showed that CHMP1B knockdown reduced removal of plasma-membrane derived gp91phox 
compared to control cells (Fig. 3E), whereas the amount of total gp91phox-positive phagosomes 
was not changed (Fig. 3D). Thus, our data indicate a role for CHMP1B in the removal of gp91phox 
from phagosomes.
Discussion
In this study, we report that gp91phox is removed from the phagosomal membrane in an autophagy-
related manner. This removal is dependent on the emanation of LC3-positive membrane structures 
from the phagosomal membrane and is dependent on ATG12, p62 and CHMP1B. Moreover, 
we found that gp91phox removal and phagosomal recruitment of LC3 are promoted by ROS 
production and accompanied by oxidative modifications and mono-ubiquitination of gp91phox. We 
previously showed that NOX2 needs to be replenished from a lysosomal pool of gp91phox in order 
to sustain ROS production required for antigen presentation (8, 9). The results from this study 
support a model how oxidatively-damaged gp91phox is removed from the phagosome: gp91phox 
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4^ Fig. 3: ESCRT-III subunit CHMP1B is involved in removal of gp91phox from the phagosomal membrane. A) 
Representative confocal images of dendritic cells transfected with myc-tagged CHMP1B and CHMP4A and immunostained 
for myc-tag (green in merge) and LC3 (magenta). The insert shows a phagosome positive for LC3. BF, bright fi eld. Scale 
bar: 10 µm. B) Representative western blot and quantifi cation of siRNA knockdown for CHMP1B (~40% knockdown 
effi ciency; n = 4 donors). NT, non-targeting siRNA control. Tubulin (Tub), loading control. C) Representative confocal images 
of dendritic cells with knockdown of CHMP1B pre-incubated with an antibody against gp91phox (preincubation; green in 
merge) and stimulated with zymosan (magenta) or with immunostaining against total gp91phox (normal; green in merge) and 
LC3 (magenta). Yellow arrowheads, gp91phox-positive phagosomes; blue arrowheads, gp91phox and LC3 double positive 
phagosomes; red arrowheads, negative for gp91phox and LC3. BF, bright fi eld. Scale bars: 10 µm. D) Quantifi cation of 
gp91phox- and LC3-positive phagosomes from panel C. Data obtained from 3 different donors. E) Quantifi cation of gp91phox-
positive phagosomes form panel C. Results show mean ± S.E.M. 
and other phagosomal components are ubiquitinated and recognized by p62, a known adapter 
for recruitment of LC3-positive phagophores, which in turn targets them to autophagosomes 
(23–28). Ubiquitinated gp91phox and other phagosomal components are also recognized by 
ESCRT-I and -II proteins (22), which in turn trigger the bulging of the membrane inwards from 
the phagosome into the cytosol, in a manner dependent on the ESCRT-III protein CHMP1B. 
Together, this results in the emanation of membrane structures from phagosomes that can then 
be encapsulated in LC3-positive autophagosomes. 
This mechanism differs from the two previously described mechanisms for degradation of integral 
membrane proteins such as gp91phox: (i) the formation of ILVs by the ESCRT machinery and (ii) 
the encapsulation of membrane structures in autophagosomes (11). Our data indicate a hybrid of 
these two mechanisms, where ESCRT subunits do not invaginate the membrane but curve it in 
the other direction, resulting in the budding of membrane from the phagosome. This proposed 
mechanism also differs from LAP (45), because we did not observe the lipidation of LC3 directly 
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at the single enclosing membrane of the phagosome, which is a central hallmark of LAP (29–36). 
In contrast, we observed LC3-positive puncta containing gp91phox juxtaposed to the phagosomal 
membrane, while the membrane itself contained gp91phox but not LC3. This difference may arise 
because of different cell types or because we probe for endogenous LC3, whereas LAP studies 
employ overexpression of LC3-GFP (29, 31–36). 
Nevertheless, the mechanism revealed in this paper contains several similarities with LAP. First, 
phagosomal recruitment of LC3 is observed rapidly after uptake and is transient (31). Second, 
both are dependent on ATG12, a member of the conjugation complex which determines the 
site of LC3 lipidation (29–33, 45). Third, LC3 recruitment is promoted by NOX2-produced ROS 
and can be inhibited by α-tocopherol (30–35). This ROS-dependency of LC3 recruitment to 
phagosomes, which is also observed in another study (46), has been previously attributed to 
the upregulation of LC3 lipidation by ROS-oxidized ATG4 (47, 48). Our data now reveal how 
this LC3 can specifically interact with phagosomes, as we found that oxidative modifications of 
phagosome components can be recognized by ubiquitin ligation systems which in turn promote 
LC3 recruitment via p62. Thereby, our findings shed light on the role of ROS in the regulation of 
autophagy. ROS can upregulate autophagy (47, 48) and, conversely, many studies show that 
dysregulation of autophagy leads to increase in oxidative stress (47). Moreover, our findings shed 
light on the interplay between autophagy and the ESCRT machinery (12, 49). Mutations in various 
subunits of the ESCRT machinery are known to result in high amounts of autophagosomes (50–
52), in line with our findings that ESCRT regulates autophagy. 
The data from this study indicate that the ESCRT machinery is not only able to bulge the 
membrane outwards (forming MVBs), but also inwards (forming autophagosomes) for the 
removal of ubiquitinated membrane proteins from endosomes and phagosomes. In contrast to 
classical macro-autophagy of the whole phagosome, the emanation of membrane structures by 
ESCRT would allow to exclusively degrade the phagosomal components destined for lysosomal 
degradation, while maintaining the remainder of the phagosome. However, this would not explain 
why ESCRT does not bulge the membrane inwards forming ILVs within the phagosomal lumen. 
This could be due to the fact that NOX2 produces ROS during very early stages of phagocytosis, 
even during the formation of the nascent cup (53). If ILVs were formed before the phagosome is 
closed, these ILVs would become extracellular vesicles which might be an unwanted outcome. 
Moreover, plasma membrane-located gp91phox also produces ROS and thereby can be expected 
to be auto-oxidized as well. In this case, oxidatively damaged gp91phox needs to be removed from 
the plasma membrane by endocytosis, thus by pulling it into the cytosol in a similar fashion as 
we observed for phagosomal membranes. Since a large fraction of the phagosomal membrane 
is derived from the plasma membrane and phagosomes contain many plasma membrane 
components (54), it could well be that this process also relies on CHMP1B-mediated tubulation. 
Together, our data reveal a new mechanism how oxidatively damaged gp91phox is removed 
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from the phagosomal membrane using the ESCRT machinery to pull the membrane from 
phagosomes that can then be encapsulated into autophagosomes. Our findings raise the 
interesting possibility that this system not only acts to remove gp91phox, and likely other oxidized 
membrane components, but also soluble cargo molecules from the lumen of phagosomes. This 
could contribute to the reported involvement of autophagy in both MHC class I and MHC class 
II antigen (cross-)presentation (30, 55–59). For instance, oxidation of soluble protein can lead 
to their denaturation and aggregation, which might result in their association with phagosomal 
membranes. Thereby, CHMP1B-emanated autophagosomes might contain these aggregated 
soluble proteins, effectively sequestering them from the normal phagosomal maturation into 
lysosomes. This might prevent or delay the excessive degradation of foreign antigens resulting 
in prolonged antigen presentation, as previously demonstrated for LAP (30, 33). Thus, the 
formation of autophagosomes containing phagosomal cargo molecules may well prove to be a 
key mechanism for antigen presentation by dendritic cells.
Material and Methods
Cells and siRNA transfection
Human monocyte-derived dendritic cells were derived from peripheral blood monocytes (PBMCs) 
obtained from buffy coats of healthy individuals (informed consent obtained and approved by 
RadboudUMC ethical committee) according to institutional guideline and as described previously 
(60). Monocytes were differentiated into immature dendritic cells by culturing 6 days at 37ºC 
and 5% CO2 in the presence of 300 U/ml interleukin-4 (IL4) and 450 U/ml GM-CSF in RPMI-
1640 medium containing 10% fetal bovine serum (FBS), 2 mM UltraGlutamine and 1% Antibiotic-
Antimytotic (AA).
To obtain knockdown of NOX2, ATG12, p62 and CHMP1B, dendritic cells were transfected with 
siRNA against gp91phox (CCGAGUCAAUAAUUCUGAUCCUUAU; ThermoFisher), ATG12 (mix of 
3 siRNAs: ACAAAGAAGUGGGCAGUAGAGCGAA, GGCCUCAGAACAGUUGUUUAUUUAU, 
GAGGAACCUGCUGGCGACACCAAGA; ThermoFisher), p62 (M-010230-00-0005; Dharmacon), 
CHMP1B (sc-72893; Santa Cruz) or with irrelevant ON-TARGET plus Non-Targeting (NT) siRNA 
#1 (Dharmacon) using a Neon Transfection System as described (9). After transfection, cells were 
cultured for 48 hours to achieve maximal knockdown efficiency. 
Immunoblotting
Knockdown efficiency was analyzed by SDS-PAGE. Proteins were detected using the primary 
antibodies mouse-IgG1 anti-NOX2/gp91phox (ab80897, Abcam), mouse-IgG2a anti-ATG12 (sc-
271688, Santa Cruz), mouse-IgG1 anti-p62 (sc-28359, Santa Cruz), mouse-IgG1 anti-CHMP1B (sc-
514013, Santa Cruz) in combination with goat anti-rabbit or goat anti-mouse IgG (H+L) conjugated 
with IRDye 800 (926-32211; Li-cor) as secondary antibodies (1:5000 dilution). Rat-IgG2a anti-tubulin 
(NB100-1639, Novus Biologicals) was used as loading control. Western blots were imaged using 
the Odyssey CLx Infrared Imaging System and processed with ImageStudio (both Li-cor).
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Immunostaining
Dendritic cells were plated on 12 mm diameter glass coverslips (50,000 – 100,000 cells/coverslip) 
in the presence of Alexa Fluor 633-labeled zymosan particles (9) at a particle-to-cell ratio of 1:5 
in serum-free RPMI medium and incubated at 37ºC. After incubation, cells were washed with 
PBS and fixed in 4% paraformaldehyde (PFA) in PBS for 15 min at room temperature. Cells were 
permeabilized and blocked with 0.1% saponin in CLSM-buffer (PBS, 20 mM glycine and 3% BSA) 
for 60 min, followed by incubation with the primary antibodies (1:200 dilution) mouse-IgG1 anti-
NOX2/gp91phox (D162-3; MBL), mouse-IgG1 anti-ubiquitin antibody (FK2; BML-PW8810-0500, 
Enzo Life Sciences), mouse-IgG1 anti-p62 (sc-28359, Santa Cruz), rabbit anti-LAMP1 (L1418, 
Sigma) and/or rabbit anti-LC3 (2775S, Cell Signaling) overnight at 4ºC. Subsequently, cells were 
washed with PBS and incubated with the secondary antibodies (1:400 dilution) goat anti-mouse 
IgG (H+L) Alexa Fluor 488 (A-11029; ThermoFisher) and goat anti-rabbit IgG (H+L) Alexa Fluor 568 
(A-11036; ThermoFisher) for 60 min at room temperature. Cells were embedded in 68% glycerol 
with 4’,6-diamidino-2-phenylindole (DAPI).
For preincubation with the NOX2 antibody, cells were plated on coverslips and incubated with 
anti-gp91phox antibody (1:400 dilution) for 30 min at 4ºC. After binding of the antibody, the cells 
were washed and stimulated with Alexa Fluor 633-labeled zymosan particles for 60 min at 37ºC. 
After incubation, cells were fixed, permeabilized and blocked as described above, followed by 
staining with the secondary antibody and mounting.
All samples were imaged with a Leica SP8 confocal laser scanning microscope with a 63x 
1.20 NA water immersion objective and evaluated with Fiji. Intensity levels on the phagosomal 
membrane and of the complete cell were measured, and positive phagosomes were measured 
with the unbiased method as previously described (8). 
STED imaging
Samples for STED were prepared as samples for immunostaining, except that as secondary 
antibodies, goat anti-mouse IgG-Abberior STAR 635 (40734, Sigma) and goat anti-rabbit IgG 
(H+L) Alexa Fluor 594 (ab150084, Abcam) were used. Samples were imaged with a STED 
microscope as described (38).
Immunoprecipitation
Cells were incubated with or without unlabeled zymosan (10 particles/cell) and in the presence 
of the antioxidant α-tocopherol (500 µM) in serum-free RPMI medium for 60 min at 37ºC. After 
incubation, cells were washed twice with PBS and lysed in IP buffer (20 mM Tris-HCl pH 706, 
137 mM NaCl, 1% IGEPAL, 2 mM EDTA). Lysated were precleared for 30 min at 4ºC, followed by 
incubation with 1 µg of mouse-IgG1 anti-NOX2/gp91phox (ab80897, Abcam), mouse-IgG1 anti-
ubiquitin antibody (FK2; BML-PW8810-0500, Enzo Life Sciences) or mouse-IgG1 isotype control 
(400102, Biolegend) for 30 min on ice. Subsequently, protein-G Sepharose was added and 
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samples were incubated overnight at 4ºC. Samples were washed with IP buffer and protein was 
eluted by boiling in SDS sample buffer. IP samples were analyzed by western blotting for gp91phox 
or ubiquitin.
To investigate if NOX2 was oxidized, LAA Click-iT chemistry was used (C10445; Life Technologies) 
in combination with immunoprecipitation. Briefly, cells were loaded with unlabeled zymosan 
particles (10 particles/cell) and cultured in the presence of 50 µM Click-iT LAA solution and 500 
µM α-tocopherol in serum-free RPMI medium for 60 min at 37ºC. Subsequently, NOX2 was 
immunoprecipitated as described above. After washing with IP buffer, samples were incubated 
with Click-iT reaction cocktail containing Cu(II)SO4 and Alexa Fluor 647 azide for 30 min at room 
temperature, followed by another washing step. Labeled samples were loaded on SDS-PAGE 
(10% acrylamide) and fluorescence was visualized using a Typhoon TRIO+ (GE Healthcare) with 
the 633 nm laser and the 670-nm band-pass filter. After scanning, western blot protocol was 
continued.
CHMP1B and CHMP4A transfection
Constructs for myc-tagged CHMP1B and CHMP4A were generated as codon-optimized synthetic 
genes in the KpnI/XhoI sites of pcDNA3.1 at the N-terminus. Dendritic cells were transfected with 
these myc-tagged CHMP1B and CHMP4A plasmid constructs as described (61, 62). Briefly, 
cells were plated on coverslips (100,000 cells/coverslip) and incubated for 4 hours in phenol-red- 
and serum-free RPMI medium without AA to obtain sufficient transfection efficiency. Cells were 
incubated with Alexa Fluor 633-labeled zymosan particles (10 particles/cell) for 60 min at 37ºC, 
followed by fixation, premeabilization and blocking as described above. Samples were stained 
with primary antibodies (1:200 dilution) mouse-IgG1 anti-c-Myc (sc40, Santa Cruz) and rabbit 
anti-LC3 (2775S, Cell Signaling) overnight at 4ºC, followed by staining with secondary antibodies 
(1:400 dilution) goat anti-mouse IgG (H+L) Alexa Fluor 488 (A-11029; ThermoFisher) and goat anti-
rabbit IgG (H+L) Alexa Fluor 568 (A-11036; ThermoFisher) for 60 min at room temperature. Cells 
were mounted and myc-positive cells were imaged.
Statistics
Data from individual donors are plotted in the graphs and analyzed using one-way ANOVA 
(following post-hoc Dunnett’s test), two-way ANOVA (following post-hoc Tukey test) or Student’s 
paired two-sided t-tests. A value of P<0.05 was considered as significant for all statistical analyses 
(* P <0.05; ** P <0.01; *** P <0.001).
102
Chapter 4
4
References
1. M. Vulcano et al., Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells. J. Immunol. 173, 5749–56 (2004).
2. C. Jancic et al., Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat. Cell Biol. 9, 367–78 (2007).
3. A. Savina et al., NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell. 126, 205–18 (2006).
4. F. Kotsias, E. Hoffmann, S. Amigorena, A. Savina, Reactive oxygen species production in the phagosome: impact on antigen presentation in dendritic cells. Antioxid. Redox 
Signal. 18, 714–29 (2013).
5. J. M. Rybicka, D. R. Balce, S. Chaudhuri, E. R. O. Allan, R. M. Yates, Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner. 
EMBO J. 31, 932–44 (2012).
6. A. Hari et al., Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis. Eur. J. Immunol. 45, 383–95 (2015).
7. E. R. O. Allan et al., NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing. J. Immunol. 192, 
4989–5001 (2014).
8. I. Dingjan et al., Oxidized phagosomal NOX2 complex is replenished from lysosomes. J. Cell Sci. 130, 1285–1298 (2017).
9. I. Dingjan et al., Lipid peroxidation causes endosomal antigen release for cross-presentation. Sci. Rep. 6, 22064 (2016).
10. A. R. Mantegazza et al., NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood. 112, 4712–22 (2008).
11. T. Lamark, T. Johansen, Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int. J. Cell Biol. 2012, 736905 (2012).
12. C. Raiborg, H. Stenmark, The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature. 458, 445–52 (2009).
13. W. M. Henne, N. J. Buchkovich, S. D. Emr, The ESCRT pathway. Dev. Cell. 21, 77–91 (2011).
14. J. Carlton, The ESCRT machinery: a cellular apparatus for sorting and scission. Biochem. Soc. Trans. 38, 1397–412 (2010).
15. O. Schmidt, D. Teis, The ESCRT machinery. Curr. Biol. 22, R116-20 (2012).
16. R. C. Piper, J. P. Luzio, Ubiquitin-dependent sorting of integral membrane proteins for degradation in lysosomes. Curr. Opin. Cell Biol. 19, 459–65 (2007).
17. J. McCullough et al., Structure and membrane remodeling activity of ESCRT-III helical polymers. Science. 350, 1548–51 (2015).
18. R. Allison et al., An ESCRT-spastin interaction promotes fission of recycling tubules from the endosome. J. Cell Biol. 202, 527–43 (2013).
19. R. Allison et al., Defects in ER-endosome contacts impact lysosome function in hereditary spastic paraplegia. J. Cell Biol. 216, 1337–1355 (2017).
20. D. J. Klionsky, S. D. Emr, Autophagy as a regulated pathway of cellular degradation. Science. 290, 1717–21 (2000).
21. T. Yorimitsu, D. J. Klionsky, Autophagy: molecular machinery for self-eating. Cell Death Differ. 12 Suppl 2, 1542–52 (2005).
22. D. C. Rubinsztein, T. Shpilka, Z. Elazar, Mechanisms of autophagosome biogenesis. Curr. Biol. 22, R29-34 (2012).
23. S. Pankiv et al., p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131–45 (2007).
24. Y. Yoshikawa et al., Listeria monocytogenes ActA-mediated escape from autophagic recognition. Nat. Cell Biol. 11, 1233–40 (2009).
25. S. Seto, K. Tsujimura, T. Horii, Y. Koide, Autophagy adaptor protein p62/SQSTM1 and autophagy-related gene Atg5 mediate autophagosome formation in response to 
Mycobacterium tuberculosis infection in dendritic cells. PLoS One. 8, e86017 (2013).
26. G. Bjørkøy et al., p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171, 603–14 
(2005).
27. Y. T. Zheng et al., The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway. J. Immunol. 183, 5909–16 (2009).
28. E. Itakura, N. Mizushima, p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. J. Cell Biol. 192, 17–27 (2011).
29. M. A. Sanjuan et al., Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature. 450, 1253–7 (2007).
30. J. Ma, C. Becker, C. a. Lowell, D. M. Underhill, Dectin-1-triggered recruitment of light chain 3 protein to phagosomes facilitates major histocompatibility complex class II 
presentation of fungal-derived antigens. J. Biol. Chem. 287, 34149–56 (2012).
31. J. Huang et al., Activation of antibacterial autophagy by NADPH oxidases. Proc. Natl. Acad. Sci. U. S. A. 106, 6226–31 (2009).
32. J. Martinez et al., Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat. Cell Biol. 17, 893–906 
(2015).
33. S. Romao et al., Autophagy proteins stabilize pathogen-containing phagosomes for prolonged MHC II antigen processing. J. Cell Biol. 203, 757–66 (2013).
34. J. M. Tam et al., Dectin-1-dependent LC3 recruitment to phagosomes enhances fungicidal activity in macrophages. J. Infect. Dis. 210, 1844–54 (2014).
35. G. Y. Lam, M. Cemma, A. M. Muise, D. E. Higgins, J. H. Brumell, Host and bacterial factors that regulate LC3 recruitment to Listeria monocytogenes during the early stages of 
macrophage infection. Autophagy. 9, 985–95 (2013).
36. O. Florey, S. E. Kim, C. P. Sandoval, C. M. Haynes, M. Overholtzer, Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single 
membranes. Nat. Cell Biol. 13, 1335–43 (2011).
37. M. Cemma, S. Grinstein, J. H. Brumell, Autophagy proteins are not universally required for phagosome maturation. Autophagy. 12, 1–7 (2016).
38. M. V. Baranov et al., SWAP70 organizes the actin cytoskeleton and is essential for phagocytosis. Cell Rep. 17, 1518–1531 (2016).
39. Y. Nagaoka et al., Specific inactivation of cysteine protease-type cathepsin by singlet oxygen generated from naphthalene endoperoxides. Biochem. Biophys. Res. Commun. 
331, 215–23 (2005).
40. D. Suto et al., Inactivation of cysteine and serine proteases by singlet oxygen. Arch. Biochem. Biophys. 461, 151–8 (2007).
41. F. Shang, A. Taylor, Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic. Biol. Med. 51, 5–16 (2011).
42. M. Fujimuro, H. Sawada, H. Yokosawa, Production and characterization of monoclonal antibodies specific to multi-ubiquitin chains of polyubiquitinated proteins. FEBS Lett. 
349, 173–80 (1994).
43. M. Babst, MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between. Curr. Opin. Cell Biol. 23, 452–7 (2011).
44. E. Reid et al., The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. Hum. Mol. Genet. 14, 19–38 
103
ESCRT-III REgulaTES auTophagy In ThE REmoval of oxIdIzEd gp91phox fRom ThE phagoSomE
4
(2005).
45. S. Lai, R. J. Devenish, LC3-Associated Phagocytosis (LAP): Connections with Host Autophagy. Cells. 1, 396–408 (2012).
46. A. de Luca et al., IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc. Natl. Acad. Sci. U. S. 
A. 111, 3526–31 (2014).
47. J. Lee, S. Giordano, J. Zhang, Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441, 523–40 (2012).
48. R. Scherz-Shouval et al., Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26, 1749–60 (2007).
49. T. E. Rusten, H. Stenmark, How do ESCRT proteins control autophagy? J. Cell Sci. 122, 2179–83 (2009).
50. T. E. Rusten, M. Filimonenko, L. M. Rodahl, H. Stenmark, A. Simonsen, ESCRTing autophagic clearance of aggregating proteins. Autophagy. 4, 233–236 (2008).
51. J.-A. Lee, A. Beigneux, S. T. Ahmad, S. G. Young, F.-B. Gao, ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr. Biol. 17, 1561–7 
(2007).
52. M. Filimonenko et al., Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J. Cell Biol. 
179, 485–500 (2007).
53. J. Bylund, K. L. Brown, C. Movitz, C. Dahlgren, A. Karlsson, Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for? Free Radic. 
Biol. Med. 49, 1834–45 (2010).
54. G. D. Fairn, S. Grinstein, How nascent phagosomes mature to become phagolysosomes. Trends Immunol. 33, 397–405 (2012).
55. M. Chemali, K. Radtke, M. Desjardins, L. English, Alternative pathways for MHC class I presentation: a new function for autophagy. Cell. Mol. Life Sci. 68, 1533–41 (2011).
56. C. Münz, Antigen processing for MHC presentation by autophagy. F1000 Biol. Rep. 2, 61 (2010).
57. Y. Li et al., Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res. 68, 6889–95 (2008).
58. J. D. Mintern et al., Differential use of autophagy by primary dendritic cells specialized in cross-presentation. Autophagy. 11, 906–17 (2015).
59. V. Kondylis et al., Endosome-mediated autophagy: an unconventional MIIC-driven autophagic pathway operational in dendritic cells. Autophagy. 9, 861–80 (2013).
60. I. J. M. de Vries, G. J. Adema, C. J. a Punt, C. G. Figdor, Phenotypical and functional characterization of clinical-grade dendritic cells. Methods Mol. Med. 109, 113–26 
(2005).
61. I. Dingjan et al., VAMP8-mediated NOX2 recruitment to endosomes is necessary for antigen release. Eur. J. Cell Biol. 96, 705-714 (2017).
62. M. V. Baranov et al., Podosomes of dendritic cells facilitate antigen sampling. J. Cell Sci. 127, 1052–64 (2014).
Scientiﬁ c Reports, 2016
Ilse Dingjan
Daniëlle Verboogen
Laurent Paardekooper
Natalia Revelo
Simone Sittig
Linda Visser
Gabriele Fischer von Mollard
Stefanie Henriet
Carl Figdor
Martin ter Beest
Geert van den Bogaart
CHAPTER
5
Lipid peroxidation 
causes endosomal 
antigen release for 
cross-presentation 
106
Chapter 5
5
Abstract
Dendritic cells (DCs) present foreign antigen in major histocompatibility complex (MHC) class 
I molecules to cytotoxic T cells in a process called cross-presentation. An important step in 
this process is the release of antigen from the lumen of endosomes into the cytosol, but the 
mechanism of antigen release is unclear. In this study, we show that reactive oxygen species 
(ROS) produced by the NADPH-oxidase NOX2 cause lipid peroxidation, a membrane disrupting 
chain reaction, which in turn results in antigen leakage from endosomes. Antigen leakage and 
cross-presentation could be inhibited by blocking ROS production or scavenging radicals and 
could be induced using a ROS-generating photosensitizer. Endosomal antigen release was 
impaired in DCs from chronic granulomatous disease (CGD) patients with dysfunctional NOX2. 
Thus, NOX2 induces antigen release from endosomes for cross-presentation by direct oxidation 
of endosomal lipids. This constitutes a new cellular function for ROS in regulating immune 
responses against pathogens and cancer.
Introduction
Dendritic cells (DCs) are antigen presenting cells of the immune system capable to activate naive 
T cells with exogenous antigen (1–3). DCs constantly sample peripheral tissues for microbial 
pathogens and tumor cells that can be taken up by phago- or endocytosis. For activation of 
CD4+ T helper cells, these antigens are subsequently degraded in lysosomal compartments and 
presented in MHC class II. For activation of CD8+ cytotoxic T cells, exogenous antigens need 
to be presented in MHC class I in a process called cross-presentation. Cross-presentation can 
occur via a lysosomal and a cytosolic pathway. In the lysosomal pathway, antigen is degraded 
by lysosomal proteases and loaded in MHC class I in the lysosomal lumen. In the cytosolic 
pathway, antigen escapes from the endosomal lumen into the cytosol where it is processed 
by the proteasome for presentation in MHC class I (1–4). Despite intensive research efforts, it 
is still unclear how antigen crosses the membrane of endosomes. The translocon Sec61 (5–7) 
from the endoplasmic reticulum associated degradation (ERAD) pathway has been shown to 
transport proteins from endosomes into the cytosol, but the interpretations as well as functional 
consequences of these studies were controversially (1–3, 8). This discussion was recently 
settled in an elegant study where they showed that the trapping of Sec61 in the endoplasmic 
reticulum with a single chain antibody blocks the release of antigen from endosomes and 
impairs cross-presentation (8). However, this may not suffice to explain how large, folded and/
or posttranslationally-modified proteins as well as nucleic acids and dextrans are released from 
endosomes (3, 9) and, as also acknowledged in the study by Zehner et al. (8), likely other pathways 
exist by which antigen is released from endosomes.
Antigen cross-presentation is promoted by the activity of the NADPH oxidase NOX2 (10–14). 
Already within 30 minutes after antigen uptake, NOX2 generates superoxide anions in the 
endosomal lumen in DCs and this production is sustained over the course of hours (10–16). 
Superoxide anions react with protons resulting in the formation of H2O2 and alkalinization of the 
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endosomal lumen. Thereby, NOX2 counteracts the activity of the V-ATPase and this inhibits the 
activation of lysosomal proteases with low pH optima, hence preserving the antigen for cross-
presentation (10–12). H2O2 and other reactive oxygen species (ROS) produced by NOX2 activity 
can also oxidatively inactivate cystein cathepsins, which further inhibit degradation of antigen in 
endosomes of DCs (14, 16, 17). ROS also react with membranes and can oxidize membrane 
proteins, cholesterol and particularly (poly)unsaturated lipids in a process called lipid peroxidation 
(18). Lipid peroxidation is a self-propagating chain reaction, which occurs very effective especially 
since oxygen is an a-polar molecule which accumulates ~5-fold in lipid membranes compared to 
the aqueous environment (19). Oxidized lipids have peroxide or aldehyde groups in their lipid tails, 
are more polar and can be shorter in length. As a consequence, lipid peroxidation is a destructive 
process, which is well-understood for over four decades to cause leakage of artificial and cellular 
membranes (see (20–22) and references therein). Whereas leakage of endo/lysosomal contents 
to the cytosol may trigger cell death, this does not necessarily have to be the case (3) and 
endosomal disruption is actually a widespread approach in the gene therapy research field for 
cellular delivery of nucleic acids (23–26). In fact, endosomal disruption can be an efficient way to 
introduce antigen into the MHC class I pathway (9, 27, 28). Therefore, we hypothesized that the 
sustained ROS produced in endosomes by NOX2 would directly cause release of antigens into 
the cytosol via lipid peroxidation-induced membrane destabilization.
Results
NOX2-produced ROS cause endosomal lipid peroxidation
We first verified that ROS produced by NOX2 could trigger lipid peroxidation. We activated DCs 
with the TLR4-ligand LPS, which is well known to induce NOX2 activity (29, 30) and thereby 
results in an increase in ROS production (Fig. 1A). ROS can cause lipid peroxidation, which can 
be measured with the Bodipy581/591-C11 probe. Bodipy581/591-C11 contains alkyne groups 
mimicking unsaturated fatty acids and making it susceptible to peroxidation (31). This probe 
incorporates into cellular membranes and peroxidation causes a blue-shift of its fluorescence over 
time, which can be measured by flow cytometry (Fig. 1B). Directly oxidizing lipids with cumene 
hydroperoxide as a positive control resulted in a >3-fold increase of the blue fluorescence. 
Culturing the cells in the presence of LPS resulted in a ~50% increase in Bodipy581/591-C11 
fluorescence (Fig. 1C) supporting a role for NOX2 in lipid peroxidation. Indeed, inhibition of NOX2 
with the inhibitor phenylarsine oxide (PAO) decreased lipid peroxidation (Fig. 1D), although this 
compound is not specific for NOX2 as it oxidizes all vicinal thiols. We could not use the (more 
specific) NOX2-inhibitor diphenyleneiodonium (DPI), as this compound was too toxic for our DCs. 
To confirm the role of NOX2-produced ROS in lipid peroxidation, we measured peroxidation in 
human DCs which were siRNA-silenced (RNAi) for gp91phox, one of the membrane components of 
NOX2 (NOX2 KD; 94% knock-down efficiency; Fig. 1E) (32). In NOX2 KD DCs, we found a ~25% 
reduction of Bodipy581/591-C11 signal (Fig. 1F), which was significant but relatively small likely 
due to residual NOX activity (15). These data indicate that NOX2 can induce lipid peroxidation in 
DCs.
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< Fig. 1: NOX2-produced ROS cause endosomal lipid peroxidation. A) H2O2 production by DCs cultured in 
absence (no LPS; blue curve) or presence of LPS (+ LPS; black) measured with Amplex Red. B) Sensor Bodipy581/591-C11 
(structure) increases fluorescence at 510 nm upon peroxidation. Histograms show fluorescence intensity distributions from 
a typical experiment of DCs labeled with Bodipy581/591-C11 and incubation with LPS for the times indicated. C-D) The 
mean fluorescence intensities (MFI) measured by flow cytometry of DCs cultured for 60 min with Bodipy581/591-C11 in 
presence or absence of LPS (C), or with LPS in absence (Ctrl) or presence of α-tocopherol (α-Toc) or phenylarsine oxide 
(PAO) (D). E) Quantification of knock-down efficiency for gp91phox (NOX2 KD) by western blot (NT, non-targeting siRNA; 
GAPDH, loading control). F) Similar to C, but now for NOX2 KD DCs. G) Similar to D, but now for mouse BMDCs. H) 
Confocal microscope images of DCs stained for gp91phox (green) after treatment with OVA conjugated with Alexa Fluor 647 
(OVA-AF647; red). I) Detection of peroxidation-modified proteins on endosomes. DCs were incubated with OVA-AF647 
and linoleamide alkyne (LAA). After incubation, cells were fixed and stained with Alexa Fluor 488 azide (LAA-AF488). The 
fluorescence threshold was set on the OVA-AF647 channel and the green fluorescence was quantified. BF, bright field. J) 
Difference between green fluorescence of the whole cell and the fluorescence thresholded on OVA-AF647. K) LAA assay 
for DCs cultured in the absence or presence of LPS. LAA-AF488 signal was quantified for at least 10 cells. L) Same as 
panel K, but now for LPS-treated DCs in the absence or presence of α-Toc. Results show individual results for at least 3 
donors/mice. Results from the same donor/mouse are connected by a black line. Scale bars: 10 µm. 
To further confirm the role of ROS in lipid peroxidation, we used vitamin E. Vitamin E is a group 
of lipid soluble antioxidants that selectively block lipid peroxidation by scavenging free electrons 
(18). In agreement, the most active form of vitamin E, α-tocopherol, decreased peroxidation of 
Bodipy581/591-C11 by ~50% (Fig. 1D). We did not expect that α-tocopherol affects endosomal 
alkanization by sequestering ROS in the endosomal lumen, because it predominantly incorporates 
in membranes. This was confirmed by experiments with the pH-sensitive fluorophores SNARF-1 
conjugated to dextran and pHrodo-Green conjugated to OVA (Fig. S1; compare to reference (13)). 
We also performed the Bodipy581/591-C11 assay with mouse bone marrow-derived DCs (BMDCs) 
in combination with α-tocopherol treatment. Similar to human DCs, lipid peroxidation in BMDCs 
was decreased after α-tocopherol treatment (Fig. 1G). Immunostaining human DCs for gp91phox 
showed that NOX2 localized to the peripheral cell membrane and to endosomal compartments 
(Fig. 1H), suggesting that substantial peroxidation occurred in endosomal membranes. To address 
this, we employed the linoleamide alkyne (LAA) assay, where LPS-activated DCs were cultured 
in the presence of LAA which incorporates in cellular membranes. Peroxidation of LAA produces 
reactive aldehydes that indiscriminately bind to proteins and these modified proteins can be 
detected with Alexa Fluor 448 azide (click chemistry) (33). By pre-exposing the cells with OVA 
conjugated to Alexa Fluor 647, we could distinguish peroxidation of endosomal membranes from 
membranes of other organelles (Fig. 1I). Indeed, endosomes (containing Alexa Fluor 647-labeled 
OVA) were 5 – 20% more peroxidated than other cellular membranes (Fig. 1J). Moreover, 
activating the cells with LPS increased lipid peroxidation in endosomal membranes ~1.7-fold (Fig. 
1K) and peroxidation could again be inhibited with α-tocopherol (Fig. 1L), in accordance with our 
results with Bodipy581/591-C11 and further supporting a role for NOX2 in lipid peroxidation in 
endosomes of DCs. We then determined whether NOX2-induced lipid peroxidation could cause 
the release of antigen from endosomes.
Lipid peroxidation causes antigen release from endosomes
We confirmed that lipid peroxidation could cause leakage of artificial membranes by measuring 
ROS-induced leakage of the 14 kDa model protein lysozyme from 400 nm-sized liposomes 
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composed of (poly)unsaturated phospholipids. These liposomes were exposed to a combination 
of H2O2 and iron, which causes formation of hydroxyl radicals, lipid peroxidation and membrane 
leakage (15, 18). Leakage of lysozyme from the liposomes makes it accessible for trypsin digestion 
and the fraction of digested lysozyme hence correlates with liposome leakage. Indeed, the 
combination of H2O2 and iron caused leakage of lysozyme (~60%) as compared to the negative 
control in absence of ROS and the positive control with complete rupture of the liposomes by 
the detergent Triton X-100 (Fig. 2A). These results confirm the well-established notion that ROS-
induced lipid peroxidation can trigger membrane leakage (20–22). We then addressed whether 
NOX2-induced lipid peroxidation would also cause endosomal leakage in DCs. 
Leakage of proteins from endosomes into the cytosol was measured by three assays. The first 
assay is based on the FRET sensor coumarin-cephalosporin-fluorescein (4)-acetoxymethyl 
(CCF4-AM) (4, 8). This probe accumulates in the cell and can be cleaved by the enzyme 
β-lactamase, which results in a loss of FRET between its coumarin (donor) and fluorescein 
(acceptor) fluorophores. We observed both CCF4 signal uniformly distributed in the cells and 
in punctate structures, indicating that CCF4 (and its cleavage products) localized partly in the 
cytosol and part in intracellular compartments. Mammalian cells do not produce β-lactamase, but 
exogenous β-lactamase can be taken up by DCs and cleave CCF4 after β-lactamase escapes 
from endosomes into the cytosol or, conversely, after CCF4 influx into the endosomes (Fig. 2B). 
CCF4 cleavage was promoted by activating the DCs with LPS, but could be blocked by the 
presence of α-tocopherol during β-lactamase uptake (Fig. 2C), demonstrating a role of lipid 
peroxidation in β-lactamase release from endosomes. α-Tocopherol protects cellular membranes 
from ROS-induced damage, not only by scavenging radicals, but also by promoting a negative 
curvature (34). CCF4 cleavage was significantly reduced in human NOX2 KD DCs compared 
to controls (Fig. 2D). We could not perform endosomal leakage experiments with PAO, as this 
compound blocks endocytosis (Fig. S2). Uptake was neither affected by α-tocopherol nor by 
knockdown of NOX2.
The second antigen leakage assay is based on the induction of apoptosis by exogenous 
cytochrome C. The presence of cytochrome C in the cytosol initiates apoptotic protease-
activating factor 1 (Apaf-1) dependent apoptosis (4, 8, 35). Leakage of exogenous cytochrome 
C from endosomes results in reduced cell viability, which can be measured by the MTT assay. 
α-Tocopherol was able to block cytochrome C-induced cell death, in accordance with our results 
with the CCF4 assay, supporting a role for NOX2-induced lipid peroxidation in cytochrome C 
escape from endosomes (Fig. 2E). RNAi knock-down of NOX2 even increased viability (compared 
to control cells without cytochrome C), which we attribute to reduced cell-damaging effects of 
ROS (Fig. 2F). 
The third antigen leakage assay is based on the recruitment of galectin-3 to β-galactoside sugars, 
which are present on glycosylated proteins on the luminal, but not the cytosolic, side of endosomal
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^ Fig. 2: Lipid peroxidation causes antigen release from endosomes. A) Liposomes with lysozyme encapsulated 
were treated with a combination of H2O2 and Fe(II)SO4 (ROS) or Triton X-100 (TX100; positive control) followed by 
incubation with trypsin. Samples were analyzed by SDS-PAGE. Graph shows semi-quantifi cations of band intensities 
from 4 independent experiments (mean ± S.E.M). B) Scheme and confocal microscope images of a CCF4 assay. The 
cytosolic FRET probe CCF4 was cleaved by exogenous β-lactamase resulting in a decreased ratio of fl uorescein (acceptor 
fl uorophore; green) over coumarin (donor; blue) fl uorescence. BF, bright fi eld. C-D) CCF4 cleavage effi ciencies for DCs 
cultured in the presence or absence of LPS or α-tocopherol (α-Toc) (C) and for NOX2 KD DCs (D). NT, non-targeting 
siRNA. E-F) Cell viability by the MTT assay of cells cultured with exogenous cytochrome C (Cyt C) and in presence or 
absence of α-tocopherol (α-Toc) (E) as well as for NOX2 KD DCs (F). Each donor is plotted in a different color. G) Confocal 
micrographs of an unstimulated (w/o LPS) and stimulated (Ctrl) DC expressing galectin-3-mAzami (green), incubated with 
OVA conjugated to Alexa Fluor 647 (OVA-AF647; red). H) Fluorescence intensities of galectin-3-mAzami thresholded on 
OVA-AF647, relative to cytosolic fl uorescence intensity, in DCs in the presence of absence of LPS and α-Toc. Results show 
individual results for at least 3 donors. Scale bars: 10 µm.
membranes. In cells with intact endosomes, heterogeneously expressed galectin-3 tagged with 
the fl uorescent protein mAzami is uniformly distributed in the cytosol of cells, but it clusters when 
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it gains access to glycosylated moieties upon endosomal disruption (36–38). As expected, LPS 
stimulation of DCs transfected with galectin-3-mAzami promoted the recruitment of galectin-3 to 
OVA-positive endosomes (Fig. 2G) and this could be blocked by inhibiting lipid peroxidation with 
α-tocopherol (Fig. 2H). Based on these data, we conclude that NOX2-induced lipid peroxidation 
can cause escape of antigen from endosomes into the cytosol.
Lipid peroxidation promotes cross-presentation
Next, we addressed whether endosomal antigen escape by lipid peroxidation promotes antigen 
cross-presentation with use of two assays. We fi rst used a well-established assay to measure 
cross-presentation based on the loading of DCs with part of the tumor antigen gp100 (residues 
272–300; long peptide) (13, 39, 40). A smaller fragment of this long peptide (residues 280–288; 
short peptide) can be derived by lysosomal proteases (lysosomal pathway) or by the proteasome 
(cytosolic pathway) and cross-presented to a Jurkat T cell line heterogeneously expressing a 
receptor specifi c for MHC class I (HLA-A2) carrying gp100 short peptide (Fig. 3A). Upon activation 
of this receptor, these Jurkat T cells increase expression of the activation marker CD69 on their 
cell surface, which can be measured by fl ow cytometry (Fig. 3B; Fig. S3A). Under our experimental 
conditions, the maximum percentage of activated Jurkat T cells was ~55%, as determined by 
incubating DCs with an excess of short peptide that can exchange with endogenous peptide in 
MHC class I (Fig. S3B-D). Importantly, the Jurkat T cell assay provides a direct measure for cross-
presentation as Jurkat activation is independent of the co-stimulatory factors that are required for 
activation of naive T cells (e.g. CD80, CD86, IL-12, IFNγ). 
^ Fig. 3: Lipid peroxidation promotes cross-presentation. A) Scheme of the cytosolic and lysosomal pathways 
leading to antigen cross-presentation. B) Time line of the Jurkat T cell activation assay with dendritic cells (DCs) presenting 
gp100. C) Jurkat T cell activation assay with DCs incubated with α-tocopherol (α-Toc), MG132 or lactacystin and with NOX2 
KD DCs after incubation with long (residues 272–300) or short peptide (residues 280–288). On the y-axes the percentages 
of CD69-positive T cells for long (residues 272–300) over short peptide are depicted. D) B3Z T cell activation assay with 
BMDCs incubated with α-tocopherol (α-Toc) after incubation with complete OVA protein or OVA peptide (SIINFEKL). On 
the y-axis the percentages of β-galactosidase producing T cells for OVA protein over OVA peptide are depicted. Results 
show individual results for at least 3 donors. Raw FACS data, and full short and long peptide T cell activation controls are 
in Fig. S3 and S4.
113
Lipid peroxidation causes endosomaL antigen reLease for cross-presentation
5
We started by confirming the known role of NOX2 in promoting cross-presentation (10, 11, 13, 
14, 41). The activation of Jurkat T-cells by NOX2 KD DCs was significantly reduced by ~20% 
compared to control, similar to the inhibitions that we observed by treatment with the proteasome 
inhibitors MG132 and lactacystin (Fig. 3C). As antigens such as gp100 can be cross-presented via 
both proteasome-dependent (i.e. cytosolic) and -independent (i.e. lysosomal) pathways (42), our 
results indicate that, under our experimental conditions, about 20% of gp100 is cross-presented 
via the cytosolic pathway and that this pathway depends on NOX2. Importantly, selectively 
inhibiting lipid peroxidation with α-tocopherol during antigen uptake by DCs also significantly 
reduced Jurkat T cell activation (Fig. 3C). 
As a second assay for cross-presentation, we performed a T cell activation assay with BMDCs 
loaded with the model antigen OVA. OVA can also be partly processed in the cytosol by the 
proteasome and cross-presented in MHC class I to B3Z cells expressing a specific T cell receptor 
(4, 10, 11, 41). Engagement of this receptor results in the production of β-galactosidase by these 
B3Z cells, which can be measured by colorimetric assays (Fig. S4A). Similar to the Jurkat T cell 
assay, B3Z cells allow to directly measure cross-presentation as B3Z activation is independent of 
the co-stimulatory factors that are required for activation of naive T cells. In accordance with our 
results from the gp100 assay with human DCs, α-tocopherol treatment decreased activation of 
B3Z cells by ~25% using OVA (Fig. 3D) and this was not changed using the specific OVA antigenic 
peptide (Fig. S4B). We were not able to perform the B3Z assay in combination with MG132 and 
lactacystein due to high toxicity of these proteasome inhibitors (Fig. S4C). These data are in 
accordance with our hypothesis that lipid peroxidation triggers endosomal antigen release and 
this promotes antigen cross-presentation. We then performed optogenetic experiments to more 
directly confirm this causal relationship.
Light-triggering lipid peroxidation causes antigen release
We developed an optogenetic approach to light-trigger lipid peroxidation specifically in endosomes 
of DCs. This system is based on the fluorescent protein KillerRed, which generates singlet oxygen 
and superoxide anion radicals upon exposure to orange light (at 590 nm) (43). KillerRed was 
targeted to the antigen processing compartment by genetic fusion to the endosomal SNARE 
protein VAMP8 (Fig. 4A), which traffics gp91phox to phagosomes (41). DCs expressing VAMP8-
KillerRed were exposed to light by culturing directly under an orange LED array. These exposure 
conditions did not result in decreased cell viability, but did result in an almost 2-fold increased 
lipid peroxidation in endosomes compared to unexposed cells and to cells without expression of 
KillerRed as determined by the LAA assay (Fig. 4B). We could not use the Bodipy581/591-C11 
assay in these experiments, because of spectral overlap of this probe with KillerRed. As expected, 
KillerRed activation also resulted in more antigen leakage from endosomes, as we observed an 
almost 2-fold increase of CCF4 cleavage efficiency compared to unexposed cells and to cells 
without expression of KillerRed (Fig. 4C). In these LAA and CCF4 experiments, we identified 
KillerRed-positive cells by residual (i.e. unbleached) fluorescence. Lipid peroxidation and the
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release of antigen upon VAMP8-KillerRed exposure was not specific for immune cells, as we 
observed similar results with the embryonic kidney cell line HEK293T (Fig. 4D-E) and with the 
human melanoma cell line MEL624. Although HEK293T cells are HLA-A2 positive (44), we did not 
observe cross-presentation by these cells with the Jurkat T cell assay, perhaps because of a lack 
of components required for subsequent antigen processing, such as the immunoproteasome (45, 
46). Together, these data prove that lipid peroxidation causes antigen leakage from endosomes.
Endosomal antigen leakage is reduced in CGD patients
In the final set of experiments, we measured endosomal leakage in DCs isolated from blood 
of patients suffering from chronic granulomatous disease (CGD). CGD patients have a genetic 
mutation resulting in dysfunctional NOX2 and increased susceptibility to infectious diseases (15). 
Cross-presentation is also impaired in DCs of CGD patients (13, 47) and this has been linked 
to the higher risk of developing autoimmune diseases (48) and impaired antifungal protection 
(47). We performed the CCF4 assay on DCs from three CGD patients with mutated p47phox (a 
cytosolic component of NOX2) and one patient with mutated membrane-bound gp91phox (Fig. 4F). 
In agreement with our experiments with NOX2 KD, CCF4 cleavage was substantially reduced in 
DCs from CGD patients compared to healthy individuals (Fig. 4G), whereas control experiments 
with BSA conjugated to Alexa Fluor 488 showed that antigen uptake was not changed significantly 
(Fig. 4H). This result demonstrates that release of antigen from endosomes is impaired in CGD 
patients, further supporting a role of NOX2 in this process.
Discussion
The pivotal role of NOX2 in facilitating cross-presentation is well-established (10–14, 41). Although 
it is clear that NOX2 preserves antigen by inhibiting endo/lysosomal proteases via oxidation (14, 
16, 17) and delaying acidification (10–12), the direct mechanistic link between NOX2-produced 
ROS and cross-presentation was unclear (13). We now show that NOX2-produced ROS induce 
lipid peroxidation in endosomal membranes and thereby can cause antigen leakage from the 
endosomal lumen into the cytosol (Fig. 4I). These findings are in line with the reduced lipid 
peroxidation observed upon inhibition of NOX2 in murine neurons and microglia (49) and with the 
role of ROS in cathepsin release from lysosomes (50, 51). Our findings explain how neutrophils, 
> Fig. 4: Direct induction of endosomal antigen release and impaired release in CGD. A) Confocal micrographs 
of a DC expressing VAMP8-KillerRed (green) and incubated with OVA conjugated to Alexa Fluor 647 (OVA-AF647; red). BF, 
bright field. Scale bar: 10 µm. B) Linoleamide alkyne lipid peroxidation assay as in Fig. 1I, but now for exposed or non-
exposed DCs with or without expression of KillerRed. C) CCF4 endosomal antigen leakage assay as in Fig. 2B, but now 
for exposed or non-exposed DCs with or without expression of KillerRed. D-E) Similar as panels B and C, but now for 
HEK293T cells. F) p47phox and gp91phox expression in lymphocytes from three p47phox-/- (CGD1-3; blue) and one gp91phox-/- 
(CGD4; green) CGD patients by western blot (GAPDH, loading control). G) CCF4 endosomal antigen release assay as in 
Fig. 2B, but now with DCs derived from monocytes from the CGD patients from panel D (Ctrl: DCs from healthy donors). H) 
Uptake of BSA conjugated to Alexa Fluor 488 (BSA-AF488) by DCs of CGD patients, presented as percentage BSA-AF488-
positive cells and MFI. Results show individual results of at least 3 donors/experiments. I) Model scheme of NOX2-induced 
antigen leakage from endosomes. Superoxide anions produced by NOX2 and protons provided by the V-ATPase form H2O2 
and hydroxyl radicals (Fenton reaction). These ROS induce lipid peroxidation, which disrupts endosomal membranes and 
causes the release of antigen (purple spheres) into the cytosol.
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which have very high NOX2 activity during the oxidative burst, can be efficient antigen cross-
presenting cells (52). Our findings also corroborate with the suggestion that cross-presentation 
is facilitated by pathogens that actively disrupt the phagosomes of their host cells (53). This 
disruption allows the microbes access to nutrients from the cytosol of the host cell and this is 
required for their replication, but could also enable their detection by the immune system.
Our study also provides a new mechanistic link of the well-established positive correlation 
between cross-presentation and autophagy (54). NOX2-generated ROS are necessary for the 
induction of autophagy by phagosomal recruitment of the autophagy protein LC3 (55, 56). This 
LC3 recruitment is compromised in CGD patients resulting in autophagic defects, which underlie 
the pathogenesis of granulomatous colitis (56). The recruitment of LC3 to phagosomes can be 
blocked with α-tocopherol (55), indicating the involvement of intracellular scavenger receptors 
that recognize endosomal products of lipid peroxidation. Our results now show that at this point 
the integrity of the phagosomal membrane can be compromised, resulting in the leakage of 
antigen into the cytosolic MHC class I pathway and hence promoting cross-presentation.
Another topic of intense study is the role of ROS in cancer and inflammation (57). ROS are 
well-known to act as secondary messengers for activation of immune cells (58) and regulate for 
instance T cell activation by DCs (59). In this study, we have identified an additional mechanism of 
regulation of the immune function by ROS. Our results show that NOX2-induced ROS can cause 
lipid peroxidation, which in turn can result in release of (tumor) antigen into the cytosol, where 
it becomes accessible to the proteasome. Cross-presentation is hence facilitated by oxidation 
of endosomal lipids and this is a new cellular role for ROS. As already suggested previously (3, 
9, 27), the aspecific leakage of endosomal compartments explains how large, folded and/or 
posttranslationally-modified proteins as well as nucleic acids and dextrans can reach the cytosol. 
Thus, although our results do not exclude roles for specific protein channels such as Sec61 (5–8), 
lipid peroxidation provides an, at least complementary, mechanism by which antigens escape 
from endosomes for cross-presentation by DCs. 
The release of antigen from endosomes by lipid peroxidation may be used as a novel strategy to 
combat disease. Augmenting ROS specifically in endosomes or phagosomes of DCs by means 
of radical inducing molecules may help to evoke a CD8+ T cell response against cancer and 
infectious disease. Such an approach might well be feasible, given that the generation of ROS 
in endosomes of target cells is already exploited for delivery of siRNA in the gene therapy field 
(23–26). Thus, our results underscore that approaches to target ROS in endosomes of antigen 
presenting cells might be a promising therapeutic strategy for cancer and (auto)immune diseases.
Material and methods
Cells and transfection
Human DCs were derived from peripheral blood monocytes (PBMCs) obtained from buffycoats 
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of healthy individuals (informed consent obtained from all individuals) according to institutional 
guidelines and as described previously (60). Briefly, after purification on a Ficoll-gradient, 
monocytes were differentiated into immature DCs by culturing 6 days at 37ºC (5% CO2) in the 
presence of 300 U/ml IL-4 and 450 U/ml granulocyte macrophage colony-stimulating factor (GM-
CSF) in complete RPMI-1640 medium (Gibco by Thermo Fisher) containing 10% fetal bovine serum 
(FBS; Greiner Bio-one), 2 mM UltraGlutamine (Lonza) and 1% Antibiotic-Antimytotic (AA; Gibco by 
Thermo Fisher). CGD DCs were derived from PBMCs obtained from blood of three p47phox-/- and 
one gp91phox-/- patients (61) using the same protocol. All CGD patients were between the age of 
5 to 13 years and free from any infectious or inflammatory diseases. HEK293T cells were cultured 
in DMEM (Gibco by Thermo Fisher) containing 10% FBS, 1% non-essential amino acids and 0,5% 
AA. Jurkat E6.1 cells expressing CD8+ T cell receptors that recognize gp100-peptide(280–288) 
in the context of HLA-A2 were used for the T cell activation assay with human DCs. They were 
cultured in RPMI-1640 containing 10% FBS, 2 mM UltraGlutamine and 0.5% AA. 
Mouse bone marrow derived dendritic cells (BMDCs) were obtained from healthy C57BL/6 mice. 
BMDCs were differentiated by culturing 7 days in the presence of 20 ng/ml mouse GM-CSF in 
RPMI-1640 containing 10% FBS, 2 mM UltraGlutamine, 1% AA and 28 µM β-mercaptoethanol. 
B3Z T cell hybridoma cells containing a lacZ construct inducible by activation of its T cell receptor 
specific for OVA peptide in the context of H-2Kb (62) were used for the T cell activation assay 
with BMDCs. B3Z cells were cultured in the presence of 1 mM hygromycin B in IMDM containing 
5% FBS, 2 mM UltraGlutamine, 1% AA and 28 µM β-mecaptoethanol. All experiments with 
human samples were conducted in accordance with the relevant guidelines. Patient tissue and 
samples were obtained in accordance with the Declaration of Helsinki and approved consent 
was obtained from all patients or their legal representatives. All experiments were approved by the 
ethics committee from Radboud University Medical Center.
For NOX2 KD, DCs were electroporated with siRNA against NOX2 subunit gp91phox 
(CCGAGUCAAUAAUUCUGAUCCUUAU; Thermo Fisher) or with irrelevant ON-TARGET plus Non-
Targeting (NT) siRNA#1 (Dharmacon) using a Neon Transfection System (Thermo Fisher; 1,000 
V, 40 ms, 2 pulses). After electroporation, cells were transferred to serum-free RPMI medium 
without AA and phenol red. After 3 hours, this medium was replaced by complete RPMI medium 
and cells were cultured for 48 hours to achieve maximal knock-down, as judged by western blot 
analysis. Proteins were detected with mouse monoclonal antibody anti-NOX2/gp91phox (ab80897, 
Abcam) and rabbit polyclonal antibody anti-p47phox (sc-14015, Santa Cruz) (all at 1:500 dilution 
(v/v)) in combination with goat anti-rabbit or goat anti-mouse conjugated with IRDye 680 or 800 
(all Li-cor) as secondary antibodies (1:5,000 dilution (v/v)).
The construct coding for VAMP8-pKillerRed was made by standard cloning procedures. First 
mouse VAMP8 with restriction sites XhoI and BamHI was generated by PCR, cut and ligated 
into pmCherry-N1. Next, mCherry was replaced with KillerRed (43) via BamHI/NotI restriction 
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sites. KillerRed-N1 was a gift from Michael Davidson (Addgene plasmid # 54636). DCs were 
electroporated with the VAMP8-KillerRed construct as described (63). HEK293T cells were 
transfected using lipofectamine (Thermo Fisher), following the procedures of the manufacturer. 
DCs and HEK293T cells were cultured for 16 hours to achieve highest expression levels of 
VAMP8-KillerRed. For exposure, DCs and HEK293T cells expressing VAMP8-KillerRed were 
cultured for 0.5 – 4 hours directly under a 109 mW LED array at 590 nm (Thorlabs).
Lysozyme leakage assay
A mixture composed of 25 mg 1,2-dioleoyl-sn-glycero-3-phosphocholine, 25 mg 1-stearoyl-2-
arachidonoyl-sn-glycero-3-phosphocholine, 5 mg DOPS 1,2-dioleoyl-sn-glycero-3-phospho-L-
serine and 5 mg cholesterol (all Avanti) in chloroform was dried in a stream of N2 followed by 
vacuum. After drying, lipids were resuspended in 1 ml PBS containing 5% (w/v) sodium cholate 
and 7 mg/ml lysozyme (from chicken egg white; Sigma). The emulsion was dialyzed (7 kDa 
MWCO) and extruded through a polycarbonate filter with 400 nm pore size. Non-encapsulated 
lysozyme was removed by gel filtration (Sephadex-G150). The liposomes were incubated with 
200 mM H2O2 and 100 µM freshly prepared Fe(II)SO4 (Sigma) for 3 hours at room temperature 
followed by incubation with 50 mg/ml trypsin for 4 hours at 37ºC. Positive control experiments 
were performed with 0.2% Triton X-100. Samples were analyzed by 15% SDS-PAGE and stained 
with Coomassie Brilliant Blue R250 (CBB). 
ROS and lipid peroxidation assays
For the Amplex Red assay, cells were incubated for 2–4 hours in a 96 well plate (100,000 cells/
well) in serum-free RPMI with 2.2 mM OVA (Sigma) and with or without 1 µg/ml LPS (Sigma). 
After incubation, the medium was changed for RPMI without phenol red containing 50 µM 
Amplex UltraRed reagent (Thermo Fisher) and 3 U/ml horseradish peroxidase (Sigma) and the 
fluorescence of resofurin was measured every 15 min for 2 hours of subsequent incubation.
For the Bodipy581/591-C11 assay, DCs were loaded with 2.2 mM OVA and cultured in the 
presence of 1 µM Bodipy581/591-C11 (4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-
diaza-s-indacene-3-undecanoic acid; Thermo Fisher) in serum-free RPMI for 60 min at room 
temperature. 1 µg/ml LPS, 100 µM α-tocopherol (Sigma) and/or 1 µM phenylarsine oxide (PAO, 
Sigma) were added together with Bodipy581/591-C11. After incubation, the Bodipy581/591-C11 
fluorescence was measured by flow cytometry (excitation: 488 nm; emission: 530/30 nm; 
FACSCaliber, BD biosciences). The signal before incubation was subtracted for background 
correction.
The LAA Click chemistry experiments were performed following the manufactures protocol 
(C10445, Thermo Fisher) with some modifications. DCs were loaded with 55.5 µM OVA-Alexa 
Fluor 647 and 1 µg/ml LPS as adjuvant and cultured in the presence of 50 µM Click-iT LAA 
solution and 100 µM α-tocopherol in serum-free RPMI for 60 min at 37ºC on 12 mm coverslips in 
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24-wells plates. KillerRed-transfected DCs were exposed during incubation as described above. 
After culturing, the cells were washed, fixed with 4% PFA, permeabilized with 0.5% Triton-X100 
and blocked with 1% BSA (all diluted in PBS and incubated at room temperature). Coverslips 
were incubated for 30 min at room temperature protected from light with Click-iT reaction cocktail 
containing Cu(II)SO4 and Alexa Fluor 488 azide. Finally, the cells were washed and embedded in 
mounting medium containing 0.01% (v/v) Trolox and 68% (v/v) glycerol. Imaging was done with a 
Leica SP8 confocal microscope with a 63x 1.20 NA water immersion objective. For analysis of 
the green fluorescent signal, the endosomes were identified by setting a threshold on the signal 
of the OVA-Alexa Fluor 647 channel. 
Antigen uptake and leakage assays
For the antigen uptake experiments, DCs were incubated with 100 µg/ml BSA-Alexa Fluor 488 
(Thermo Fisher) and 1 µg/ml LPS for 60 min in the presence or absence of 500 µM α-tocopherol 
or 1 µM PAO. After washing the cells, the percentage of BSA-AF488-positive cells was measured 
by flow cytometry.
For the cytochrome C experiments (35), DCs were incubated with 10 mg/ml cytochrome C (from 
equine heart; Sigma), 1 µg/ml LPS and/or 500 µM α-tocopherol in complete RPMI for 20 hours at 
37ºC. After incubation, the medium was removed and 0.5 mg/ml MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) was added to each sample. After 1–4 hours incubation, lysis 
buffer containing 90% iso-propanol, 0.0125% SDS and 4% 1 M HCl was added and absorbance 
was measured at 595 nm to determine cell death.
The CCF4/β-lactamase assay (36) was performed in Willco petri dishes according to the protocol 
of the manufacturer (K1095, Thermo Fisher). Briefly, DCs were incubated with 1 µM Substrate 
Loading Solution, 1 µg/ml LPS as adjuvant and if applicable 500 µM α-tocopherol in Live Cell 
Imaging Medium (Thermo Fisher) for 90 min at 37ºC. After 90 min incubation time, DCs were 
washed and incubated with 1 mg/ml β-lactamase (Sigma). In addition, 1 µg/ml LPS and/or 500 
µM α-tocopherol were included together with the β-lactamase if these were added during the first 
incubation step. The second incubation step was done in Live Cell Imaging Medium for 3 hours at 
37ºC. The KillerRed-transfected DCs were exposed or shielded from light during the last 30 min 
of incubation. Cells were washed again and imaged with a Leica SP8 confocal microscope and 
a 63x 1.20 NA water immersion objective (405 nm excitation; 419–458 nm blue and 504–600 
nm green emission of the coumarin donor and fluorescein acceptor fluorophores, respectively). 
The FRET efficiencies F were calculated as the ratio of the green over the blue fluorescence 
intensities. The FRET efficiency of control cells in absence of β-lactamase Fneg was used as a 
negative control. The FRET cleavage C was then calculated as:
C = (Fneg – F ) / (Fneg).
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For the galectin-3 experiments, galectin-3-mAzami was cloned from mAG-GAL3 (38) into the NotI 
and PspOMI sites of pCDNA6-myc His B (Life Technologies). mAG-GAL3 was a gift from Niels 
Geijsen (Addgene plasmid # 62734). DCs were transfected with galectin-3-mAzami, following 
the same procedure as for Vamp8-KillerRed. After electroporation, the DCs were cultured for 16 
hours on coverslips and subsequently incubated with OVA conjugated to Alexa Fluor 647 for 60 
min in the presence or absence of 1 µg/ml LPS and/or 500 µM α-tocopherol. After incubation, 
cells were fixed with 4% PFA and embedded in mounting medium containing 0.01% (v/v) Trolox 
and 68% (v/v) glycerol. Imaging was done with a Leica DM6000 epi-fluorescence microscope 
fitted with a 63x 1.40 NA oil immersion objective and appropriate filters for mAzami (excitation: 
BP470/40; dichroic: LP495; emission: BP524/50) and Alexa Fluor 647 (excitation: BP620/60; 
dichroic: LP660; emission: BP700/75). For analysis, the fluorescence intensities of galectin-3-
mAzami from individual releasing endosomes, identified by the OVA-Alexa Fluor 647 channel, 
were corrected for the cytosolic fluorescence intensities similar as described (64).
pH measurements
For the labeling of OVA with pHrodo, a stock solution of 9 mM pHrodo-Green STP ester (Thermo 
Fisher) in DMSO was mixed with 10 volumes of 10 mg/ml OVA and incubated for 2 hours at 
room temperature. DCs were pulsed with 1 mM pHrodo-conjugated OVA and 1 µg/ml LPS in 
the presence or absence of 500 µM α-tocopherol for 15 min, followed by a chase of 150 min. 
The fluorescence intensities of pHrodo was measured by flow cytometry at 20, 40, 60, 90, 120 
and 150 min after starting with the chase (excitation: 488 nm; emission: 530/30 nm). pH was 
calibrated by measuring the fluorescence of pHrodo in a standard solution series of known pH. 
For the SNARF-1 experiments, DCs adhered to glass bottom microdishes were washed and 
incubated for 30 min with 1 mg/ml SNARF-1 dextran 10,000 MW (D3303, Thermo Fisher) with 
or without 500 µM α-tocopherol or 1 µM PAO. DCs were imaged with a Leica SP8 confocal 
microscope and a 63x 1.20 NA water immersion objective (540 nm excitation; 550–600 nm 
green and 620–700 nm red emission peaks of SNARF-1). The pH calibration curve was created 
by imaging SNARF-1 dextran containing DCs that were incubated with buffers of different pH (10 
mM phosphate buffer, 150 mM NaCl) and 0.003% Triton-X100.
Cross-presentation assays
For the human T cell activation assay, HLA-A2-positive DCs (70,000 cells/well) were incubated 
for 60 min at 37ºC in X-vivo medium (Lonza) containing 2% human serum in 96-wells plates. 
Cells were then washed and incubated with gp100 short peptide (10 µM gp100(280–288); 
GenScript) or long peptide (100 µM gp100(272–300); JPT) in combination with T cell receptor 
stimulation mix (4 µg/ml R-848 and poly(I:C); Enzo Life Sciences) for 4 hours in X-vivo medium 
at 37ºC. If applicable 500 µM α-tocopherol, 10 µM MG132 (Sigma) or 10 µM lactacystin (Sigma) 
were also added during this time step. After incubation, cells were washed and resuspended in 
X-vivo medium containing Jurkat E6.1 cells (100,000 cells/well) carrying a specific T cell receptor 
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recognizing HLA-A2 with gp100(280–288) (65) and co-cultured for 18 hours at 37ºC. T cells 
were stained with αCD69-FITC (1:10, BD biosciences), αCD3-APC (1:10, eBiosciences) and 
7AAD viability staining (1:14, Biolegend) or Propidium Iodide (PI; 0.5 µg/ml) and analyzed with a 
FACSCalibur (BD biosciences). CD69 expression to measure T cell activation was analyzed using 
FlowJo software and Prism 5. Briefly, cells were gated on viability (7AAD or PI), followed by gating 
for CD3 staining, and CD69 expression was measured. T cell activation was calculated as the 
ratio of CD69-positive cells stimulated with long over stimulation with short peptide.
For the T cells activation assay with mouse cells, BMDCs (from H-2Kb-positive C57BL/6 mice; 
80,000 cells/well) were incubated with 80 µg/ml OVA protein, 5 ng/ml OVA peptide (residues 
257-264; (SIINFEKL), 1 µg/ml LPS and if applicable 500 µM α-tocopherol in complete RPMI-1640 
for 30 min (OVA peptide) or 5 hours (OVA protein) at 37ºC. After incubation, cells were washed 
and incubated in complete RPMI-1640 containing B3Z cells (80,000 cells/well) for 18 hours. 
Supernatant was removed and cells were incubated with Z-buffer containing 10 mM DTT (MP 
Biomedicals), 9 mM MgCl2, 0.15 mM CPRG (Calbiochem) and 0.125% NP40 (Sigma) for 1-5 hours 
at 37ºC. Absorbance was measured at 595 nm. Total T cell activation was calculated as the ratio 
of the absorbance of cells stimulated with the full-length OVA protein over stimulation with the 
OVA peptide.
Statistical analysis
All experiments were assessed using Student's paired two-sided t-tests, except for the data with 
CGD patient material where an Student's unpaired two-sided t-test was used. A value of P<0.05 
were considered to be statistically significant (* P <0.05, ** P <0.01, *** P <0.001).
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Supplementary Figures
^ Fig. S1: Endosomal pH is unaffected by α-tocopherol. A) Endosomal pH determined with the intensiometric 
probe pHrodo-Green linked to OVA for DCs incubated with or without α-tocopherol. The pH was calibrated by measuring 
the fl uorescence of pHrodo-Green in buffers of known pH. B-D) Intensiometric probes are prone to artifacts caused by 
ROS-induced oxidation and we therefore confi rmed the results from panel A with the ratiometric probe SNARF-1 conjugated 
to dextran. B) Confocal microscope images of DCs with SNARF-1 with and without PAO. PAO results in endosomal 
acidifi cation apparent from a green shift of the fl uorescence of SNARF-1. Scale bar: 10 μm. C) The pH calibration curve was 
created by imaging cells after uptake of SNARF-1-labeled dextran and incubation with buffers of different pH and 0.003% 
Triton-X100. The curve was fi tted with a standard reaction model with pKa = 7.3 for SNARF-1 (at 37ºC; Life Technologies; 
solid line). D) Average of endosomal pH of > 100 cells (pooled from 3 independent experiments) within 30–60 min after 
SNARF-1 uptake. PAO resulted in acidifi cation of endosomal compartments. Results show mean ± S.E.M of 3 donors.
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^ Fig. S2: Controls for the endosomal leakage experiments. A) Representative FACS data for uptake experiments 
of BSA conjugated to Alexa Fluor 488 (BSA-AF488) by DCs. Left dot plot, side (SSC) and forward (FSC) scatter plot for 
gating of DCs. Right histograms, fl uorescence distributions of BSA-AF488 signal at the indicated times after begin of 
uptake. B-C) Uptake of BSA conjugated to Alexa Fluor 488 (BSA-AF488) was measured after 60 min for DCs cultured 
in the absence (Ctrl) or presence of α-tocopherol (α-Toc) or PAO (B) as well as for NOX2 KD DCs (C). NT, non-targeting 
siRNA control. PAO decreased uptake of BSA by ~50%. Results show results of 3 donors (indicated with different colors).
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< Fig. S3: Short and long peptide controls for Jurkat T cell activation. A) Representative FACS data for analysis 
of CD69-positive T cells. Jurkat T cells were selected based on scatter (left dot plot) and gating on PI-negative, CD3-
positive cells (middle histograms). Right histogram, CD69 intensity distribution for Jurkat T cells.  B) Activation of Jurkat T 
cells by DCs incubated with a concentration range of short peptide (gp100 residues 280–288). For all concentrations, we 
observed a maximum activation of ~55% CD69-positive T cells with short peptide. C-D) Jurkat T cells activation assay 
with DCs incubated with α-tocopherol (α-Toc), MG132 or lactacystin (C) and with NOX2 KD DCs (D) after incubation with 
short peptide. E) Similar to panel B, but now for a concentration range of the long peptide (residues 272-300). F) CD69-
expression on T cells after incubation with DCs treated with irrelevant, short or long peptide. As a negative control, T cells 
were incubated with long peptide in absence of DCs. As a positive control, T cells were activated by PMA. Results show 
mean ± spread of 2 donors.
^ Fig. S4: B3Z T cell activation assay with mouse BMDCs. A) Time line of the B3Z T cell activation assay with 
BMDCs presenting OVA. B) B3Z T cell activation assay with BMDCs incubated with α-tocopherol (α-Toc) after incubation 
with 5 ng/ml OVA peptide (SIINFEKL). C) Toxicity of proteasome inhibitors MG132 and lactacystin. BMDCs were treated with 
different concentrations of MG132 and lactacystin for 4 hours at 37ºC. After incubation, the medium was removed and 0.5 
mg/ml MTT was added to each sample. After 1-4 hours incubation, lysis buffer was added and absorbance was measured 
at 595 nm to determine cell viability. Results show average ± S.E.M. of at least 3 experiments.
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Abstract
Cross-presentation of foreign antigen in major histocompatibility complex (MHC) class I by dendritic 
cells (DCs) requires activation of the NADPH-oxidase NOX2 complex. We recently showed that 
NOX2 is recruited to phagosomes by the SNARE protein VAMP8 where NOX2-produced reactive 
oxygen species (ROS) cause lipid peroxidation and membrane disruption, promoting antigen 
translocation into the cytosol for cross-presentation. In this study, we extend these findings by 
showing that VAMP8 is also involved in NOX2 trafficking to endosomes. Moreover, we demonstrate 
in both human and mouse DCs that absence of VAMP8 led to decreased ROS production, lipid 
peroxidation and antigen translocation, and that this impaired cross-presentation. In contrast, 
knockdown of VAMP8 did not affect recruitment of MHC class I and the transporter associated 
with antigen processing 1 (TAP1) to phagosomes, although surface levels of MHC class I were 
reduced. Thus, in addition to a secretory role, VAMP8 mediates trafficking of NOX2 to endosomes 
and phagosomes and this promotes induction of cytolytic T cell immune responses.
Introduction
Dendritic cells (DCs) are key antigen presenting cells of the immune system that take up pathogens 
by endo- and phagocytosis to kill, degrade and finally present pathogen-derived antigens for 
activation of T cells (1–3). Activation of CD8+ ‘killer’ T cells requires ingested antigens to be 
presented on major histocompatibility (MHC) class I molecules following a process called cross-
presentation. Essential for cross-presentation is the NADPH oxidase NOX2 complex which resides 
on endosomes and phagosomes, and produces reactive oxygen species (ROS) within the endo/
phagosomal lumen (4–9). NOX2 promotes antigen cross-presentation by three mechanisms. 
First, ROS production results in alkalization of the endosomal lumen, thereby inhibiting activation 
of lysosomal proteases with low pH optima and preventing excessive antigen degradation (7–9). 
Second, lysosomal proteases of the cystein cathepsin family are reversibly oxidized by ROS, 
which also preserves antigen (10–12). Last, we showed that NOX2-produced ROS oxidize lipids 
of the endosomal membrane, resulting in membrane disruption and release of antigen from the 
endosomal lumen into the cytosol (4). Within the cytosol, the antigen becomes accessible to 
proteasomal degradation for generation of MHC class I-compatible peptides (1–3).
Recently, we examined how the integral membrane-component of NOX2, cytochrome b558, which 
consists of gp91phox and p22phox, traffics to antigen-containing phagosomes in human blood-
isolated monocyte-derived DCs (13). We showed that gp91phox is recruited from the plasma 
membrane to phagosomes during their formation. After, or perhaps already during, phagosome 
sealing, phagosomal NOX2 is replaced from intracellular compartments of late endosomal/
lysosomal nature and this serves to replace oxidatively damaged NOX2. The final fusion step that 
merges NOX2-containing transport vesicles with the phagosomal membrane is catalyzed by the 
complexing of the SNARE proteins VAMP8 with syntaxin-7 and SNAP23 (13). In mouse DCs, this 
trafficking step is targeted by the intracellular pathogen Leishmania, which selectively cleaves VAMP8 
thereby preventing NOX2 function and cross-presentation and evading immune recognition (14). 
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In this study, we sought to determine whether VAMP8 would also be responsible for trafficking 
of NOX2 components to endosomes and whether this would be important for antigen cross-
presentation by human DCs. Our data showed that siRNA knockdown of VAMP8 resulted in 
impaired recruitment of gp91phox, but not of MHC class I and the transporter associated with 
antigen processing 1 (TAP1), to endosomes and phagosomes in human DCs, corroborating our 
previous findings (13). Moreover, we show that the lack of VAMP8 led to reduced formation of 
endosomal ROS and decreased oxidation of endosomal components, which in turn blocked the 
translocation of antigen into the cytosol. VAMP8 knockdown impaired antigen cross-presentation 
by human DCs, similar to previous findings with VAMP8-negative mouse DCs (14). Finally, our 
data indicate that VAMP8 is involved in multiple transport routes within DCs, and, in addition to the 
recruitment of NOX2 to the antigen-containing compartment, mediated trafficking of MHC class I 
to the plasma membrane. Our study strengthens the emerging concept that the replenishment of 
NOX2 from late endosomal/lysosomal compartments is important for antigen cross-presentation 
and the initiation of cytolytic T cell immune responses. 
Results
To investigate the role of VAMP8 in antigen cross-presentation in human DCs, we performed 
siRNA knockdown of VAMP8 in blood-isolated monocyte-derived DCs. We achieved 79 ± 11% 
(average ± S.D. from 9 different donors) knockdown efficiency by western blot (Fig. 1A). We also 
generated bone marrow derived DCs (BMDCs) from VAMP8-/- mice. VAMP8 is a SNARE protein 
that catalyzes various endosomal and secretory membrane fusion steps and locates to both early 
and late endosomes as well as to phagosomes and secretory vesicles (19–25). VAMP8 also has 
a secretory function in DCs as VAMP8 ablation led to a significant reduction of the surface levels 
of MHC class I in human DCs and of both MHC class I and II in BMDCs (Fig. 1B-C). Moreover, 
VAMP8 knockdown resulted in a trend of reduced secretion of interleukin-1 receptor antagonist 
(IL-1ra; Fig. 1D-E). These results indicate that VAMP8 could mediate the exocytosis of secretory 
vesicles containing MHC molecules and IL-1ra and/or plays a role at upstream trafficking events.
Recently, we showed that VAMP8 mediates the recruitment of gp91phox to zymosan-containing 
phagosomes in human DCs (13). Others (14) showed that VAMP8 also mediates recruitment of 
gp91phox to latex beads and Leishmania-containing phagosomes in BMDCs. In line with this, we 
observed that siRNA knockdown of VAMP8 resulted in a reduction of gp91phox recruitment to both 
latex bead-bearing phagosomes and OVA-containing endosomes compared to the non-targeting 
siRNA control (Fig. 2A-B). Thus, our data show that VAMP8 mediates the recruitment of gp91phox, 
the integral membrane component of NOX2, to antigen-containing endosomes and phagosomes 
in human DCs, corroborating previous findings in human DCs and BMDCs (13, 14). Importantly, 
VAMP8-mediated recruitment of gp91phox seems to be a general mechanism that does not 
depend on signaling by pathogen recognition receptors (PRRs), as it was observed for a wide 
range of model antigens and also for latex beads that do not activate PRRs (Fig. 2A-B; (13, 14)).
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^ Fig. 1: Loss of VAMP8 results in decreased surface-levels of MHC class I. A) siRNA knockdown for VAMP8 in 
human DCs (VAMP8 KD; NT, non-targeting siRNA; see reference (4) for quantifi cation) and VAMP8 expression in BMDCs 
from VAMP8+/- and -/- mice by western blot. GAPDH, loading control. B) Representative fl ow cytometry histograms of 
surface staining of MHC class I and II molecules in VAMP8 KD (blue) and NT (green) human DCs (upper graphs) and for 
VAMP8-/- (blue) and VAMP8+/- (green) mouse BMDCs (lower graphs). The grey curves show the mean fl uorescence 
intensities of the isotype controls. C) Expression levels of HLA-A2 molecules (MHC-I), HLA-DR molecules (MHC-II), CD11c 
or CD86 on the surface of VAMP8 KD human DCs (left) or VAMP8-/- mouse BMDCs (right) normalized to control cells. D) 
Representative dot blot of cytokine array blots for NT and VAMP8 KD human DCs. The grey values are proportional to the 
levels of secreted cytokines. The four most abundant cytokines are indicated: IL-1ra; macrophage migration inhibitory factor 
(MIF); interleukin-8 (IL-8); Serpin E1. E) Quantifi cation of the cytokine secretion levels from panel D normalized to the highest 
intensities. Results are from at least three donors and plotted as mean ± S.E.M.
We then tested whether the reduced phagosomal recruitment of gp91phox upon VAMP8 
knockdown would lead to impaired cellular ROS production. VAMP8-knockdown DCs produced 
less H2O2 compared to non-targeting siRNA control cells, as measured with the Amplex Red 
assay (Fig. 2C). In these experiments, we stimulated the DCs with the Toll like receptor 4 (TLR4) 
agonist lipopolysaccharide (LPS) O111:B4 from E. coli which resulted in increased surface levels 
of the maturation markers MHC class I, MHC class II, CD86 and CD83 (Fig. S1), and is known 
to promote the cross-presentation effi ciency of DCs (18). For our ROS measurements, it did not 
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^ Fig. 2: VAMP8 is responsible for NOX2 recruitment to endosomes and phagosomes. A) Representative 
confocal micrographs showing the recruitment of gp91phox (green in merge) to phagosomes containing latex beads by 
immunofl uorescence in VAMP8 KD and control DCs (non-targeting siRNA; NT). Magenta, immunolabeling for VAMP8. 
Arrow heads indicate phagosomes positive for gp91phox. The graph shows the quantifi cation by manual counting of gp91phox-
positive phagosomes of DCs from 3 individual donors (linked by solid lines; p = 0.0067). B) Same as panel A, but now 
for OVA-containing endosomes (OVA; magenta; p = 0.0391). Recruitment was quantifi ed from the gp91phox signal at OVA-
positive compartments relative to the total imaged cell area. C) H2O2 production by VAMP8 KD DCs (red curve) compared to 
NT control DCs (black) measured with the Amplex Red assay. The symbols show the individual donors. D) Representative 
fl ow cytometry histograms of lipid peroxidation sensor Bodipy581/591-C11 for VAMP8 KD (blue) and NT (green) human 
DCs (upper graph) and for VAMP8-/- (blue) and VAMP8+/- (green) mouse BMDCs (lower graph) after 60 min incubation 
with LPS and OVA. The red curves show the background fl uorescence distribution from cells without Bodipy581/591-C11. 
E) Percentage of lipid peroxidation over time in VAMP8 KD (red curve) and NT (black) human DCs. The symbols show the 
individual donors. F) Quantifi cation of panel D. Relative lipid peroxidation: mean fl uorescence intensities of VAMP8 KD DCs 
(4 donors; p = 0.0154) and VAMP8-/- BMDCs (3 mice; p = 0.0474) relative to the NT and VAMP8+/- controls. Scale bars: 
10 µm.
matter whether the antigen was continuously present with the DCs or washed away after initial 
preincubation at 4ºC (where the antigen binds but is not taken up; Fig. S2A). Previously, VAMP8 
was shown to act as a negative regulator of phagocytosis, because VAMP8-negative BMDCs 
showed an increased phagocytosis, while VAMP8 overexpression resulted in the reverse effect 
(21, 26). However, for our human monocyte-derived DCs, we did not observe an effect of VAMP8 
on phagocytosis and VAMP8-knockdown DCs ingested zymosan or latex particles with similar 
effi ciency as control cells. Endocytosis was also not affected by VAMP8, as the uptake of the model 
antigen albumin from bovine serum (BSA) labeled with Alexa Fluor 488 by VAMP8-knockdown 
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DCs was not changed (Fig. S2B-C). Thus, we did not observe effects of VAMP8 knockdown 
on antigen uptake, indicating that the decreased cellular ROS production in absence of VAMP8 
is likely caused by the impaired trafficking of NOX2 to the antigen-containing compartment. 
ROS react indiscriminately and hence NOX2 activity causes self-damage by oxidizing endosomal 
and phagosomal proteins and lipids within the DC (4, 10–13). We expected that the absence of 
VAMP8 would reduce this damage, since our results show that siRNA knockdown of VAMP8 
resulted in impaired endosomal and phagosomal recruitment of gp91phox and reduced ROS 
production. To investigate this possibility, we measured peroxidation of cellular lipids with the lipid 
peroxidation probe Bodipy581/591-C11 in human DCs. This probe mimics a polyunsaturated lipid 
and its oxidation results in an increased fluorescence emission at 510 nm that can be measured 
by flow cytometry (Fig. 2D). Incubating human DCs with this probe revealed time-dependent lipid 
peroxidation, and this was reduced in DCs with siRNA knockdown of VAMP8 compared to DCs 
transfected with non-targeting siRNA (Fig. 2E). This reduction in lipid peroxidation was similar 
to what we observed previously with siRNA knockdown of gp91phox, or upon treatment of the 
DCs with the NOX2-inhibitor phenylarsine oxide or the lipophilic radical scavenger α-tocopherol 
(4). Lipid peroxidation was also reduced in BMDCs isolated from VAMP8-/- mice compared to 
BMDCs from wild-type mice (Fig. 2F; (14, 27)), although in this case LPS maturation only resulted 
in increased surface expression of CD86 and did not affect MHC class I, MHC class II and 
CD11c levels (Fig. S1B). These data show that genetic ablation of VAMP8 results in a significant 
reduction of lipid peroxidation in both human DCs and BMDCs (Fig. 2E-F), further supporting the 
requirement of VAMP8 for NOX2 activity. 
We recently showed that the oxidation of endosomal lipids promotes the translocation of antigen 
from the phagosomal lumen into the cytosol (4). Since our data showed a requirement for 
VAMP8 in NOX2 activity, we examined whether the genetic ablation of VAMP8 would block the 
translocation of antigen over endosomal membranes. We used an antigen-leakage assay based 
on Förster resonance energy transfer (FRET) with the probe coumarin-cephalosporin-fluorescein 
(4)-acetoxymethyl (CCF4-AM) (4, 28, 29). CCF4 accumulates in the cytosol and can be cleaved 
by the enzyme β-lactamase, which results in a loss of FRET between its coumarin (donor) and 
fluorescein (acceptor) fluorophores. Mammalian cells do not produce β-lactamase, but exogenous 
β-lactamase can be taken up by DCs and escape from endosomes into the cytosol where 
it can cleave CCF4. We performed side-by-side comparisons where we first loaded VAMP8 
knockdown and control DCs with CCF4 and then cultured them in the presence of exogenous 
β-lactamase purified from Escherichia coli (Fig. 3A-B). The DCs were stimulated with LPS in these 
experiments, although we cannot exclude additional PRR-signaling from bacterial contaminants 
in the β-lactamase. Compared to the control cells, CCF4 cleavage was reduced both in human 
DCs with siRNA knockdown of VAMP8 and in mouse VAMP8-/- BMDCs (Fig. 3C-D). Thus, the 
absence of VAMP8 leads to reduced antigen translocation over endosomal membranes. 
135
VamP8-meDiateD noX2 reCruitment to enDosomes is neCessarY For antiGen release 
6
^ Fig. 3: Antigen cross-presentation depends on VAMP8-mediated traffi cking of NOX2. A) Representative 
confocal microscope images of the CCF4 endosomal leakage assay for VAMP8 siRNA knockdown (VAMP8 KD) and non-
targeting siRNA (NT) human DCs. The cytosolic FRET probe CCF4 was cleaved by exogenous β-lactamase (β-lac) resulting 
in a decreased ratio of fl uorescein (acceptor fl uorophore; green in merge) over coumarin (donor; blue) fl uorescence. B) 
Representative confocal microscope images as in panel A, but now for VAMP8-/- and VAMP8+/- BMDCs. C) Quantifi cation 
of panel A. The graph shows the CCF4 cleavage effi ciencies (see reference (4)) of DCs from 3 donors (linked by solid lines; p 
= 0.0312). D) Same as panel C, but now for VAMP8-/- and VAMP8+/- BMDCs (panel B; p = 0.0457). E) Representative fl ow 
cytometry histograms of CD69 expression by Jurkat cells carrying a gp100-specifi c T cell receptor. The Jurkat T cells were 
co-cultured with VAMP8 KD (blue) and NT (green) DCs that were loaded with short (residues 280–288; left-hand graphs) 
or long (residues 272–300; right) gp100 peptide. The percentages CD69-positive T cells are indicated in the graphs. F) 
Quantifi cation of T cell activation from panel E for 4 donors (p = 0.0461). Scale bars: 10 µm.
The release of antigen from endosomes into the cytosol is well-known to promote antigen cross-
presentation by making it accessible to degradation by the proteasome (1–3). We therefore 
reasoned that the reduced endosomal antigen release we observed upon genetic ablation of 
VAMP8 could well explain known defects in antigen cross-presentation by BMDCs from VAMP8-
/- mice (14). To further examine the potential involvement of VAMP8 in cross-presentation, we 
investigated whether knockdown of VAMP8 would impair antigen cross-presentation by human 
DCs. We cultured our human DCs with a long peptide of the melanoma antigen gp100 (residues 
272–300). DCs that take up and process this peptide can cross-present a small fragment of this 
peptide (residues 280–288) to a Jurkat T cell line carrying a receptor specifi c for this fragment (4). 
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We also incubated DCs with this short gp100280-288 peptide which can be directly loaded on 
MHC class I and thereby allows to measure direct presentation. Jurkat T cell activation results in 
upregulated expression of the maturation marker CD69 on its surface. Jurkat T cell activation by 
VAMP8-knockdown DCs was reduced compared to the non-targeting siRNA control for the long, 
but not the short, peptide (Fig. 3E-F). Although this reduction was relatively small, it was significant 
and similar to the inhibitions that we observed previously by direct siRNA knockdown of gp91phox 
or by treatment with the proteasome inhibitors MG132 and lactacystin (4), which suggests that 
NOX2 activation is necessary for cross-presentation via the cytosolic, TAP- and proteasome-
dependent pathway. The decreased T cell activation upon VAMP8 knockdown was not caused by 
reduced surface levels of MHC class I (Fig. 1C) because this reduction was no longer significant 
for matured DCs (Fig. S3) and because direct presentation of the short gp100280-288 peptide was 
not affected. Together, these data are in accordance with a role for VAMP8 in delivery of gp91phox 
to the antigen-containing compartment for antigen cross-presentation.
In the final set of experiments, we investigated whether the VAMP8-mediated transport of gp91phox 
to phagosomes would also be responsible for the recruitment of other components involved 
in antigen cross-presentation. Antigen cross-presentation is promoted by the phagosomal 
presence of TAP1, an antigen transporter channel that mainly resides at the endoplasmic reticulum 
(ER) (Fig. S4A; Guermonprez et al., 2003). TAP1 is recruited from the ER to antigen-containing 
phagosomes by the action of Sec22b, another R-SNARE active at the ER-Golgi intermediate 
compartment (ERGIC; Fig. S4B; (28)). The phagosomal recruitment of TAP1 was not affected by 
knockdown of VAMP8 (Fig. 4A). Moreover, we observed only little, if any, localization of Sec22b to 
the phagosome and did not observe overlap between gp91phox and the ER marker Calnexin (Fig. 
S4C-D), indicating that gp91phox and TAP1 are recruited to the phagosome via different pathways. 
We also tested whether VAMP8 would mediate recruitment of MHC class I to phagosomes. 
MHC class I molecules are recruited to phagosomes from Rab11a-positive recycling endosomal 
compartments (31). This is critical for antigen cross-presentation as Rab11a-silencing reduces 
MHC class I recruitment and results in impaired cross-presentation (31). MHC class I traffics 
to phagosomes by the action of the SNARE SNAP23 (31), which also mediates phagosomal 
recruitment of gp91phox together with VAMP8 (13). However, despite that both gp91phox and 
MHC class I traffic to phagosomes by the action of SNAP23 (13, 31), VAMP8 does not seem 
to mediate phagosomal trafficking of the latter, because genetic ablation of VAMP8 does not 
affect the recruitment of MHC class I to phagosomes in BMDCs (31). This is in agreement with 
our findings, as siRNA knockdown of VAMP8 did not affect phagosomal recruitment of MHC 
class I in human DCs (Fig. 4B), even though part of gp91phox located at Rab11a-positive recycling 
endosomal compartments and phagosomes (Fig. S4E). Overall, our results and published data 
(28, 31) argue for the independent trafficking of gp91phox, MHC class I and TAP1 to the antigen-
containing compartment, with each of these proteins facilitating the processing of the antigen for 
cross-presentation. 
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^ Fig. 4: Recruitment of TAP1 and MHC class I molecules to phagosomes is VAMP8-independent. A) 
Representative confocal micrographs showing the recruitment of TAP1 (green in merge) and VAMP8 (magenta) to zymosan-
containing phagosomes by immunofl uorescence in VAMP8 KD and NT human DCs. Arrow heads indicate phagosomes 
positive for TAP1. The graph shows the quantifi cation by manual counting of TAP1-positive phagosomes of DCs from 3 
individual donors. B) Same as panel A, but now for MHC class I (MHC-I; green in merge). Scale bars: 10 µm; ns, not 
signifi cant.
Discussion
This study is an extension of two previous studies where we showed (i) that NOX2-produced 
ROS induce antigen translocation from endosomes into the cytosol promoting antigen cross-
presentation (4) and (ii) that phagosomal recruitment of the integral membrane component of 
NOX2 is mediated by the SNARE protein VAMP8 (13). This study is also an extension of a recent 
study by Matheoud et al. (14) who showed that gp91phox recruitment to phagosomes is inhibited 
in the absence of VAMP8 and that this leads to alkalization of the phagosomal lumen, decreased 
proteolysis and defects in antigen cross-presentation. In this study, we showed that genetic 
ablation of VAMP8 in both human and mouse DCs not only impairs NOX2 recruitment to the 
antigen-containing compartment, but also prevents auto-oxidation of endosomal membranes and 
blocks endosomal antigen release into the cytosol. Our data support the previously observed role 
for VAMP8 in antigen cross-presentation in BMDCs (14), as we showed that siRNA knockdown of 
VAMP8 leads to impaired antigen cross-presentation in human DCs. 
VAMP8-mediated traffi cking of NOX2 to phagosomes seems independent from the phagosomal 
recruitment of TAP1 and MHC class I, two other protein complexes required for antigen cross-
presentation. We found that whereas VAMP8 knockdown resulted in reduced recruitment of 
gp91phox to phagosomes, the phagosomal presence of TAP1 and MHC class I were not affected. 
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This finding data is in line with literature: Nair-Gupta et al. showed that MHC class I is recruited 
to phagosomes from Rab11a-positive recycling endosomes and this recruitment is not affected 
in BMDCs from VAMP8-knockout mice (31). Cebrian et al. showed that TAP1 is recruited to 
phagosomes from the ERGIC compartment by the action of Sec22b, another R-SNARE (28). 
In contrast, our data and literature (13, 14) show that gp91phox is recruited to phagosomes from 
compartments of lysosomal nature by the action of VAMP8. Thus, it is becoming increasingly 
clear that NOX2 traffics to phagosomes independent of TAP1 and MHC class I. NOX2 has a 
role early in cross-presentation and promotes the translocation of antigen into the cytosol and 
reduces activation of endo/lysosomal proteases by increased pH and/or reversible oxidation (4, 
7–9, 11, 12). In addition, NOX2 mediates the killing of ingested microbes by DCs (32). TAP1 and 
MHC class I play roles later during cross-presentation as they mediate antigen transport, loading 
and presentation (1–3). The independent trafficking of NOX2 to antigen-containing compartments 
might allow to uncouple ROS production from these later functions and thereby could allow better 
spatial and/or temporal control of antigen processing and presentation. 
The defects we observed in endosomal antigen release and cross-presentation upon genetic 
ablation of VAMP8 are relatively mild. This is likely caused by the fact that not all gp91phox traffics 
to the antigen-containing compartment by the action of VAMP8, but that part of gp91phox reaches 
the phagosome from the plasma membrane during antigen internalization (13). Another likely 
explanation for the relatively small effects of VAMP8 knockdown/knockout is that SNARE proteins 
are redundant and promiscuous and other SNARE proteins may at least partially compensate 
for the absence of VAMP8. Indeed, in many studies knockdown or knockout of SNARE proteins 
did not result in clear changes in phenotype (31, 33, 34). Moreover, we found relatively mild 
phenotypes with a ~25% reduction of surface-expressed MHC class I and a trend towards lower 
IL-1ra secretion upon VAMP8 knockdown in human DCs. A key candidate for such a compensatory 
role is VAMP3, which locates to endosomes and phagosomes similar to VAMP8 (14, 31, 35). The 
observed differences in antigen presentation might also be relatively small, because the absence 
of VAMP8 does not influence phagosomal recruitment of MHC class I and TAP1 and part of the 
cross-presentation machinery remains intact.
Our data support the following model of how VAMP8 promotes antigen cross-presentation by 
DCs (Fig. 5). First, foreign antigen is ingested by the DCs. Second, gp91phox traffics to the antigen-
containing compartment by the concerted action of VAMP8, SNAP23 and syntaxin-7 (13). Third, 
NOX2 assembles on the antigen-containing compartment and produces ROS in the organellar 
lumen. These ROS lead to an increase of the luminal pH as well as to auto-oxidation of endo/
lysosomal proteases and of the endo/phagosomal membrane. Fourth, the auto-oxidation disrupts the 
membrane integrity, allowing the translocation of antigen into the cytosol, where itbecomes accessible 
to proteasomal degradation. In the final step, the proteasome-derived peptide fragments can either 
be re-imported into the endo/phagosomes or be imported in the endoplasmatic reticulum by the 
transporter associated with antigen processing (TAP) for loading onto MHC class I molecules (1–3).
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^ Fig. 5: Model of VAMP8-mediated antigen cross-presentation. (1) Uptake of antigen via endocytosis or 
phagocytosis. (2) Recruitment of cytochrome b558 (Cyt b558) to the antigen-containing compartment by VAMP8, SNAP23 
and syntaxin-7. (3) Fully assembled NOX2 on the phagosome produces ROS in the organellar lumen. (4) ROS lead to 
disruption of the phagosomal membrane allowing translocation of antigen into the cytosol. In the cytosol, the antigen 
becomes accessible for degradation by the proteasome. The proteasome-derived peptide fragments are imported in the 
endoplasmatic reticulum (ER) by the transporter associated with antigen processing (TAP) for loading onto MHC class I 
molecules (MHC-I). (5) The MHC-I:peptide complex is transported to the cell surface to cross-present the antigen to naive 
cytolytic T cells.
In addition to the SNARE molecules VAMP8, SNAP23 and syntaxin-7 (13), previous studies have 
identifi ed several key molecules for regulating the delivery of gp91phox to the antigen-containing 
compartment. One of these molecules is synaptotagmin-11 which mediates the delivery of 
gp91phox to phagosomes in RAW264.7 macrophages (36). Another key protein is the small GTPase 
Rab27a which is necessary for effi cient recruitment of gp91phox to phagosomes in BMDCs (8). Our 
data show that both these proteins are expressed in human DCs (not shown) and it seems likely 
that these proteins also regulate the delivery of gp91phox to the antigen-containing compartment 
in these cells. If and by which mechanism synaptotagmin-11 and Rab27a regulate the SNARE 
complexing of VAMP8 with SNAP23 and sytaxin-7 remains to be elucidated. Overall, our results 
strengthen the emerging concept that the intracellular traffi cking of the integral component of 
NOX2 to phagosomes is a key regulatory mechanism for antigen cross-presentation.
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Material and Methods
Cell culture
Human DCs were derived from peripheral blood mononuclear cells (PBMCs) obtained from 
healthy volunteers according to institutional guidelines and as described previously (4). Briefly, 
monocytes were differentiated into immature DCs by culturing for 6 days at 37ºC, 5% CO2 in the 
presence of 300 U/ml interleukin-4 and 450 U/ml GM-CSF in complete RPMI-1640 (containing 
10% fetal bovine serum (FBS), 2 mM UltraGlutamine and 1% Antibiotic-Antimytotic (AA)). Jurkat 
E6.1 cells were used for the T cell activation assays with human DCs. These cells contain CD8+ 
T cell receptors that recognize gp100-peptide (residues 280–288) in complex with HLA-A2. They 
were cultured in the presence of 5 ng/ml interleukin-2 in complete RPMI-1640. Mouse bone 
marrow derived DCs (BMDCs) from VAMP8-/- mice (JAX strain B6;129S-Vamp8Gt(OST20346)
Lex/J) were differentiated by culturing 7 days in the presence of 20 ng/ml GM-CSF in RPMI-1640 
containing 10% FBS, 2 mM UltraGlutamine, 1% AA and 28 µM β-mercaptoethanol.
siRNA knock-down
DCs were electroporated with siRNA against VAMP8 (mix of 3 siRNAs: 5'-GAGGA AAUGA 
UCGUG UGCGG AACCU-3', 5'-GAGGU GGAGG GAGUU AAGAA UAUUA-3', 5'-CGACA 
UCGCA GAAGG UGGCU CGAAA-3'; ThermoFisher) or with non-targeting stealth RNAi siRNA 
Negative Control (NT) siRNA#1 (ThermoFisher) using a Neon Transfection System (ThermoFisher; 
1,000 V, 40 ms, 2 pulses) as described (4, 13, 15). Cells were used 48 hours post-transfection 
to ensure maximal knock-down. To test knock-down efficiency, DCs were lysed with 1% SDS in 
10 mM Tris-HCl at pH 6.8 and lysates (20 µg total protein) were ran on 16% Tricine-SDS-PAGE 
and blotted to PVDF. VAMP8 was detected with rabbit anti-serum raised against VAMP8 (1:1,000 
dilution; catalog nr. 104 302, Synaptic Systems) in combination with goat anti-rabbit conjugated 
with IRDye 800 (Li-Cor) as secondary antibody (1:5,000).
Plasmid transfection
DCs were transfected with 8 µg of a plasmid encoding human Rab11a N-terminally fused to 
GFP (16) per 1×106 cells using a Neon Transfection System (ThermoFisher; 1,000 V, 40 ms, 2 
pulses) as described (17). Cells were stimulated with zymosan particles 4 hours post-transfection, 
followed by immunostaining with anti-gp91phox.
Antigen uptake
Uptake of bovine serum albumin (BSA) labeled with Alexa Fluor 488 was measured by incubating 
DCs with 100 µg/ml BSA-Alexa Fluor 488 (ThermoFisher) and 1 µg/ml LPS (Invivogen, catalog 
number TLR-eblps; isolated from Escherichia coli 0111:B4, UltraPure) for different time points. After 
incubation, the cells were washed and the percentage of BSA-AF488-positive cells was measured 
by flow cytometry (excitation: 488 nm; emission: 530/30 nm; FACS Caliber, BD Biosciences).
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Immunofluorescence
Cells were cultured at 50,000 cells per 12-mm-diameter coverslip in the presence of 4.5 µm-
sized microspheres (10 beads/cell; Polysciences), ovalbumin conjugated with Alexa Fluor 647 
(2.5 µg/ml; OVA; Hyglos, catalog number 321000; endotoxin-free) or Alexa Fluor 633-labeled 
zymosan particles (5 particles/cell) in serum-free RPMI for 60 min at 37ºC. Cells were fixed with 
4% PFA for 15 min and permeabilized and blocked with 0.1% saponin in CLSM-buffer (PBS with 
20 mM glycine and 3% BSA) at room temperature. For immunostaining, cells were incubated 
overnight at 4ºC with rabbit serum anti-VAMP8 (104302, Synaptic Systems), mouse-IgG1 anti-
gp91phox (D162-3, MBL), mouse-IgG1 anti-TAP1 (MABF125, Millipore), mouse-IgG2a anti-HLA 
class I (ab7855, Abcam), mouse-IgG2a anti-Sec22b (sc-101267, Santa Cruz), mouse-IgG1 anti-
ERGIC-53 (ABS300, Enzo) and/or rabbit serum anti-Calnexin (ab22595, Abcam) at 1:200 dilution 
in CLSM-buffer containing 0.1% saponin. Subsequently, the cells were washed and incubated 
with goat anti-rabbit IgG labeled with Alexa Fluor 568 or 647 and goat anti-mouse IgG labeled 
with Alexa Fluor 488 (both Life Technologies) as secondary antibodies at 1:400 dilution. Finally, 
the cells were washed and embedded in mounting medium containing 0.01% Trolox (6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid) and 68% glycerol in 200 mM sodium phosphate 
buffer at pH 7.5. Cells were imaged on an Olympus FV1000 confocal laser scanning microscope 
with a 60x 1.35 NA oil immersion objective.
DC phenotyping
Cells were incubated overnight with or without 1 µg/ml LPS, detached and blocked with human 
serum. This was followed by surface staining for 30 min at 4ºC with the following antibodies for 
human DCs (all BD Biosciences): PE-labeled anti-HLA-A2 (catalog number 558570), anti-HLA-DR 
(555812), anti-CD11c (333149) and anti-CD86 (555658), APC-labeled anti-CD86 (555660) and 
FITC-labeled anti-CD83 (556910). The following antibodies were used for BMDCs: PE-labeled 
anti-HLA-A2 (114608; Biolegend), anti-HLA-DR (12-5321-82; eBioscience), anti-CD11c (553802; 
BD Biosciences) and anti-CD86 (105008; Biolegend)). After washing, fluorescence intensities 
were measured by flow cytometry (FACS Caliber).
Cytokines levels in supernatants of human DCs transfected with NT or VAMP8 siRNA was 
assessed with the Proteome Profiler Human Cytokine Array Kit (ARY005; R&D systems) following 
the protocol of the manufacturer, except that the membrane was stained with IRDye 800CW 
Streptavidin and imaged with the Odyssey CLx Infrared Imaging System (Li-Cor). 
ROS measurements
To measure cellular production of H2O2, we used the Amplex Red assay as described previously 
(4). Briefly, cells were incubated for 2–4 hours in a 96-well plate (100,000 cells/well) in serum-free 
RPMI with 2.2 µM OVA (Hyglos, endotoxin-free) and 1 µg/ml LPS (Invivogen, E. coli 0111:B4). This 
is UltraPure LPS without contaminants of other bacterial components that can influence cross-
presentation (18). After incubation, the medium was changed for serum-free RPMI containing 50 
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µM Amplex UltraRed reagent (ThermoFisher) and 3 U/ml horseradish peroxidase (Sigma) and the 
fluorescence of resorufin (excitation: 530 nm; emission: 590/30 nm) was measured every 20 min 
during 2 hours of subsequent incubation.
Production of superoxide anion was measured with 2',7'-dichlorodihydrofluorescein diacetate 
(H2DCFDA; ThermoFisher). Briefly, DCs were washed once with cold PBS, followed by incubation 
on ice for 30 min with zymosan particles (5 particles/cell). After this pulse, the pulse-chase 
samples were washed 3 times with cold PBS. Then H2DCFDA was added at a concentration of 
10 µg/ml to each sample and fluorescence (excitation: 485/20 nm; emission: 530/30 nm) was 
measured after different incubation times using a CytoFluor II microplate reader (ThermoFisher). 
Background fluorescence was subtracted and samples were normalized to the amounts of cells 
as determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Lipid peroxidation was measured with the Bodipy581/591-C11 assay as described previously 
(4). DCs were loaded with 2.2 µM OVA, 1 µg/ml LPS and cultured in the presence of 1 µM 
Bodipy581/591-C11 (4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-3-
undecanoic acid; ThermoFisher) in serum-free RPMI for different time points at room temperature. 
After incubation, the Bodipy581/591-C11 fluorescence was measured by flow cytometry 
(excitation: 488 nm; emission: 530/30 nm; FACS Caliber). The signal from unstained cells was 
subtracted for background correction.
CCF4/β-lactamase assay
The CCF4/β-lactamase assay was performed in Willco petri dishes according to the protocol of 
the manufacturer (K1095, Life Technologies) and as described previously (4). Briefly, DCs were 
incubated with 1 µM Substrate Loading Solution and 1 µg/ml LPS as adjuvant for 90 min, then 
washed and incubated with 1 mg/ml β-lactamase (from Pseudomonas aeruginosa, expressed in E. 
coli; L6170, Sigma) and 1 µg/ml LPS for 3 hours. Cells were washed again and imaged with a 
Leica SP8 confocal microscope equipped with a 63x 1.20 NA water immersion objective (405 
nm excitation; 419–458 nm blue and 504–600 nm green emission of the coumarin donor and 
fluorescein acceptor fluorophores, respectively). The FRET cleavage was calculated as the ratio 
of the green over the blue fluorescence intensities. The FRET efficiency of cells in absence of 
β-lactamase was used as ‘no cleavage’ control.
Cross-presentation assay
For the T cell activation assay, HLA-A2-positive human DCs were adhered for 60 min at 37ºC in 
X-vivo medium (Lonza) containing 2% human serum in 96-wells plates. Cells were then washed 
and incubated with gp100 short (10 µM gp100 (residues 280–288); GenScript) or long (100 µM 
gp100 (residues 272–300); JPT) peptide with T cell receptor stimulation mix (4 µg/ml R-848 and 
poly(I:C); Enzo Life Sciences) for 4 hours. After incubation, cells were washed and resuspended 
in X-vivo medium containing Jurkat E6.1 cells (ratio 1 DC : 2 T cells) and co-cultured for 18 
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hours at 37ºC. T cells were stained with αCD69-FITC (1:10; BD biosciences), αCD3-APC (1:10; 
eBiosciences) and Propidium Iodide (PI; 0.5 µg/ml) and analyzed with a FACS Calibur (BD 
Biosciences). CD69 surface levels as a measure of T cell activation were analyzed using FlowJo 
software and Prism 5. Briefly, cells were gated on viability (PI), followed by gating for CD3-positive 
cells, and the CD69 signal was determined. T cell activation was calculated as the ratio of CD69-
positive cells stimulated with long over stimulation with short peptide.
Statistical analysis
Results of at least three independent experiments were plotted as raw data or normalized to 
control cells (100%). All experiments were assessed using Student’s paired t-tests or two-way 
ANOVA (following post-hoc Bonferroni’s test). Two-sided P values < 0.05 were considered to be 
statistically significant (* P <0.05, ** P <0.01, *** P <0.001).
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Supplementary Figures
^ Fig. S1: Maturation of human DCs and BMDCs upon stimulation with LPS. A) The levels of HLA-A2 (MHC-I), 
HLA-DR (MHC-II), CD11c, CD86 and CD83 on the surface of human DCs after overnight stimulation with LPS. Shown 
are the mean fl uorescence intensities normalized to the unstimulated conditions (Ctrl). B) Same as panel A, but now for 
BMDCs. Results are for at least three donors (A) or mice (B) and are plotted as mean ± S.E.M.; ns, not signifi cant.
^ Fig. S2: ROS production and antigen uptake are not changed upon VAMP8 knockdown. A) Percentage 
of ROS production over time in human DCs stimulated constantly with zymosan (black curve; continuous) or pulsed 
with zymosan for 30 min, washed and chased (red curve; pulse-chase). The symbols show the individual donors. B) 
Representative fl ow cytometry histograms of endocytosis of bovine serum albumin labeled with Alexa Fluor 488 (BSA-
AF488) over time for non-targeting siRNA control (NT; left histograms) and VAMP8 KD (right) human DCs. C) The percentage 
of Alexa Fluor 488-positive cells from panel B for three donors (individual donors shown).
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^ Fig. S3: Surface levels of MHC class I upon knockdown of VAMP8. HLA-A2 expression on the cell surface of 
human DCs transfected with non-targeting control (NT) or VAMP8 siRNA (VAMP8 KD) in the presence (mature) or absence 
(Ctrl) of overnight stimulation. Results are normalized to unstimulated NT DCs for at least three donors and plotted as mean 
± S.E.M.
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6^ Fig. S4: Localization of gp91
phox, Sec22b and TAP1 relative to the ER and Rab11a-positive endosomes. 
A) Representative confocal micrographs human DCs pulsed with zymosan and immunolabeled for TAP1 (green in merge) 
and Calnexin (ER-marker; magenta). The insets show a TAP1-positive phagosome and a magnifi cation of a cellular region 
with overlap of TAP1 and Calnexin. B) Same as panel A, but now for ERGIC-53 (marker of the ER-Golgi intermediate 
compartment; green) and Sec22b (magenta). Both ERGIC-53 and Sec22b did not notable localize to phagosomes. C) 
Same as panel A, but now for gp91phox (green) and Calnexin (magenta). D) Representative confocal micrographs of zymosan-
pulsed DCs with non-targeting control siRNA (NT) or VAMP8 knockdown and immunostained for Sec22b (green in merge) 
and VAMP8 (magenta). Yellow arrowhead, phagosome positive for VAMP8. E) Representative confocal micrographs of 
unstimulated or zymosan-pulsed DCs expressing Rab11a-GFP (green in merge) and immunostained for gp91phox (magenta). 
The insets show magnifi cations of the indicated regions. Scale bars: 10 µm.
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Although it is well-understood how NOX2-produced radical oxygen species (ROS) in the 
phagosomal lumen of dendritic cells promote the preservation of antigen by reducing the 
proteolytic degradation (1–5), the mechanisms by which NOX2 promotes antigen translocation 
into the cytosol were not known. In this thesis, I identified a novel role for NOX2-produced ROS 
in promoting CD8+ T cell activation by disrupting endo/phagosomal membranes for antigen 
translocation. In addition, I studied the role of SNARE proteins in the trafficking of NOX2 to 
phagosomes and in phagosome maturation and elucidated the mechanism mediating removal 
of oxidized NOX2 from the phagosomal membrane. The results presented in this thesis provide 
novel insights in the mechanisms responsible for NOX2 recruitment to and its removal from the 
antigen-containing compartment, as well as in the mechanisms of NOX2-mediated antigen 
translocation into the cytosol.
Cross-presentation
Processing of antigens and cross-presentation of the derived peptides in major histocompatibility 
complex class I (MHC-I) molecules by antigen presenting cells to CD8+ cytotoxic T cells is 
important for the induction of immune responses against tumor cells as well as against cells 
infected with bacteria and viruses. The cross-presentation of exogenous proteins in MHC-I is a 
complex process, with numerous molecules involved during multiple steps of this process (6–11).
 
Despite many studies addressing the cell biological mechanisms of cross-presentation (12–17), 
to date, not a single integrated model for cross-presentation exists that incorporates all findings 
concerning the processing and presentation of exogenous proteins on MHC-I. Rather, our current 
understanding shows that there are at least two separate pathways for cross-presentation of 
exogenous proteins differing in the manner of protein degradation. In the first so-called cytosolic 
pathway, exogenous proteins that escape the endosome or phagosome are degraded by the 
proteasome and translocated into the endoplasmic reticulum (ER) by the transporter associated 
with antigen processing (TAP) where loading onto MHC-I occurs. In the second vacuolar 
pathway, exogenous proteins are degraded by lysosomal proteases in the endo/phagosome and 
subsequently loaded onto MHC-I within the endocytic compartment. However, antigen cross-
presentation is more complex and cross-talk between the two pathways exists. For instance, it 
has been shown that TAP can transport epitopes generated by the proteasome into endosomes 
instead of the ER, and that loading onto MHC-I can occur within the endosomal lumen (18–20). 
The presence of multiple mechanistic pathways for cross-presentation is supported by the finding 
that cross-presentation is not an exclusive property of dendritic cells, as previously believed 
(21), but other antigen presenting cells, including macrophages, B cells and neutrophils, can 
cross-present as well (22–26). Since these cells have different protein contents compared to 
dendritic cells, and therefore likely use different intracellular pathways, it seems unlikely that a 
single universal mechanism for cross-presentation exists. 
On the one hand, it seems strange that multiple pathways for antigen cross-presentation relying 
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on different proteolytic enzymes evolved. To obtain a specific CD8+ T cell response against 
infections and cancer, the MHC-I cross-presented epitopes derived from the endo/phagocytosed 
antigens in the dendritic cell should exactly match the epitopes generated by the conventional 
MHC-I self-presentation pathway in the infected/tumor cell. In this conventional self-presentation 
pathway, peptides are proteolytically degraded by the proteasome, trimmed by aminopeptidases 
and loaded into the ER, where the peptides are further trimmed by ER-resident aminopeptidase 
associated with antigen processing (ERAAP) for loading on MHC-I molecules (27). While epitopes 
generated in the cytosolic cross-presentation pathway will be identical to the endogenous 
epitopes generated in the self-presentation pathway, since both rely on the proteasome, it is 
more difficult to envision how peptides generated by lysosomal proteases in the vacuolar pathway 
can be identical. 
On the other hand, the existence of multiple independent pathways of antigen cross-presentation 
could offer clear advantages for immune function. This functional redundancy could make it more 
difficult for viruses and other pathogens to mutate proteins for preventing their cross-presentation, 
for instance by mutating critical sites for proteasomal cleavage. This could make it less likely that 
these pathogens or tumors can evade an immune response by inhibiting the cross-presentation of 
their pathogen/tumor-specific epitopes. Thereby, the vacuolar pathway could act as a backup for 
cross-presentation of viruses that block the cytosolic pathway by inhibition of the TAP transporter, 
antigen proteolysis, peptide loading, or MHC-I transit (28). 
Cytosolic pathway
Cross-presentation of most epitopes is considered to be at least partly dependent on the 
proteasome, which requires the translocation of antigens from the lumen of endo/phagosomes 
into the cytosol to become accessible for proteasomal degradation. Members of the ER-
associated degradation (ERAD) pathway, responsible for the delivery of misfolded proteins 
from the ER to the cytosol, are found on endo/phagosomes (19, 20), suggesting that ERAD 
components could be responsible for antigen translocation from endo/phagosomes into the 
cytosol. This involvement has been shown for the AAA-ATPase p97, which might provide the 
energy for translocation of antigen, and for the translocon Sec61, which is suggested to mediate 
antigen release from endo/phagosomes. In line with thins, silencing of p97 or transfection with a 
dominant negative form of p97 decreases cross-presentation efficiency (29–32) due to reduced 
antigen transport into the cytosol (31). Similarly, RNA silencing or inhibition by Exotoxin A of Sec61 
blocks cross-presentation (29, 32) and expression of an ER-located single-chain antibody against 
Sec61 was shown to block antigen translocation and cross-presentation (33), all suggesting that 
Sec61 is the translocon for transport. However, other studies oppose a role for Sec61 as the 
translocon for cross-presentation, as its acute inhibition or silencing did not change the cross-
presentation capacity in human monocyte-derived dendritic cells and CD8+ murine dendritic 
cells (30, 34). Moreover, treatment with a Sec61-specific inhibitor can cause defects in cross-
presentation upstream of the antigen translocation, because of inhibition of Sec61-mediated ER 
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import and down-regulation of MHC-I, making it difficult to resolve a specific role of Sec61 in 
antigen translocation from endo/phagosomes (34). 
It is still unclear how ERAD components and Sec61 reach the phagosome. However, this process 
has been studied for the peptide transporter TAP, another protein normally confined to the ER. 
TAP is found on phagosomes (18–20) and inhibition of TAP in dendritic cells results in decreased 
cross-presentation efficiency, suggesting that TAP imports proteasome-derived peptides into the 
ER or back into endo/phagosomes for loading on MHC-I (18). It was first suggested that TAP is 
delivered to endo/phagosomes by ER-mediated phagocytosis (19, 35), but this is controversial 
as the ER is no longer believed to contribute to phagosome formation (chapter 6) (36, 37). 
Later studies using Sec22b knockout mice showed a role for the SNARE protein Sec22b in 
phagosomal TAP recruitment from the ER-Golgi intermediate compartment (ERGIC) (38). In line 
with this, a study using mice with conditional knockout of Sec22b in dendritic cells showed 
defects in cross-presentation (39). However, this is controversial as the observed results could 
be due to off-target effects of the RNA interference (40), and no effects on cross-presentation 
were found in studies using mice with conditional knockout of Sec22b in dendritic cells (40) or 
with Sec22b silenced human monocyte-derived dendritic cells (41). Thus, a role of Sec22b in TAP 
trafficking to phagosomes is still controversial and needs to be confirmed. 
Vacuolar pathway
Next to ERAD components and TAP, MHC-I molecules are also found at antigen-containing endo/
phagosomes (19, 20). These pools of MHC-I are necessary for the cross-presentation of peptides 
transported into endo/phagosomes by TAP or of peptides degraded by lysosomal proteases in 
the vacuolar pathway. The vacuolar pathway is important for initiating antigen-specific CD8+ T cell 
responses against viruses by plasmacytoid dendritic cells (42) and for the cross-presentation of 
long peptides by human monocyte-derived dendritic cells (41).
MHC-I is not trafficked to the phagosome by Sec22b, but is recruited to phagosomes from 
recycling endosomal compartments. This MHC-I trafficking from endosomal recycling 
compartments to endo/phagosomes is mediated by the activity of the small GTPase Rab11a (43). 
The small GTPase Rab22a is important for the stabilization of this intracellular pool of MHC-I at 
Rab11a-positive recycling endosomes (44). The recruitment of MHC-I from recycling endosomes 
is mediated by the SNARE protein SNAP23, and this is regulated by Toll-like receptor (TLR)-
dependent phosphorylation of SNAP23 (43). Thereby, the recruitment of MHC-I to the antigen-
containing compartment is dependent on pathogen recognition by the dendritic cell. Moreover, 
the transport of MHC-I to endosomes depends on TAP and on the chaperone CD74 (45). CD74 
forms a complex with MHC-I in dendritic cells and is required for vacuolar cross-presentation of 
viral proteins and cell-associated antigens (45).
Peptides presented via the vacuolar pathway are proteolytically processed by lysosomal proteases 
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present in endo/phagosomal compartments. These proteases also generate the epitopes for 
presentation on MHC-II (46). Since these MHC-II-binding epitopes are larger than the epitopes 
presented on MHC-I, this raises the question how they can generate both MHC-I and MHC-II 
compatible epitopes. The lysosomal protease cathepsin S, preferentially expressed in antigen 
presenting cells, was shown to be responsible for the preparation of MHC-I peptides presented 
via the TAP-independent vacuolar pathway, as this pathway was completely blocked in dendritic 
cells from cathepsin S knockout mice (47). Furthermore, cathepsin S is the only lysosomal 
protease that is stable and active at a neutral pH (48), which is present in compartments involved 
in cross-presentation (49). Viral and bacterial infections trigger the production of antiviral cytokines, 
including interferon γ, which can induce cathepsin S expression (48, 50, 51).
Role of NOX2 in antigen presentation
Besides the potential trafficking from the ERGIC by the action of Sec22b (38), and the trafficking 
from recycling endosomes by SNAP23 (43), antigen-containing compartments can receive 
components from late endosomes and lysosomes during phagosome maturation. The trafficking 
from lysosomal compartments is mediated by Rab27a and mediates the delivery of the NADPH 
oxidase NOX2 to the endo/phagosome (2). Following dendritic cell activation, NOX2 produces 
superoxide anions in the endo/phagosomal lumen, which convert into other ROS. Compared 
to macrophages, prolonged NOX2 activity in dendritic cells causes sustained ROS generation 
(52). The superoxide anion produced by NOX2 can dismutate with protons forming hydrogen 
peroxide, and thereby actively resulting in a higher pH in the endo/phagosomal lumen which 
impairs protease activity, preserves the antigen from excessive degradation, and promotes antigen 
cross-presentation (1–3, 52). Although it is clear that NOX2-produced ROS prevent antigen 
degradation, the role of the phagosomal pH in this regulation is still debated (4). An alternative, 
or complementary, mechanism by which NOX2 preserves antigen for cross-presentation is that 
ROS can directly modify cysteine residues located in the catalytic core of cysteine cathepsins 
(4, 53). Indeed, the inhibition of cathepsin S by oxidative modifications by NOX2-derived ROS 
promotes antigen cross-presentation via the vacuolar pathway (5). Since different lysosomal 
proteases have different sensitivities to oxidative modification, NOX2-produced ROS also change 
the epitope repertoire, as shown for MHC-II antigen presentation (54). This is especially the case 
for macrophages, as these express far higher levels of the cysteine cathepsins S and L than 
dendritic cells (55). Cathepsin S is also required for the activation of MHC-II itself, as it degrades 
the invariant chain that prevents loading of antigen into MHC-II molecules (56).
In this thesis, I showed that NOX2 promotes the antigen cross-presentation capacity also 
via another mechanism. My data indicate that NOX2-derived ROS are responsible for lipid 
peroxidation and thereby causes disruption of endo/phagosomal membranes, antigen release to 
the cytosol and antigen cross-presentation (chapter 5). How does this relate to the potential role 
of the Sec61 translocon in antigen transport from the endo/phagosomal lumen into the cytosol? 
As already discussed above, the influence of Sec61 on cross-presentation is likely upstream of 
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antigen translocation. Sec61 is important for the insertion of newly transcribed MHC-I molecules 
in the ER membrane, thus before the MHC-I molecules are transported to the peptide loading 
compartments. It is difficult to delineate this role of Sec61 in MHC-I function from a putative role 
in antigen translocation to the cytosol, and it could well be that (part of) the previously observed 
effects on cross-presentation can be attributed to a more general defect in MHC-I function. In any 
case, Sec61 cannot be the only mechanisms by which antigen reaches the cytosol, because the 
pore size of Sec61 is too small for the export of functional folded proteins, such as β-lactamase 
(57), HRP or cytochrome C (38, 58), that have all been shown to translocate to the cytosol intact. 
Thus, there must be an alternative way for antigenic proteins to translocate from endosomes 
and phagosomes to the cytosol not relying on a discrete translocon, such as Sec61, but rather 
on a-specific antigen leakage such as caused by lipid peroxidation (59). The model presented 
in chapter 5, where lipid peroxidation disrupts endo/phagosomal membranes leading to the 
a-specific release of antigen, is supported by the finding that the membrane of the ER is locally 
destabilized by lipid bodies, which can also promote antigen cross-presentation (60). 
Nevertheless, the findings from this thesis do not allow to exclude a role for Sec61 or other 
proteins in antigen translocation from endo/phagosomes. First, inhibiting NOX2, scavenging ROS, 
or inhibiting the proteasome did not result in complete blockage of cross-presentation (59), in line 
with published findings (41, 52). Probably the cytosolic pathway is not the main route for antigen 
cross-presentation of the tumor antigen gp100, or there are other ROS-independent pathways of 
cross-presentation. Repeating the experiments of chapter 5 with cathepsin S inhibitors and with 
other antigens that are known to be mainly presented via the cytosolic pathway will allow to better 
delineate the contribution of lipid peroxidation in antigen translocation from endo/phagosomes. A 
main limitation is that current assays for studying antigen cross-presentation in human dendritic 
cells rely mainly on cross-priming of primary T cells or cell lines expressing antigen-specific T 
cell receptors (61). Since these assays only exist for a limited set of antigens and are relatively 
insensitive and technically challenging, this makes it difficult to study the mechanisms of antigen 
cross-presentation.
Regulation of immune response
Due to the complexity of the mechanisms of antigen cross-presentation, it is difficult to elucidate 
how cross-presentation is regulated. Many studies showed that the mechanisms and regulation of 
cross-presentation are influenced by the form and mode of delivery of antigens (62–65). Antigens 
can differ in sizes, shapes, receptor-targeting specificity, and activation of pattern recognition 
receptors (PRRs), which all can result in rerouting of the intracellular processing mechanisms 
for antigen (cross-)presentation. As an example of this, SNAREs, Rab GTPases, microbial and 
cytokine signals, and ion fluxes can all influence the recruitment and/or activity of NOX2 to 
antigen-containing phagosomes, which thereby regulate antigen (cross-)presentation (66).
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Antigen uptake mechanisms
Exogenous antigens can be presented on MHC-II to CD4+ T cells. However, to obtain a CD8+ 
cytotoxic T cell response, the antigen should be loaded on MHC-I molecules, and thus be 
directed to cross-presentation pathways following endo/phagocytosis. The mode of antigen 
uptake by the antigen presenting cell determines the extent of antigen cross-presentation. For 
example, uptake of the model antigen ovalbumin (OVA) by the mannose receptor (MR) directs it to 
cross-presentation, whereas pinocytosis of OVA leads to mainly MHC-II antigen presentation (31, 
64, 67). This is due to the fact that OVA endocytosed by MR traffics to early endosomes, whereas 
pinocytosed OVA is transported towards lysosomes with high proteolytic activity (64). Moreover, 
the ubiquitination of MR promotes the recruitment of p97 to antigen-containing endosomes, 
which in turn facilitates translocation of OVA-antigen into the cytosol and thereby enhances the 
antigen cross-presentation efficiency (31). However, in contrast to soluble OVA, the MR is not 
necessary for the uptake and cross-presentation of cell-associated OVA, which suggests that 
cell-associated OVA can be internalized via alternative receptors which can also activate cross-
presentation (67). Furthermore, it is found that positively charged nanoparticles enhance the 
cross-presentation ability of dendritic cells, likely by destabilizing the membranes of phagosomes 
resulting in antigen translocation into the cytosol (68).
Another parameter influencing cross-presentation is the size of the antigen. Tran et al. (69) incubated 
dendritic cells with OVA coupled to particles of different sizes. The uptake of intermediate (0.5 µm-
diameter) and large (3 µm) particles resulted in efficient cross-presentation and these particles 
were trafficked to relatively alkaline compartments with low proteolytic activity. In contrast, antigen 
bound to small (50 nm) particles was transported to acidic compartments, which resulted in 
increased antigen degradation and relatively inefficient cross-presentation. In line with the findings 
that the size of antigen and its mode of cell entry determine cross-presentation efficiency, it 
was found that aggregated antigens, antigen associated with cellular debris, and precipitated 
immune complexes are cross-presented better than their soluble counterparts (9, 70, 71). In 
general, stimulation of phagocytosis promotes cross-presentation compared to endocytosis of 
smaller antigens (5). Even cell types that are generally considered not to cross-present, such as 
the human 293T kidney cell line, are able to cross-present if they internalize precipitated OVA-
containing immune complexes via overexpression of the Fc receptor FcγRIIA (70). 
The precise route of antigen uptake could decide if an antigen enters the cytosolic or vacuolar 
pathway of cross-presentation. It was found that antigen bound to single microspheres of 0.8 µm 
in size are cross-presented via the cytosolic pathway, whereas aggregates of these microspheres 
are cross-presented via the vacuolar pathway (72). Moreover, OVA coupled to iron-oxide beads 
required TAP activity for efficient cross-presentation, whereas OVA incorporated in PLGA particles 
was mainly presented via a TAP-independent pathway (47). Finally, mechanical stimuli can affect 
cross-presentation, because disruption of dendritic cell-cell contacts by repeated pipetting 
promoted proteasomal degradation and cross-presentation of an intracellular pool of OVA (73).
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Involvement of TLR stimulation
Next to the route of antigen internalization, also the activation of dendritic cells by PRRs, such as 
TLRs, can influence cross-presentation. Stimulation of TLR4 with lipopolysaccharide (LPS) is well-
known to enhance the cross-presentation efficiency of dendritic cells (73–75). LPS stimulation 
can enhance the internalization of antigen, promote its translocation into the cytosol, increase 
proteasome activity and upregulate TAP expression (74). Maturation of dendritic cells via TLR 
stimuli could also reroute the intracellular trafficking orchestrating cross-presentation (76, 77), 
because TLR2 stimulation during phagocytosis resulted in the upregulation of Rab7 and this 
promoted cross-presentation via the vacuolar pathway (77).
In addition to the TLRs located on the cell surface of dendritic cells, stimulation of intracellular 
TLRs can enhance the cross-presentation capacity of dendritic cells as well. TLR3 and TLR9 
signaling in endosomal membranes via MyD88 activation induce cross-presentation of OVA via 
the cytosolic pathway (78). This could well be physiological, given that TLR3 stimulation is required 
for sensing the presence of double stranded RNA, a hallmark of certain viruses, and cross-
presentation is essential for inducing a CD8+ T cell response against viruses (79). In dendritic 
cells, the increased cross-presentation following TLR9 stimulation is due to increased NOX2-
mediated ROS production (80), in line with our model that ROS promote cross-presentation via 
disruption of endosomal membranes.
Stimulation of TLRs can promote the recruitment of essential proteins for cross-presentation 
to the antigen-containing compartment. Recruitment of MHC-I and TAP to antigen-containing 
endosomes and phagosomes is dependent on TLR4-triggered MyD88 activation (43, 75). 
Similarly, Sec61 is recruited to phagosomes in a TLR-dependent manner mediated by the 
adapter TRIF, and this is believed to ensure that antigen cannot translocate into the cytosol in 
absence of danger signaling (33). Finally, NOX2 activity on antigen-containing endosomes is 
promoted by ITAM signaling downstream PRRs, which thereby controls ROS production and 
cross-presentation (81).
SNAREs involved in antigen presentation
As I described in chapter 2, currently 30 SNAREs have been identified at the endosomal and 
phagosomal membrane. However, only a small number of these SNAREs is shown to be involved 
in the trafficking events responsible for antigen presentation. The Qa-SNARE syntaxin-11 (Stx11), 
the Qb-SNAREs Vti1a and Vti1b and the R-SNAREs Sec22b, VAMP7 and VAMP8 can all act as 
negative regulators of phagocytosis by sequestering other SNAREs by forming non-fusogenic 
SNARE complexes (82–86). In contrast, Stx18 and SNAP23 are shown to have a positive 
influence on phagocytosis (87, 88). SNAREs might also have a role in trafficking proteins with 
known roles in cross-presentation to the antigen-containing compartment, such as the possibly 
role for Sec22b in TAP trafficking to phagosomes (see above) (38–41, 43). Moreover, SNAP23 
is involved in phagosomal recruitment of NOX2 (88, 89), the V-ATPase (88) and MHC-I by TLR-
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triggered phosphorylation (43). VAMP8 is also involved in recruitment of NOX2 to the phagosome 
and is thereby required for efficient cross-presentation (89–91). In this thesis, I confirmed the 
role of VAMP8 in cross-presentation (chapter 6) and showed that VAMP8 promotes NOX2-
mediated ROS production, lipid peroxidation and antigen transport, which results in CD8+ T cell 
activation. Knockout or knockdown of VAMP8 reduced the recruitment of NOX2 from lysosomal 
compartments to zymosan-containing phagosomes, latex bead-containing phagosomes and 
OVA-positive endosomes (chapter 3 & 6). Here, VAMP8 forms a complex with SNAP23 and 
Stx7 for recruitment of NOX2 to the phagosomal membrane (chapter 3), instead of the previously 
believed Stx4 (38, 43).
Intracellular pathogens often hijack SNARE-mediated membrane trafficking to evade their 
clearance by the immune system or facilitate their survival in the host cell, for instance by 
downregulating or promoting SNARE expression and/or recruitment to the phagosome. For 
example, some pathogens target Stx4 to the endosomal compartment or, oppositely, inhibit 
Stx8 or Stx6 recruitment in order to arrest the maturation of endosomes and delay lysosomal 
degradation (92, 93). A Salmonella effector protein recruits Stx6 and VAMP2 to phagosomes, 
which results in the recruitment of LAMP1 and thereby inhibits fusion with lysosomes to stabilize 
the pathogen’s intracellular niche (94). As another example, recruitment of VAMP7, Vti1a and Vti1b 
to Coxiella replicative vacuoles is required for fusion events that favor the biogenesis of these 
vacuoles (95). Finally, the intracellular parasite Leishmania is able to prevent cross-presentation of 
its proteins by cleavage of the SNARE VAMP8 within the host dendritic cell (90). This cleavage 
of VAMP8 is mediated by a protease secreted by Leishmania, reminiscent of the cleavage of the 
neuronal SNAREs by the clostridial neurotoxins. This results in decreased recruitment of NOX2 
to Leishmania-harboring phagosomes and thereby stalls phagosomal acidification and antigen 
degradation (90). 
ROS involvement in immune cell activation
Leishmania is not the only pathogen that has developed an evasion strategy via NOX2 modulation. 
It is found that Salmonella typhimurium somehow is able to reduce the presence of the membrane-
bound subunits of the NOX2 complex at the phagosomal membrane, thereby preventing NOX2 
assembly (96). Listeria monocytogenes uses a pore-forming cytolysin for the escape to the cytosol, 
but also for inhibition of NOX2 recruitment to the phagosome (97). Francisella tularensis can inhibit 
NOX2 activation by multiple mechanisms, such as preventing phagosomal recruitment of the 
membrane-bound subunits of NOX2, diminishing phosphorylation of a cytosolic subunit of NOX2, 
or membrane accumulation of dysfunctional NOX2 (98). Thus, multiple microbial pathogens can 
evade immune cell activation via disruption of NOX2 assembly or inhibition of NOX2 activation. 
Genetic mutations in NOX2 are the cause of a hereditary disease. Mutations or deletions in the 
genes encoding subunits of the NOX2 complex lead to chronic granulomatous disease (CGD; 
(99). Patients with CGD have a decreased phagocytic oxygen consumption, defects in microbial 
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killing and a higher production of pro-inflammatory cytokines (100). They frequently suffer from 
severe, recurrent bacterial and fungal infections and are also plagued by a variety of inflammatory 
disorders (101). Mutations in the membrane-bound protein gp91phox are found in most CGD 
patients (70%), followed by mutations in the cytosolic subunits p47phox (20%) and p67phox (6%) 
(102, 103). Patients with mutations in gp91phox are not able to produce ROS by NOX2, whereas 
a low level of ROS production is found in patients with mutations in p47phox as p67phox can partly 
compensate for the loss of p47phox. As the infections and inflammations in p47phox mutant patients 
are generally milder than in gp91phox mutant patients (104), it is suggested that even the low levels 
of NOX2-generated ROS can be clinically beneficial.
Limits in detection of phagosomal ROS
Because of the high instability of ROS, measuring the amount of ROS that is produced within 
the lumen of phagosomes of dendritic cells, and determining which form of ROS is responsible 
for modulation of antigen presentation, is technically challenging. To detect the ROS produced 
by NOX2, many optical techniques are developed based on fluorescent probes that alter their 
spectroscopic properties upon oxidation. We used several fluorescent probes in our studies 
which in principle allow for quantitative measurements of one or more species of ROS even at the 
single phagosomal level.
Amplex (Ultra)Red is a non-fluorescent probe that become fluorescent after oxidation by H2O2 
(105). Amplex (Ultra)Red has the drawback that it is cell impermeable and needs to be used in 
combination with horseradish peroxidase (HRP), allowing to only measure H2O2 at the outside 
of the cell. Moreover, the probe is sensitive to background oxidation from molecular oxygen, 
which makes it difficult to specifically and reproducibly measure ROS production by NOX2. 
To overcome these problems, we measured ROS production inside the dendritic cell with 
2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA). This probe is cell permeable, and upon 
its internalization the acetate groups are hydrolyzed resulting in trapping of the probe within the 
cell. Oxidation of H2DCFDA after reaction with superoxide and H2O2 results in its conversion to 
fluorescent 2',7'-dichlorofluorescein (DCF). However, H2DCFDA can be oxidized by reduction of 
iron already in the absence of ROS (106), it can also generate free radicals by itself (107), and 
it can spontaneously oxidize upon exposure to light (108), limiting the specificity of this probe. 
Finally, we used the ROS probe OxyBURST-Green H2DCFDA succinimidyl ester (SE). This probe 
had the advantage that by using SE conjugation, we could directly couple OxyBURST-Green 
H2DCFDA to zymosan particles, allowing to selectively deliver the probe inside phagosomes. 
However, this probe has the same drawbacks as H2DCFDA. Another problem is that Amplex 
(Ultra)Red, H2DCFDA and other probes in principle only allow to measure one (or a few) molecular 
species of ROS, and quantitative assessment of total ROS production within phagosomes is 
technically challenging.
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A major challenge for studying the roles of ROS on cell function is that blocking or scavenging of 
ROS is generally incomplete and not very specific, because ROS consist of many different species 
with different reactivities. Vitamin E (α-tocopherol), the ROS scavenger we used, is a lipophilic 
soluble peroxyl radical-scavenging antioxidant, which inhibits lipid peroxidation (109). However, 
due to its lipophilic nature, it has no or limited scavenging effects on hydrophilic ROS species 
such as hydroxyl or alkoxyl radicals and on hydrogen peroxide. A combination of vitamin E with 
hydrophilic antioxidants, such as vitamin C or the vitamin E-derivative Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), has more potential for scavenging radicals (109). Besides 
ROS scavengers, also NOX2 inhibitors have been developed that limit ROS production. Many 
papers use the inhibitor diphenylene iodonium (DPI), which is suggested to be a NOX2 inhibitor, 
but also blocks other sources of ROS production such as from mitochondria (110). Apocynin is 
more specific as it inhibits ROS production by the inhibition of NOX2 assembly (111). However, 
apocynin also has off-target effects and could work as an antioxidant (112, 113). We used the 
inhibitor phenylarsine oxide (PAO) as NOX2 inhibitor, which is able to modify the membrane-bound 
subunit gp91phox and thereby inhibits NOX2 activation (114). However, drawbacks of PAO are 
that it inhibits endocytosis (59), blocks protein kinase C activity and inactivates phosphotyrosine 
phosphatases (115). A promising NOX2 inhibitor is VAS2870, which is thought to be more specific 
for NOX2 compared to DPI, PAO and apocynin (116). Recently, it was shown that this compound 
does not have anti-oxidant activity and is specific for NADPH oxidases, and VAS2870 could 
block ROS production in cell-free systems, cells and in vivo by inhibiting the functional assembly 
of NOX2 (117).
NOX2 activation by autophagy 
Several studies link autophagy-associated proteins to NOX2 activity via mechanisms suggested 
to allow the detection of microbes or cytokine exposure by dendritic cells. Activation of dendritic 
cells by interferon γ induces activation of guanylate-binding proteins (Gpb) to sequester microbial 
pathogens (118). Gbp7 could interact with the membrane-bound subunit p22phox, the cytosolic 
subunit p67phox and the protease of the autophagy pathway ATG4 (119), which suggests that Gbp7 
can recruit NOX2 and autophagy-related proteins to mycobacteria-containing phagosomes. 
Triggering of the microbial sensor Slamf1 by Gram-negative bacteria leads to the recruitment of 
the phosphoinositide 3-kinase VSP34 and the two autophagy-associated proteins Beclin-1 and 
UVRAG to the phagosomal membrane (120, 121). A complex of VPS34, Beclin-1 and UVRAG, 
which is not present on starvation-induced phagosomes, promotes NOX2 activity by the 
accumulation of phosphatidylinositol 3-phosphate [PI(3)P] at the phagosomal membrane (120). 
PI(3)P is required for the recruitment and assembly of the cytosolic subunit p40phox of NOX2 and 
promotes ROS production (122, 123). VSP34, Beclin-1 and UVRAG can form a complex with 
Rubicon, another autophagy-related protein that is found on late endosomes/lysosomes, which 
negatively regulates autophagolysosomal fusion and results in sustained production of PI(3)P 
(124). Rubicon can interact with the membrane-bound subunits of NOX2, gp91phox and p22phox, 
facilitating their stabilization and recruitment at the phagosomal membrane and thereby positively 
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regulating NOX2 activity (125). Activity of Rubicon with NOX2 and the VPS34-Beclin1-UVRAG 
complex results in the recruitment of conjugation systems that are required for recruitment of LC3 
to the single membrane of phagosomes during LC3-associated phagocytosis (LAP) (124). As 
explained below, LAP plays an important role in pathogen clearance by promoting phagosomal 
acidification and lysosomal fusion (124, 126, 127). However, other studies showed that LAP 
delays phagosomal maturation in order to reduce antigen degradation and thereby preserves the 
antigen for presentation in MHC-II (128, 129).
NOX2 can promote autophagy-related mechanisms. First evidence for this comes from the 
finding that CGD patients do not show an autophagy response against fungal infections (130). 
Autophagy and endosomal alkalization by NOX2 are required for the transport of phagocytosed 
Aspergillus conidia from the early endosome to Rab14-positive compartments (131). This will result 
in MHC-I presentation to CD8+ T cells to stimulate an immune response against intracellular 
fungal pathogens (131). More evidence linking NOX2 to the induction of autophagy comes from 
studies that showed that LC3 recruitment to phagosomes during LAP is dependent on ROS 
production by NOX2 (124, 126, 128, 129, 132, 133).
Immune defense by autophagy 
Macro-autophagy, hereafter referred to as autophagy, plays a role in the immune defense 
against viruses and intracellular bacteria and parasites (134). Bacteria and parasites, present 
in the lumen of phagosomes or in the cytosol after escape from the phagosome, are captured 
into autophagosomes and then degraded after fusion of the autophagosomes with lysosomes 
(135–138). 
How does a dendritic cell recognize autophagic targets, and how are these targets directed into 
the autophagy pathway for degradation? It is known that aggregates of damaged and misfolded 
proteins are marked by chaperones and ubiquitin ligases, which results in their labeling with 
ubiquitin (139). These ubiquitinated aggregates are then recognized by the ubiquitin-binding 
autophagy receptors p62 and NBR1, which in turn form a complex with the scaffold protein 
ALFY to initiate the formation of autophagosomes for degradation (139). It is not fully understood if 
ubiquitination of pathogens serves as a signal for autophagy recognition. The bacteria Salmonella 
typhimurium is able to escape from phagosomes into the cytosol and thereby becomes accessible 
for ubiquitination (140). However, this ubiquitination may not be involved in S. typhimurium clearance 
by autophagy, because the kinetics of autophagy and ubiquitination of this pathogen are different 
(136). In contrast, another study showed that ubiquitination of S. typhimurium resulted in p62 
recruitment, autophagy and restriction of intracellular pathogen replication (141). It is also shown 
for the intracellular pathogen Listeria monocytogenes that when the bacterial ActA protein is mutated 
(ActA mediates bacterial actin-based motility), it can escape from phagosomes, subsequently 
gets ubiquitinated, and leads to formation of autophagosomes via recruitment of p62 and LC3 
(142). Although these studies show that pathogens can be targeted to autophagosomes when 
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they are free in the cytosol, the question how cells can recognize invading pathogens before they 
escape to the cytosol still remains open. 
One of the possible mechanisms by which cells can recognize pathogens within phagosomes 
is by the rupture or modifications of the phagosomal membrane by factors elicited from the 
pathogen or by NOX2-produced ROS. Damaged endosomes are marked by galectins, cytosolic 
lectins that recognize glycosylated proteins, and galectin-3 is found to colocalize with p62 on 
damaged endosomal membranes (143). Inhibition of galectin-3 results in reduced recruitment 
of p62 and impaired autophagy, which suggests that galectins are required for autophagy 
activation via p62 interaction (143). Binding of galectin-8 to damaged endosomes can trigger the 
recruitment of the adaptor NDP52 to activate anti-bacterial autophagy (144). Autophagosomes 
can also recognize damaged endosomes via ubiquitination of endosomal proteins, which in turn 
leads to the recruitment of autophagy-related proteins, including a complex of the autophagy-
related protein ATG16L1 and a complex of the serine/threonine kinase ULK1 and the FAK 
family kinase-interacting protein FIP200 (145). Direct interaction between ubiquitin, FIP200 and 
ATG16L1 is required for LC3 recruitment to endosomes (145). A recent study found that the 
tripartite motif-containing protein TRIM16 is involved in this autophagy-related mechanism by 
binding to galectin-3 in an ULK1-dependent manner (146). TRIM16 binding to galectin-3 results 
in recruitment of ubiquitin and ATG16L1 to as well as stabilization of ULK1 and Beclin-1 at the 
damaged phagosomes, thereby promoting an autophagy response (146).
Another possible mechanism by which cells can recognize pathogens within the lumen 
of phagosomes is by PRRs. Recent studies showed that TLR activation can directly induce 
autophagy upon infection with intracellular pathogens. Stimulation of TLR1, TLR3, TLR4, TLR5, 
TLR6 and TLR7 can activate autophagy in macrophages (147–149). TLR7 stimulation can induce 
autophagy by activation of the downstream signaling adaptor MyD88 (147), which stimulates 
NOX2 assembly and activation via p38 MAPK-dependent phosphorylation of the cytosolic 
subunit p47phox (150). TLR4 stimulation can also induce phosphorylation of p47phox, as it is a 
substrate for interleukin-1 receptor-associated kinase 4 (IRAK-4) downstream of TLR4 activation 
(151). Moreover, TLR4 stimulation promotes VPS34 incorporation into the pre-autophagosomal 
membrane which in turn facilitates autophagosome formation as described above (148). TLR3 
and TLR4 stimulation activate the downstream signaling adaptors MyD88 and TRIF, which recruit 
Beclin-1 to antigen-containing compartments and thereby reduce the interaction between anti-
apoptotic protein Bcl-2 and Beclin-1, thereby stimulating Beclin-1-dependent autophagy (149). 
TLR2 or TLR4 signaling in phagosomes can induce the phagosomal recruitment of LC3 and 
Beclin-1 and increase the levels of PI(3)P at the phagosomal membrane (127). Finally, autophagy 
can enhance TLR recognition by facilitating the delivery of TLR ligands from the cytosol to 
intracellular compartments containing the TLR (152).
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Autophagy and antigen (cross-)presentation
Because TLR stimulation and ROS production both activate antigen (cross-)presentation and 
autophagy and because autophagy-associated proteins regulate NOX2 activity, the processes of 
antigen (cross-)presentation and autophagy are linked. Direct support for this link comes from the 
finding that cross-presentation of OVA, when conjugated to α-Al2O3 nanoparticles, was blocked 
when the autophagy pathway was inhibited (153). Moreover, the yellow fever vaccine enhances 
cross-presentation via autophagy, as dendritic cells from ATG5-/-, ATG7-/- or Beclin-1-/- mice 
could not cross-present antigens from viral infected cells to CD8+ T cells (154). The dendritic 
cell subset that is considered to be mainly responsible for cross-presentation in mice, CD8α+ 
dendritic cells, upregulates autophagy upon activation by granulocyte macrophage colony 
stimulating factor (GM-CSF) (155). In the cytosol of these activated dendritic cells, more ubiquitin 
and p62-positive aggregates are found than in immature CD8α+ cells. Furthermore, loss of the 
autophagy protein ATG7 results in decreased cross-presentation of soluble antigens by CD8α+ 
dendritic cells (155) and dendritic cells from VPS34 knockout mice are no longer capable to 
cross-present antigens associated with dying cells (156), demonstrating that cross-presentation 
is regulated by autophagy.
Antigens from bacteria that escape from the phagosomal lumen into the cytosol can also be 
cross-presented via an autophagy-related mechanism. Chlamydia, when present in the cytosol, is 
engulfed by autophagosomes, which then fuse with recycling endosomes (157). This results in 
the formation of a compartment containing TAP and MHC-I together with the chlamydia antigens, 
and this compartment allows cross-presentation of the antigens in MHC-I to CD8+ T cells (157). 
Similarly, rupture of vacuoles containing Toxoplasma gondii promotes cross-presentation of antigens 
derived from this pathogen. Here, autophagy-related proteins regulate the recruitment of ubiquitin 
and p62 to the damaged vacuole (158). The autophagy-related pathway by which chlamydia 
antigens are cross-presented is also used by B cells. After endocytosis of antigenic proteins by B 
cells, MHC-I-binding epitopes are derived from the proteins by an autophagy- and proteasome-
dependent pathway, loaded on MHC-I in autophagolysosomes and finally presented to CD8+ T 
cells (23). However, this pathway does not require TAP for antigen cross-presentation, but relies 
on p97-mediated recruitment of LC3 to antigen-containing compartments (23).
Autophagy also plays a role in the self-presentation of antigens in MHC-I. Viral antigens in infected 
cells are normally presented via conventional self-presentation in MHC-I. However, as a second 
pathway, autophagy can promote the MHC-I presentation via inclusion of the viral particles into 
autophagosomes. Macrophages infected with herpes simplex virus trigger this second pathway 
for an increased CD8+ T cell response (159). The presentation of human cytomegalovirus can 
also follow this pathway (160). However, where the autophagy-mediated presentation of herpes 
simplex virus was dependent on proteasomal degradation and TAP-mediated peptide loading into 
the ER/Golgi, the cytomegalovirus is presented via a proteasome- and TAP-independent pathway 
(159, 160). 
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Finally, autophagy can play a role in the self-presentation of endogenous proteins onto MHC-
II. In this case, endogenous antigen, such as cytosolic proteins or viral antigens, are captured 
by autophagosomes and delivered to MHC-II-loading compartments (161–164). This pathway is 
important for the induction of CD4+ T cell responses against infections, but might also deliver 
self-antigens in MHC-II molecules of epithelial cells of the thymus for positive and negative CD4+ 
T cell selection (165). 
SNAREs in autophagy
By far most of the members of the SNARE protein family locate at the endo/phagosomal membrane, 
and a part of them are involved in antigen presentation and autophagy, as reviewed in chapter 
2. Especially Stx17 is identified as a major autophagosomal SNARE, and Stx17 forms a complex 
with SNAP29 and VAMP8 to fuse autophagosomes with lysosomes (166, 167). This complex is 
stabilized by binding of Stx17 to the Beclin-1-associated autophagy-related key regulator ATG14 
(168). Other SNAREs play a role in autophagy as well. VAMP7, Vti1b, Stx7 and Stx8 regulate the 
homotypic fusion required for the formation of autophagophores and autophagosomes, and they 
are also involved in the autophagosome-lysosome fusion (169). Fusion between autophagosomes 
and multivesicular bodies is regulated by VAMP3, Vti1b and Stx6 (170, 171). Sec22b is found at 
autophagosomes, where it interacts with TRIM16 and galectin-8 to promote secretory autophagy 
of IL-1β (172). As TRIM16 is required for LC3 recruitment to damaged phagosomes by binding to 
galectin-3 and ubiquitin (146), it could well be that Sec22b promotes LC3 recruitment via TRIM16.
ESCRT machinery in autophagy
Multivesicular bodies (MVB) are produced by activation of the endosomal sorting complexes 
required for transport (ESCRT) machinery to degrade damaged membrane proteins and lipids 
(173). This mechanism plays a role in cellular degradation of integral membrane proteins present 
at the endosomal membrane. These proteins are first ubiquitinated for recognition by the ESCRT 
machinery. The ESCRT machinery pushes these membrane proteins outwards from the cytosol 
into the lumen of the endosome forming intraluminal vesicles (174). It is found that mutations in the 
ESCRT machinery results in accumulation of autophagosomes (175), and that a functional ESCRT 
machinery and MVB formation are required for autophagic degradation of protein aggregates 
(176). However, it is not known which step in autophagy is inhibited by mutations in ESCRT. It 
could be that ESCRT is required for the induction of autophagy, the closure of autophagosomes, 
fusion between autophagosomes and lysosomes or lysosomal biogenesis (177).
As we described in chapter 4, we identified a novel link between the ESCRT pathway and 
autophagy for the removal of oxidized gp91phox from the phagosomal membrane. Oxidatively 
modified gp91phox is ubiquitinated and p62 and LC3 are recruited to phagosomes, as reported for 
damaged phagosomes containing bacterial pathogens (145, 146). Furthermore, we showed that 
the autophagy-related proteins p62 and ATG12 are involved in the removal of gp91phox from the 
phagosomal membrane. This suggests that oxidized gp91phox is removed and degraded via an 
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autophagy-related mechanism. Finally, we showed that CHMP1B, an ESCRT-III protein, is involved 
in pulling gp91phox-containing compartments inwards from the phagosome towards the cytosol 
and is required for the removal of gp91phox from the phagosome. This finding suggests that the 
ESCRT machinery can sort endo/phagosomal proteins into autophagosomes by sequestering 
them from the endo/phagosomal membrane. Electron microscopy coupled to immunogold 
labeling of LC3 should enable to visualize the ultrastructure of the interplay between phagosomes 
and autophagosomes, and to link this mechanism to LAP. 
Conclusion and future directions
The model shown in Figure 1 combines all data from this thesis on the role of NOX2 in antigen 
cross-presentation and autophagy. It shows that NOX2 expressed on the plasma membrane is 
internalized together with the pathogen during phagocytosis, and this leads to NOX2 activation 
on the phagosomal membrane. Following activation, NOX2 produces ROS in the phagosomal 
lumen, which lead to oxidation of lipids, antigen and membrane proteins. One of the membrane 
proteins that is oxidized is NOX2 itself, which is replenished by functional NOX2 from lysosomal 
compartments via SNARE complex formation between Stx7, SNAP23 and VAMP8. Oxidation 
of lipids causes lipid peroxidation and membrane disruption. This mediates the translocation 
of the antigen from the endo/phagosome into the cytosol for processing by the proteasome. 
Subsequently, the antigen is cross-presented via the cytosolic pathway in MHC-I to CD8+ T 
cells. For the removal of oxidized NOX2 complex from phagosomes, the membrane-bound 
subunit p91phox is first ubiquitinated. Ubiquitination results in the recruitment of p62 and LC3. 
This activates an autophagy-related mechanism involving p62, ATG12 and the ESCRT-III protein 
CHMP1B for removing damaged NOX2 from phagosomes. This mechanism could well relate 
to cross-presentation, because antigen might be degraded together with NOX2 and thereby 
might enter the MHC-I cross-presentation pathway. This model recapitulates all findings from 
this thesis, and explains how dendritic cells are capable to sustain ROS production by NOX2 for 
hours after uptake. It also provides a mechanistic understanding of how NOX2 promotes antigen 
cross-presentation, which is well known from the literature (1–3, 5, 52). Finally, it could provide 
a mechanistic link between autophagy and cross-presentation, which is also known in literature 
(153–156). 
A key challenge for the future is to determine how autophagy relates to the two pathways of 
cross-presentation. For the cytosolic pathway, it could well be that autophagosomes enclose 
oxidized and/or aggregated antigens present in the cytosol together with proteasomes. For the 
vacuolar pathway, it could well be that the autophagosomes that remove oxidatively modified 
NOX2 from phagosomes also sequester antigenic proteins from the phagosomes. This seems 
likely, considering that MHC-I epitopes are mostly very hydrophobic and therefore can be 
expected to interact with the phagosomal membrane (178). In this case, autophagy will link the 
two mechanisms of antigen cross-presentation and explain the known roles of autophagy in 
both the cytosolic and the vacuolar pathway (153–156). Thus, I expect that autophagy will prove 
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to be a key mechanism for antigen cross-presentation, and that autophagy will be a promising 
therapeutic target to tailor antigen cross-presentation for treatment of infectious disease, cancer 
and autoimmune disease.
^ Fig 1: Mechanisms of NOX2-generated ROS in the induction of antigen cross-presentation and 
autophagy. (1) During phagocytosis, the membrane-bound subunits of NOX2, gp91phox (gp91) and p22phox (p22), which 
are present on the plasma membrane, are internalized together with the antigen. (2) To form an active NOX2 complex, the 
cytosolic subunits p67phox, p47phox and p40phox are recruited to the membrane-bound subunits. Activation of NOX2 results 
in the generation of ROS in the phagosomal lumen, which cause oxidation of the antigen, the lipids of the phagosomal 
membrane, and NOX2 itself. (3) An intracellular pool of NOX2 residing in LAMP1-rich late endosomes/lysosomes traffics 
towards recycling endosomes. (4) Oxidized NOX2 is replenished from this intracellular pool through the action of the 
SNARE proteins VAMP8, Stx7 and SNAP23. (5) Oxidation of lipids in the phagosomal membrane causes membrane 
disruption, which leads to translocation of parts of the antigen to the cytosol. (6) Antigen present in the cytosol is processed 
by the proteasome and transported to the lumen of the endoplasmic reticulum (ER) via the transporter associated with 
antigen processing (TAP). (7) In the ER lumen, antigen is loaded on MHC-I molecules. (8) The MHC-I:peptide complexes 
are trafficked via secretory vesicles to the plasma membrane for presentation to CD8+ T cells. (9) Oxidized NOX2 is 
ubiquitinated, followed by recruitment of p62 and LC3-positive autophagophores. (10) These autophagophores form 
autophagosomes which remove oxidized NOX2 from the phagosomal membrane via ATG12 and CHMP1B activity. (11) 
Next to oxidized NOX2, also parts of the antigen might be present in the autophagosome, which thereby might enter an 
autophagy-dependent MHC-I cross-presentation pathway.
166
Chapter 7
7
References
1. A. Savina et al., NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell. 126, 205–18 (2006).
2. C. Jancic et al., Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat. Cell Biol. 9, 367–78 (2007).
3. F. Kotsias, E. Hoffmann, S. Amigorena, A. Savina, Reactive oxygen species production in the phagosome: impact on antigen presentation in dendritic cells. Antioxid. Redox 
Signal. 18, 714–29 (2013).
4. J. M. Rybicka, D. R. Balce, S. Chaudhuri, E. R. O. Allan, R. M. Yates, Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner. 
EMBO J. 31, 932–44 (2012).
5. A. Hari et al., Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis. Eur. J. Immunol. 45, 383–95 (2015).
6. O. P. Joffre, E. Segura, A. Savina, S. Amigorena, Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12, 557–69 (2012).
7. C. Kreer, J. Rauen, M. Zehner, S. Burgdorf, Cross-presentation: how to get there - or how to get the ER. Front. Immunol. 2, 87 (2011).
8. P. Cresswell, A. L. Ackerman, A. Giodini, D. R. Peaper, P. A. Wearsch, Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 207, 
145–57 (2005).
9. K. L. Rock, L. Shen, Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207, 166–83 (2005).
10. S. Amigorena, A. Savina, Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr. Opin. Immunol. 22, 109–17 (2010).
11. E. Segura, J. A. Villadangos, A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. Traffic. 12, 1677–85 (2011).
12. E. B. Compeer, T. W. H. Flinsenberg, S. G. van der Grein, M. Boes, Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation. 
Front. Immunol. 3, 37 (2012).
13. V. Schuette, S. Burgdorf, The ins-and-outs of endosomal antigens for cross-presentation. Curr. Opin. Immunol. 26, 63–8 (2014).
14. J. Neefjes, C. Sadaka, Into the intracellular logistics of cross-presentation. Front. Immunol. 3, 31 (2012).
15. F. M. Cruz, J. D. Colbert, E. Merino, B. A. Kriegsman, K. L. Rock, The biology and underlying mechanisms of cross-presentation of exogenous antigens on MHC-I molecules. 
Annu. Rev. Immunol. 35, 149–176 (2017).
16. P. Nair-Gupta, J. M. Blander, An updated view of the intracellular mechanisms regulating cross-presentation. Front. Immunol. 4, 401 (2013).
17. J. E. Grotzke, D. Sengupta, Q. Lu, P. Cresswell, The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation. Curr. Opin. Immunol. 46, 89–96 (2017).
18. A. L. Ackerman, C. Kyritsis, R. Tampé, P. Cresswell, Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. 
Proc. Natl. Acad. Sci. U. S. A. 100, 12889–94 (2003).
19. P. Guermonprez et al., ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature. 425, 397–402 (2003).
20. M. Houde et al., Phagosomes are competent organelles for antigen cross-presentation. Nature. 425, 402–6 (2003).
21. I. Mellman, R. M. Steinman, Dendritic cells: specialized and regulated antigen processing machines. Cell. 106, 255–8 (2001).
22. M. Kovacsovics-Bankowski, K. Clark, B. Benacerraf, K. L. Rock, Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by 
macrophages. Proc. Natl. Acad. Sci. U. S. A. 90, 4942–6 (1993).
23. V. Dasari et al., Autophagy and proteasome interconnect to coordinate cross-presentation through MHC class I pathway in B cells. Immunol. Cell Biol. 94, 964–974 (2016).
24. H. Hon, A. Oran, T. Brocker, J. Jacob, B lymphocytes participate in cross-presentation of antigen following gene gun vaccination. J. Immunol. 174, 5233–42 (2005).
25. C. Beauvillain et al., Neutrophils efficiently cross-prime naive T cells in vivo. Blood. 110, 2965–73 (2007).
26. N. S. Potter, C. V Harding, Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. J. Immunol. 
167, 2538–46 (2001).
27. J. Neefjes, M. L. M. Jongsma, P. Paul, O. Bakke, Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11, 823–36 
(2011).
28. H. L. Ploegh, Viral strategies of immune evasion. Science. 280, 248–53 (1998).
29. J. Imai, H. Hasegawa, M. Maruya, S. Koyasu, I. Yahara, Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-
presentation by dendritic cells. Int. Immunol. 17, 45–53 (2005).
30. J. Ménager et al., Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or 
Derlin-1. PLoS One. 9, e89897 (2014).
31. M. Zehner et al., Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation. Proc. Natl. Acad. 
Sci. U. S. A. 108, 9933–8 (2011).
32. A. L. Ackerman, A. Giodini, P. Cresswell, A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity. 25, 
607–17 (2006).
33. M. Zehner et al., The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8(+) T cells. Immunity. 42, 850–63 
(2015).
34. J. E. Grotzke et al., Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export. Proc. Natl. Acad. Sci. U. S. A. 114, 
E5910–E5919 (2017).
35. E. Gagnon et al., Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell. 110, 119–31 (2002).
36. N. Touret et al., Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell. 123, 157–70 (2005).
37. L. D. Rogers, L. J. Foster, The dynamic phagosomal proteome and the contribution of the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 104, 18520–5 (2007).
38. I. Cebrian et al., Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell. 147, 1355–68 (2011).
39. A. Alloatti et al., Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity. J. Exp. Med. 214, 2231–2241 (2017).
40. S. J. Wu et al., A critical analysis of the role of SNARE protein Sec22b in antigen cross-presentation. Cell Rep. 19, 2645–2656 (2017).
167
General discussion & future perspectives
7
41. W. Ma et al., Long-peptide cross-presentation by human dendritic cells occurs in vacuoles by peptide exchange on nascent MHC class I molecules. J. Immunol. 196, 
1711–20 (2016).
42. T. Di Pucchio et al., Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. 
Immunol. 9, 551–7 (2008).
43. P. Nair-Gupta et al., TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation. Cell. 158, 506–21 (2014).
44. I. Cebrian, C. Croce, N. A. Guerrero, N. Blanchard, L. S. Mayorga, Rab22a controls MHC-I intracellular trafficking and antigen cross-presentation by dendritic cells. EMBO Rep. 
17, 1753–1765 (2016).
45. G. Basha et al., A CD74-dependent MHC class I endolysosomal cross-presentation pathway. Nat. Immunol. 13, 237–45 (2012).
46. S. I. van Kasteren, H. S. Overkleeft, Endo-lysosomal proteases in antigen presentation. Curr. Opin. Chem. Biol. 23, 8–15 (2014).
47. L. Shen, L. J. Sigal, M. Boes, K. L. Rock, Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity. 21, 
155–65 (2004).
48. H. A. Chapman, R. J. Riese, G. P. Shi, Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59, 63–88 (1997).
49. H. Schmid et al., Modulation of the endosomal and lysosomal distribution of cathepsins B, L and S in human monocytes/macrophages. Biol. Chem. 383, 1277–83 (2002).
50. J. P. Liuzzo, S. S. Petanceska, D. Moscatelli, L. A. Devi, Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate 
interactions. Mol. Med. 5, 320–33 (1999).
51. K. Storm van ’s Gravesande et al., IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression. J. Immunol. 168, 4488–94 (2002).
52. A. R. Mantegazza et al., NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood. 112, 4712–22 (2008).
53. D. Suto et al., Inactivation of cysteine and serine proteases by singlet oxygen. Arch. Biochem. Biophys. 461, 151–8 (2007).
54. E. R. O. Allan et al., NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing. J. Immunol. 192, 
4989–5001 (2014).
55. L. Delamarre, M. Pack, H. Chang, I. Mellman, E. S. Trombetta, Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science. 307, 1630–4 
(2005).
56. R. J. Riese et al., Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity. 4, 357–66 (1996).
57. R. M. Voorhees, I. S. Fernández, S. H. W. Scheres, R. S. Hegde, Structure of the mammalian ribosome-Sec61 complex to 3.4 Å resolution. Cell. 157, 1632–43 (2014).
58. A. Rodriguez, A. Regnault, M. Kleijmeer, P. Ricciardi-Castagnoli, S. Amigorena, Selective transport of internalized antigens to the cytosol for MHC class I presentation in 
dendritic cells. Nat. Cell Biol. 1, 362–8 (1999).
59. I. Dingjan et al., Lipid peroxidation causes endosomal antigen release for cross-presentation. Sci. Rep. 6, 22064 (2016).
60. L. Bougnères et al., A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells. Immunity. 31, 232–44 (2009).
61. N. Schaft, B. Lankiewicz, J. W. Gratama, R. L. H. Bolhuis, R. Debets, Flexible and sensitive method to functionally validate tumor-specific receptors via activation of NFAT. J. 
Immunol. Methods. 280, 13–24 (2003).
62. M. Schnurr et al., Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Blood. 105, 2465–72 (2005).
63. B. Chatterjee et al., Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells. Blood. 120, 
2011–20 (2012).
64. S. Burgdorf, A. Kautz, V. Böhnert, P. a Knolle, C. Kurts, Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science. 316, 612–6 
(2007).
65. Y. Liu et al., Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes. J. Immunol. 177, 8440–7 (2006).
66. P. Nunes, N. Demaurex, M. C. Dinauer, Regulation of the NADPH oxidase and associated ion fluxes during phagocytosis. Traffic. 14, 1118–31 (2013).
67. S. Burgdorf, V. Lukacs-Kornek, C. Kurts, The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J. Immunol. 176, 
6770–6 (2006).
68. Y. Mou et al., The Effect of Superparamagnetic Iron Oxide Nanoparticle Surface Charge on Antigen Cross-Presentation. Nanoscale Res. Lett. 12, 52 (2017).
69. K. K. Tran, H. Shen, The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells. Biomaterials. 30, 1356–62 (2009).
70. A. Giodini, C. Rahner, P. Cresswell, Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells. Proc. Natl. Acad. Sci. U. S. A. 106, 
3324–9 (2009).
71. M. Li et al., Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J. Immunol. 166, 6099–103 (2001).
72. A. Mant, F. Chinnery, T. Elliott, A. P. Williams, The pathway of cross-presentation is influenced by the particle size of phagocytosed antigen. Immunology. 136, 163–75 (2012).
73. L. Delamarre, H. Holcombe, I. Mellman, Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially 
regulated during dendritic cell maturation. J. Exp. Med. 198, 111–22 (2003).
74. B. C. Gil-Torregrosa et al., Control of cross-presentation during dendritic cell maturation. Eur. J. Immunol. 34, 398–407 (2004).
75. S. Burgdorf, C. Schölz, A. Kautz, R. Tampé, C. Kurts, Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat. Immunol. 9, 
558–66 (2008).
76. N. C. Robson, H. Beacock-Sharp, A. M. Donachie, A. M. Mowat, Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-indepen-
dent mechanism of major histocompatibility complex class I loading. Immunology. 109, 374–83 (2003).
77. K.-Y. Shen et al., Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells. J. Immunol. 192, 4233–41 (2014).
78. S. K. Datta et al., A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J. Immunol. 170, 4102–4110 (2003).
79. O. Schulz et al., Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature. 433, 887–92 (2005).
80. A. Lahiri et al., TLR 9 activation in dendritic cells enhances salmonella killing and antigen presentation via involvement of the reactive oxygen species. PLoS One. 5, e13772 
168
Chapter 7
7
(2010).
81. D. B. Graham et al., An ITAM-signaling pathway controls cross-presentation of particulate but not soluble antigens in dendritic cells. J. Exp. Med. 204, 2889–97 (2007).
82. Y. H. S. Ho, D. T. Cai, C.-C. Wang, D. Huang, S. H. Wong, Vesicle-associated membrane protein-8/endobrevin negatively regulates phagocytosis of bacteria in dendritic cells. J. 
Immunol. 180, 3148–57 (2008).
83. K. Hatsuzawa et al., Sec22b is a negative regulator of phagocytosis in macrophages. Mol. Biol. Cell. 20, 4435–43 (2009).
84. D. T. Cai et al., Aspirin regulates SNARE protein expression and phagocytosis in dendritic cells. Mol. Membr. Biol. 28, 90–102 (2011).
85. Y. H. S. Ho, D. T. Cai, D. Huang, C. C. Wang, S. H. Wong, Caspases regulate VAMP-8 expression and phagocytosis in dendritic cells. Biochem. Biophys. Res. Commun. 387, 
371–5 (2009).
86. S. Zhang et al., Syntaxin-11 is expressed in primary human monocytes/macrophages and acts as a negative regulator of macrophage engulfment of apoptotic cells and 
IgG-opsonized target cells. Br. J. Haematol. 142, 469–79 (2008).
87. K. Hatsuzawa et al., Involvement of syntaxin 18, an endoplasmic reticulum (ER)-localized SNARE protein, in ER-mediated phagocytosis. Mol. Biol. Cell. 17, 3964–77 (2006).
88. C. Sakurai et al., SNAP-23 regulates phagosome formation and maturation in macrophages. Mol. Biol. Cell. 23, 4849–63 (2012).
89. I. Dingjan et al., Oxidized phagosomal NOX2 complex is replenished from lysosomes. J. Cell Sci. 130, 1285–1298 (2017).
90. D. Matheoud et al., Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8. Cell Host Microbe. 14, 15–25 
(2013).
91. I. Dingjan et al., VAMP8-mediated NOX2 recruitment to endosomes is necessary for antigen release. Eur. J. Cell Biol. 96, 705-14 (2017).
92. I. Vergne et al., Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endoso-
mal fusion. Mol. Biol. Cell. 15, 751–60 (2004).
93. R. A. Fratti, J. Chua, I. Vergne, V. Deretic, Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. U. S. A. 
100, 5437–42 (2003).
94. R. Madan, R. Rastogi, S. Parashuraman, A. Mukhopadhyay, Salmonella acquires lysosome-associated membrane protein 1 (LAMP1) on phagosomes from Golgi via SipC 
protein-mediated recruitment of host Syntaxin6. J. Biol. Chem. 287, 5574–87 (2012).
95. E. M. Campoy, M. E. Mansilla, M. I. Colombo, Endocytic SNAREs are involved in optimal Coxiella burnetii vacuole development. Cell. Microbiol. 15, 922–41 (2013).
96. A. Gallois, J. R. Klein, L. A. Allen, B. D. Jones, W. M. Nauseef, Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase 
assembly from the phagosomal membrane. J. Immunol. 166, 5741–8 (2001).
97. G. Y. Lam et al., Listeriolysin O suppresses phospholipase C-mediated activation of the microbicidal NADPH oxidase to promote Listeria monocytogenes infection. Cell Host 
Microbe. 10, 627–34 (2011).
98. R. L. McCaffrey et al., Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis. J. Leukoc. Biol. 88, 791–805 (2010).
99. S. M. Holland, Chronic granulomatous disease. Hematol. Oncol. Clin. North Am. 27, 89–99, viii (2013).
100. J. Bylund, K. L. Brown, C. Movitz, C. Dahlgren, A. Karlsson, Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for? Free Radic. 
Biol. Med. 49, 1834–45 (2010).
101. S. D. Rosenzweig, Inflammatory manifestations in chronic granulomatous disease (CGD). J. Clin. Immunol. 28 Suppl 1, S67-72 (2008).
102. D. Roos et al., Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells. Mol. Dis. 44, 291–9 
(2010).
103. D. Roos et al., Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells. Mol. Dis. 45, 246–65 (2010).
104. J. A. Winkelstein et al., Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 79, 155–69 (2000).
105. M. Zhou, Z. Diwu, N. Panchuk-Voloshina, R. P. Haugland, A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: ap-
plications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal. Biochem. 253, 162–8 (1997).
106. O. Myhre, J. M. Andersen, H. Aarnes, F. Fonnum, Evaluation of the probes 2’,7’-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. 
Biochem. Pharmacol. 65, 1575–82 (2003).
107. E. Eruslanov, S. Kusmartsev, Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol. Biol. 594, 57–72 (2010).
108. P. Bilski, A. G. Belanger, C. F. Chignell, Photosensitized oxidation of 2’,7’-dichlorofluorescin: singlet oxygen does not contribute to the formation of fluorescent oxidation 
product 2’,7’-dichlorofluorescein. Free Radic. Biol. Med. 33, 938–46 (2002).
109. M. G. Traber, J. F. Stevens, Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic. Biol. Med. 51, 1000–13 (2011).
110. Y. Li, M. A. Trush, Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Com-
mun. 253, 295–9 (1998).
111. J. Stefanska, R. Pawliczak, Apocynin: molecular aptitudes. Mediators Inflamm. 2008, 106507 (2008).
112. S. Heumüller et al., Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertens. (Dallas, Tex.  1979). 51, 211–7 (2008).
113. E. Aldieri et al., Classical inhibitors of NOX NAD(P)H oxidases are not specific. Curr. Drug Metab. 9, 686–96 (2008).
114. J. Doussiere, A. Poinas, C. Blais, P. V. Vignais, Phenylarsine oxide as an inhibitor of the activation of the neutrophil NADPH oxidase--identification of the beta subunit of the 
flavocytochrome b component of the NADPH oxidase as a target site for phenylarsine oxide by photoaffinity labeling and photoina. Eur. J. Biochem. 251, 649–58 (1998).
115. H. Kutsumi, K. Kawai, R. B. Johnston, K. Rokutan, Evidence for participation of vicinal dithiols in the activation sequence of the respiratory burst of human neutrophils. Blood. 
85, 2559–69 (1995).
116. C. Stielow et al., Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells. Biochem. Biophys. Res. Commun. 344, 200–5 (2006).
117. S. Altenhöfer et al., The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell. Mol. Life Sci. 69, 2327–43 (2012).
118. B.-H. Kim, A. R. Shenoy, P. Kumar, C. J. Bradfield, J. D. MacMicking, IFN-inducible GTPases in host cell defense. Cell Host Microbe. 12, 432–44 (2012).
169
General discussion & future perspectives
7
119. B.-H. Kim et al., A family of IFN-γ inducible 65-kD GTPases protects against bacterial infection. Science. 332, 717–21 (2011).
120. S. B. Berger et al., SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages. Nat. Immunol. 11, 920–7 (2010).
121. C. Ma et al., Receptor signaling lymphocyte-activation molecule family 1 (Slamf1) regulates membrane fusion and NADPH oxidase 2 (NOX2) activity by recruiting a Beclin-1/
Vps34/ultraviolet radiation resistance-associated gene (UVRAG) complex. J. Biol. Chem. 287, 18359–65 (2012).
122. F. Kanai et al., The PX domains of p47phox and p40phox bind to lipid products of PI(3)K. Nat. Cell Biol. 3, 675–8 (2001).
123. C. D. Ellson et al., PtdIns(3)P regulates the neutrophil oxidase complex by binding to the PX domain of p40(phox). Nat. Cell Biol. 3, 679–82 (2001).
124. J. Martinez et al., Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat. Cell Biol. 17, 893–906 
(2015).
125. C.-S. Yang et al., Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation. Cell Host Microbe. 11, 
264–76 (2012).
126. J. Huang et al., Activation of antibacterial autophagy by NADPH oxidases. Proc. Natl. Acad. Sci. U. S. A. 106, 6226–31 (2009).
127. M. A. Sanjuan et al., Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature. 450, 1253–7 (2007).
128. J. Ma, C. Becker, C. A. Lowell, D. M. Underhill, Dectin-1-triggered recruitment of light chain 3 protein to phagosomes facilitates major histocompatibility complex class II 
presentation of fungal-derived antigens. J. Biol. Chem. 287, 34149–56 (2012).
129. S. Romao et al., Autophagy proteins stabilize pathogen-containing phagosomes for prolonged MHC II antigen processing. J. Cell Biol. 203, 757–66 (2013).
130. A. de Luca et al., IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc. Natl. Acad. Sci. U. S. 
A. 111, 3526–31 (2014).
131. A. De Luca et al., CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease. J. Clin. Invest. 
122, 1816–31 (2012).
132. G. Y. Lam, M. Cemma, A. M. Muise, D. E. Higgins, J. H. Brumell, Host and bacterial factors that regulate LC3 recruitment to Listeria monocytogenes during the early stages of 
macrophage infection. Autophagy. 9, 985–95 (2013).
133. J. M. Tam et al., Dectin-1-dependent LC3 recruitment to phagosomes enhances fungicidal activity in macrophages. J. Infect. Dis. 210, 1844–54 (2014).
134. D. Schmid, C. Münz, Innate and adaptive immunity through autophagy. Immunity. 27, 11–21 (2007).
135. I. Nakagawa et al., Autophagy defends cells against invading group A Streptococcus. Science. 306, 1037–40 (2004).
136. C. L. Birmingham, A. C. Smith, M. A. Bakowski, T. Yoshimori, J. H. Brumell, Autophagy controls Salmonella infection in response to damage to the Salmonella-containing 
vacuole. J. Biol. Chem. 281, 11374–83 (2006).
137. R. M. Andrade, M. Wessendarp, M.-J. Gubbels, B. Striepen, C. S. Subauste, CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent 
fusion of pathogen-containing vacuoles and lysosomes. J. Clin. Invest. 116, 2366–77 (2006).
138. M. G. Gutierrez et al., Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 119, 753–66 (2004).
139. T. Lamark, T. Johansen, Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int. J. Cell Biol. 2012, 736905 (2012).
140. A. J. Perrin, X. Jiang, C. L. Birmingham, N. S. Y. So, J. H. Brumell, Recognition of bacteria in the cytosol of Mammalian cells by the ubiquitin system. Curr. Biol. 14, 806–11 
(2004).
141. Y. T. Zheng et al., The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway. J. Immunol. 183, 5909–16 (2009).
142. Y. Yoshikawa et al., Listeria monocytogenes ActA-mediated escape from autophagic recognition. Nat. Cell Biol. 11, 1233–40 (2009).
143. X. Chen et al., Autophagy induced by calcium phosphate precipitates targets damaged endosomes. J. Biol. Chem. 289, 11162–74 (2014).
144. T. L. M. Thurston, M. P. Wandel, N. von Muhlinen, A. Foeglein, F. Randow, Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature. 
482, 414–8 (2012).
145. N. Fujita et al., Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. J. Cell Biol. 203, 115–28 (2013).
146. S. Chauhan et al., TRIMs and galectins globally cooperate and TRIM16 and galectin-3 co-direct autophagy in endomembrane damage homeostasis. Dev. Cell. 39, 13–27 
(2016).
147. M. A. Delgado, R. A. Elmaoued, A. S. Davis, G. Kyei, V. Deretic, Toll-like receptors control autophagy. EMBO J. 27, 1110–21 (2008).
148. Y. Xu et al., Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity. 27, 135–44 (2007).
149. C.-S. Shi, J. H. Kehrl, MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J. Biol. Chem. 283, 33175–82 (2008).
150. F. S. Laroux, X. Romero, L. Wetzler, P. Engel, C. Terhorst, Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gram-negative bacteria. J. Immunol. 
175, 5596–600 (2005).
151. S. Pacquelet et al., Cross-talk between IRAK-4 and the NADPH oxidase. Biochem. J. 403, 451–61 (2007).
152. H. K. Lee, J. M. Lund, B. Ramanathan, N. Mizushima, A. Iwasaki, Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science. 315, 1398–401 (2007).
153. H. Li, Y. Li, J. Jiao, H.-M. Hu, Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response. Nat. Nanotechnol. 6, 
645–50 (2011).
154. R. Ravindran et al., Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation. Science. 343, 313–317 (2014).
155. J. D. Mintern et al., Differential use of autophagy by primary dendritic cells specialized in cross-presentation. Autophagy. 11, 906–17 (2015).
156. V. V. Parekh et al., Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α(+) dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 
114, E6371–E6380 (2017).
157. D. Fiegl et al., Amphisomal route of MHC class I cross-presentation in bacteria-infected dendritic cells. J. Immunol. 190, 2791–806 (2013).
158. Y. Lee et al., p62 Plays a Specific Role in Interferon-γ-Induced Presentation of a Toxoplasma Vacuolar Antigen. Cell Rep. 13, 223–33 (2015).
159. L. English et al., Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat. Immunol. 10, 480–7 (2009).
170
Chapter 7
7
160. S.-K. Tey, R. Khanna, Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway. Blood. 
120, 994–1004 (2012).
161. D. Schmid, M. Pypaert, C. Münz, Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. 
Immunity. 26, 79–92 (2007).
162. J. Dengjel et al., Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl. Acad. Sci. U. S. A. 102, 7922–7 (2005).
163. F. Nimmerjahn et al., Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur. J. Immunol. 33, 1250–9 (2003).
164. C. Paludan et al., Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science. 307, 593–6 (2005).
165. D. Schmid, C. Münz, Immune surveillance of intracellular pathogens via autophagy. Cell Death Differ. 12 Suppl 2, 1519–27 (2005).
166. E. Itakura, C. Kishi-Itakura, N. Mizushima, The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell. 151, 
1256–69 (2012).
167. B. Guo et al., O-GlcNAc-modification of SNAP-29 regulates autophagosome maturation. Nat. Cell Biol. 16, 1215–26 (2014).
168. J. Diao et al., ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes. Nature. 520, 563–6 (2015).
169. N. Furuta, N. Fujita, T. Noda, T. Yoshimori, A. Amano, Combinational soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins VAMP8 and Vti1b mediate 
fusion of antimicrobial and canonical autophagosomes with lysosomes. Mol. Biol. Cell. 21, 1001–10 (2010).
170. C. M. Fader, D. G. Sánchez, M. B. Mestre, M. I. Colombo, TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multive-
sicular body pathways. Biochim. Biophys. Acta. 1793, 1901–16 (2009).
171. T. Nozawa, A. Minowa-Nozawa, C. Aikawa, I. Nakagawa, The STX6-VTI1B-VAMP3 complex facilitates xenophagy by regulating the fusion between recycling endosomes and 
autophagosomes. Autophagy. 13, 57–69 (2017).
172. T. Kimura et al., Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. EMBO J. 36, 42–60 (2017).
173. C. Raiborg, H. Stenmark, The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature. 458, 445–52 (2009).
174. W. M. Henne, N. J. Buchkovich, S. D. Emr, The ESCRT pathway. Dev. Cell. 21, 77–91 (2011).
175. J.-A. Lee, A. Beigneux, S. T. Ahmad, S. G. Young, F.-B. Gao, ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr. Biol. 17, 1561–7 
(2007).
176. M. Filimonenko et al., Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J. Cell Biol. 
179, 485–500 (2007).
177. T. E. Rusten, H. Stenmark, How do ESCRT proteins control autophagy? J. Cell Sci. 122, 2179–83 (2009).
178. F. Bianchi, J. Textor, G. van den Bogaart, Transmembrane helices are an overlooked source of major histocompatibility complex class I epitopes. Front. Immunol. 8, 1118 
(2017).
171
General discussion & future perspectives
7
Ilse Dingjan
CHAPTER
8
Samenvatting
Dankwoord
Curriculum Vitae
Publications
174
Chapter 8
8
Het immuunsysteem
Na een infectie met pathogenen, zoals bacteriën of virussen, wordt het menselijk afweersysteem 
geactiveerd. Dit afweersysteem, ook wel immuunsysteem genoemd, fungeert als het lichamelijke 
verdedigingsmechanisme tegen deze ongewenste indringers. Daarnaast is activatie van 
het immuunsysteem ook belangrijk bij het opruimen van verkeerd delende cellen, welke zich 
kunnen ontwikkelen tot kanker. Het proces van het herkennen van een infectie of kankercel 
tot aan het elimineren ervan, wordt een immuunreactie genoemd. Deze reactie start met de 
activatie van cellen behorend tot het aspecifieke immuunsysteem: een eerste verdedigingslinie 
zonder specifieke herkenningsmechanismen voor indringers. Deze activatie zorgt er vervolgens 
voor dat immuuncellen die behoren tot het adaptieve immuunsysteem zich verplaatsen door het 
lichaam naar de geïnfecteerde plek of de tumor. Daar zorgen deze cellen voor een specifieke 
immuunreactie tegen de infectie of de kankercellen.
Sommige immuuncellen, zoals de dendritische cellen, spelen een belangrijke rol in de interactie 
tussen het aspecifieke en het adaptieve immuunsysteem. Een dendritische cel kan, na herkenning, 
een pathogeen of een kankercel opnemen, deze afbreken en stukjes hiervan, antigenen 
genaamd, op het celoppervlak presenteren aan adaptieve immuuncellen. Immuuncellen met 
deze eigenschap worden ook wel antigeen-presenterende cellen genoemd. De herkenning van 
het specifieke antigeen door immuuncellen van het adaptieve immuunsysteem, de T- en B-cellen, 
zorgt voor een specifieke immuunreactie tegen het pathogeen of de kankercel.
Antigeen cross-presentatie
Het presenteren van antigenen door antigeen-presenterende cellen gaat via een eiwit complex 
genaamd MHC (major histocompatibility complex). MHC wordt onderverdeeld in twee klassen: 
MHC I en MHC II. Intracellulaire pathogenen, zoals virussen, worden gepresenteerd op MHC 
I en leiden tot activatie van cytotoxische T cellen (Fig. 1.1). Deze cytotoxische T cellen kunnen 
na activatie de geïnfecteerde cel doden. Pathogenen die worden opgenomen, zoals bacteriën, 
worden gepresenteerd op MHC II aan helper T cellen, welke B cellen en andere immuuncellen 
kunnen activeren (Fig. 1.2). Dendritische cellen hebben echter ook nog de mogelijkheid om de 
opgenomen pathogenen te presenteren op MHC I door middel van een proces genaamd antigeen 
cross-presentatie (Fig. 1.3). Dit is nodig voor het initiëren van een cytotoxische immuunreactie 
tegen kankercellen.
Endocytose/fagocytose
Het opnemen van pathogenen wordt ook wel endocytose (voor antigenen < 0,5 µm) of fagocytose 
(voor antigenen > 0,5 µm) genoemd. Tijdens endocytose of fagocytose ontstaat een vroege 
endo-/fagosoom, welke zich ontwikkelt tot een late endo-/fagosoom, en uiteindelijk fuseert met 
een lysosoom: een blaasje vol met enzymen die het pathogeen afbreken (Fig. 1.2). Het uiterlijk van 
de endosoom of fagosoom verandert continu tijdens het ontwikkelingsproces. De samenstelling 
van eiwitten die zich op het oppervlak, ook wel membraan genoemd, bevinden verandert tijdens
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^ Fig. 1: Antigeen presentatie in dendritische cellen. 1) Intracellulaire pathogenen, zoals virussen (rood ovaal), 
worden in de cel afgebroken tot kleinere stukjes (blauwe bolletjes) en daarna gepresenteerd in MHC I (oranje structuur) 
op het celoppervlak. 2) Pathogenen die worden opgenomen via fagocytose, zoals bacteriën (groen ovaal), komen in een 
vroege fagosoom terecht. Deze ontwikkelt zich tot een late fagosoom, die fuseert met een lysosoom. Hierdoor wordt het 
pathogeen afgebroken (kleine groene bolletjes) en kan het worden gepresenteerd in MHC II (blauwgrijze structuur) op 
het celoppervlak. 3) De gefagocyteerde pathogenen kunnen ook de fagosoom verlaten, waarna ze de MHC I antigeen 
presentatie route volgen. Dit proces heet antigeen cross-presentatie.
de verschillende stadia van het ontwikkelingsproces. 
SNARE eiwitten in het immuunsysteem
Eén groep van eiwitten op het oppervlak van de endo-/fagosoom zijn de zogenaamde SNARE 
eiwitten. Deze eitwitten zorgen voor de fusie van de membranen van verschillende organellen in 
de cel. Zo zorgen ze onder andere voor de fusie van de late endo-/fagosomen met de lysosomen. 
Voor deze fusie moet zich in beide membranen tenminste één SNARE eiwit bevinden, welke 
samen een SNARE complex kunnen vormen. Een SNARE complex bestaat uiteindelijk uit vier 
verschillende SNARE eiwitten. Verschillende SNAREs zijn gevonden op vroege en late endo-/
fagosomen en lysosomen, en elk eiwit uit de SNARE familie heeft een of meer functies in de 
dendritische cel. In hoofdstuk 2 heb ik een overzicht gegeven van de SNAREs die betrokken 
zijn bij fusies tijdens de ontwikkeling van endosomen en fagosomen. We hebben gevonden 
dat van de 38 SNARE eiwitten die in het menselijk lichaam voorkomen, er 30 SNARE eiwitten 
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aanwezig zijn op endosomen en fagosomen, en dat deze zorgen voor de beweging naar, en fusie 
met, andere endosomen, lysosomen, het celoppervlak en andere organellen zoals het Golgi 
apparaat en autofagosomen.
NOX2 complex
Een andere eiwitcomplex dat zich op het oppervlak van de endo-/fagosoom bevindt is NOX2. 
NOX2 is een complex, bestaande uit vijf onderdelen, dat verantwoordelijk is voor de formatie van 
zuurstofradicalen (ROS) in het lumen van de endo-/fagosoom waar zich het pathogeen bevindt. 
De productie van ROS is nodig voor de afbraak van het pathogeen, maar ook voor de activatie 
van een goede immuunrespons tegen de kankercellen. Eén van de onderdelen van het NOX2 
complex is het membraaneiwit gp91phox. In hoofdstuk 3 heb ik onderzocht hoe gp91phox naar het 
membraan van de endo-/fagosoom wordt getransporteerd. Tijdens fagocytose wordt gp91phox, 
wat zich op het celoppervlak van de dendritische cel bevindt, mee naar binnen genomen samen 
met het pathogeen (Fig. 2.1). Dit zorgt voor de formatie van het complete NOX2 complex op het 
membraan van de fagosoom, gevolgd door ROS productie. Een nadeel van de productie van 
ROS is dat het leidt tot oxidatie van gp91phox (Fig. 2.2), gevolgd door verwijdering van gp91phox van 
het membraan. We vonden echter ook dat deze gp91phox weer wordt aangevuld door gp91phox dat 
zich op late endosomale structuren bevindt, zodat de ROS kan blijven worden geproduceerd. 
Gp91phox op late endosomale structuren wordt naar de fagosoom toe bewogen door de formatie 
van een SNARE complex, bestaande uit VAMP8, SNAP23 en syntaxin-7 (Fig. 2.3). 
De rol van autofagie in NOX2 activiteit
In hoofdstuk 4 ben ik gaan onderzoeken welke processen betrokken zijn bij de afbraak en 
verwijdering van geoxideerd gp91phox. Cellen gebruiken verschillende mechanismes om defecte, 
niet-werkende of verkeerd gevouwen eiwitten op te ruimen. Eén mechanisme is de formatie van 
zogenaamde multi-vesicular bodies door de activatie van ESCRT complexen. Deze complexen 
duwen defecte membraaneiwitten in de endosoom zodat deze, nadat de endosoom fuseert met 
een lysosoom, worden opgeruimd. Een ander mechanisme is autofagie, waarbij het eiwit dat 
moet worden opgeruimd wordt omsloten door een LC3-positief dubbelwandig membraan: een 
autofagosoom. Deze fuseert met een lysosoom tot een autolysosoom, wat leidt tot de afbraak van 
het eiwit. Naast het opruimen van defecte eiwitten, fungeert autofagie ook als verdedigingssysteem 
tegen pathogenen die zich in een cel hebben genesteld door bijvoorbeeld via het membraan van 
een endosoom te ontsnappen. Deze pathogenen worden gelabeld door de cel met specifieke 
structuren, ubiquitine genaamd, wat zorgt voor herkenning door het adaptereiwit p62 en het 
aantrekken van autofagosomen. Wij vonden dat geoxideerd gp91phox ook wordt gelabeld met 
ubiquitine, en dat dit leidt tot de herkenning door p62 en activatie van autofagie-gerelateerde eiwitten. 
De activatie van deze eiwitten zorgt voor de aantrekking van LC3-positieve autofagosomen naar 
het membraan van de fagosoom (Fig. 2.5). Om uiteindelijk gp91phox ook werkelijk van de fagosoom 
af te halen, is activatie van het ESCRT-III eiwit CHMP1B nodig. Dit komt omdat CHMP1B, naast 
membraaneiwitten de endosoom in te duwen, de defecte eiwitten ook naar buiten kan trekken.
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^ Fig. 2: Regulatie van NOX2 activiteit in een dendritische cel na opname van een pathogeen. 1) Tijdens 
fagocytose van een pathogeen wordt gp91phox, een onderdeel van NOX2, mee naar binnen genomen, en daardoor bevindt 
het zich op het membraan van de fagosoom. Hier wordt het volledige NOX2 complex gevormd. 2) Activatie van NOX2 
leidt tot de formatie van zuurstofradicalen (ROS). ROS is nodig voor de degradatie van het pathogeen tot antigenen, maar 
oxideert ook NOX2 en lipiden in het membraan van de fagosoom. 3) Geoxideerd NOX2 wordt vervangen door NOX2 dat 
zich in late endosomale structuren bevindt en naar de fagosoom beweegt door de formatie en activatie van een SNARE 
complex, bestaande uit VAMP8, SNAP23 en syntaxin-7. 4) Oxidatie van lipiden in het membraan zorgt ervoor dat het 
membraan lek wordt. Hierdoor kunnen stukjes antigeen naar het cytosol bewegen, waar ze worden 'geknipt' door de 
antigeen processor. Deze kleinere antigenen worden via antigeen cross-presentatie gepresenteerd op het celoppervlak 
aan cytotoxische T cellen (zie Fig. 1). 5) Geoxideerd NOX2 wordt gelabeld met ubiquitine, wat leidt tot herkenning door 
p62 en aantrekking van een LC3-positieve autofagosoom. Dit zorgt ervoor dat het stukje membraan met NOX2 van de 
fagosoom wordt gehaald.  6) De gevormde autofagosoom fuseert met een lysosoom tot een autolysosoom voor de afbraak 
van geoxideerd NOX2.
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NOX2 activiteit in antigeen cross-presentatie
Het was al bekend dat NOX2 belangrijk is voor het induceren van een immuunreactie tegen 
kankercellen, maar het mechanisme hierachter was nog niet volledig ontrafeld. In de literatuur 
is beschreven dat ROS geproduceerd door NOX2 de degradatie van opgenomen kankercellen 
kan vertragen, hetgeen een positieve invloed heeft op een immuunrespons tegen kankercellen. 
Dit komt omdat er grotere stukjes antigeen nodig zijn voor het ‘maken’ van de kleinere stukjes 
antigenen die worden gecross-presenteerd op MHC I op het celoppervlak van de dendritische 
cel, hetgeen leidt tot de activatie van een immuunrespons tegen kankercellen. Om te worden 
verwerkt tot antigeen en uiteindelijk via cross-presentatie op MHC I tot een immuunrespons te 
leiden, moeten de grote stukjes van de kankercel de fagosoom verlaten in de richting van het 
cytosol van de dendritische cel. Het was echter onbekend hoe deze translocatie plaatsvindt. In 
hoofdstuk 5 heb ik mijn bevindingen beschreven dat ROS, naast het oxideren van gp91phox, 
ook de lipiden in het membraan van de endo-/fagosoom kan oxideren (Fig. 2.2). Dit leidt tot 
lekkage van het endosomale membraan, waardoor de stukjes antigeen zich naar het cytosol 
kunnen bewegen (Fig. 2.4). Hierna worden de stukjes via cross-presentatie gepresenteerd aan 
cytotoxische T cellen.
In hoofdstuk 6 hebben we verder gekeken naar de invloed van SNARE eiwitten op de functie 
van NOX2 en de relatie tot antigeen cross-presentatie. We vonden dat cellen die geen VAMP8 
tot expressie brengen geen immuunreactie kunnen induceren. Aangezien VAMP8 betrokken is 
bij het aantrekken van gp91phox naar het membraan van de fagosoom, is het ook betrokken bij 
oxidatie van lipiden en de translocatie van stukjes antigeen over het membraan.
Functie van NOX2 en autofagie in antigeen cross-presentatie
In hoofdstuk 7 zijn de resultaten van mijn onderzoek, zoals die beschreven zijn in dit proefschrift, 
samengevat en bediscussieerd. De bevindingen hebben ervoor gezorgd dat er een completer 
model is ontstaan over de rol van NOX2 en autofagie in antigeen cross-presentatie. Verder vormen 
de bevindingen een basis voor nieuwe inzichten in de manier waarop ROS het immuunsysteem 
activeert en reguleert.
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nieuwe studenten…), hadden we een klik. Ik kon altijd bij jou terecht met vragen gerelateerd 
aan ROS, maar je was zeker ook in voor een gezellig praatje. Onder andere onze lieve poesjes 
hebben voor vele leuke gesprekjes gezorgd! En daarnaast; bedankt dat ik soms gebruik mocht 
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maken van jullie logeerkamer, dat scheelde wat nachtelijke ritjes met de trein. Maxim, ik vraag 
mij nog steeds af hoe het je is gelukt om het LC3 blotje meteen de eerste keer zo mooi te krijgen. 
Jouw enthousiasme werkt erg aanstekelijk, en je doorzettingsvermogen is groot. Hoe snel jij 
Nederlands hebt geleerd, is heel knap, en ik hoop dat je snel dat Nederlandse paspoort krijgt! 
Al heb je die in Canada straks niet meer zo hard nodig ;). Natalia, your knowledge, enthusiasm 
and accuracy significantly contributed to work discussions and the papers we wrote together. 
I’m happy that you tried to get EM data for my paper, I know it isn’t easy. And of course, I really 
enjoyed your wedding with the whole group in Leipzig! Thanks for the invitation! Peter, ik ben 
blij dat jij mijn eerste student was. Je was leergierig, zelfstandig en ijverig, en je resultaten kon ik 
mooi gebruiken in een publicatie met jou als coauteur. Nu als PhD in de groep van Geert, help 
je mij vaak uit de brand als ik weer problemen heb met bijvoorbeeld Fiji… Frans, bedankt voor 
de fijne gesprekken over het mogelijke vervolg van mijn carrière. Daarnaast was je out-of-the-box 
denken erg fijn en vernieuwend. Ik hoop dat je die Veni gaat binnen slepen. Elke, sinds jij er bent 
hoef ik niet meer iedere dag alleen terug naar Utrecht. Je bent een gezellig trein-reis-maatje met 
wie je over van alles kan praten. Alleen hoe vaak ik wel niet de trein van 15:58 uur heb gemist het 
laatste half jaar… ;). Tijdens mijn PhD heb ik ook nog drie (nouja, eigenlijk tweeënhalf; sorry Linda 
;)) andere studenten mogen begeleiden: Linda, Luuk en Rebecca. Bedankt voor al jullie input, 
enthousiasme en resultaten. Het heeft zeker een grote bijdrage geleverd aan mijn projecten!
Natuurlijk wil ik ook de andere (ex-)TILlers bedanken voor de fijne tijd op het lab. Ik heb door 
mijn onmogelijke werk/trein-tijden en sportverplichtingen veel moeten missen. Maar als het kon 
probeerde ik erbij te zijn. Ik heb erg genoten van de kerstfeesten (en ik het eerste jaar maar 
denken dat het verkleden wel mee zou vallen…), de PhD diners, de filmavonden, ‘sportieve’ 
activiteiten (lasergamen en trampolinespringen) en natuurlijk de jaarlijkse TIL Day Out. En, Harm, 
Tom, Sjoerd en Altuna, we hebben gelukkig toch maar mooi twee keer die beker omhoog 
mogen houden, die mooi staat te pronken in de vitrinekast in de koffieruimte!
Lieve vrienden, jullie zorgen altijd voor de nodige ontspanning. Wendy en Amber, we kennen 
elkaar al sinds de tijd dat we in de luiers zaten. Soms zien we elkaar door onze drukke levens 
niet zo vaak als we zouden willen, maar gelukkig weet ik dat het altijd goed zit. Gezellige etentjes, 
dagje kerstmarkt of avondje bowlen is met jullie altijd een feest. Erna, ik ben blij dat wij elkaar na 
de middelbare schoolperiode niet uit het oog zijn verloren, en dat je nu gewoon gesetteld bent 
in Nederland! Het is fijn om met jou bij te kletsen tijdens een spelletje of puzzel. En ik geniet ook 
zeker van onze bezoekjes aan het theater of boswandelingen! Simone, direct tijdens onze eerste 
ontmoeting tijdens de Summerschool in Sardinië hadden we een klik. En wat een mazzel dat je 
dan ook nog 5 minuten van mij vandaan woonde. Nu zullen we 30 minuten verder moeten reizen, 
maar ons maandelijkse etentje zal daardoor niet minder gezellig worden! Martijn, bedankt voor 
je gezellige lunchafspraakjes! We moeten er altijd een stukje voor reizen, maar dat heb ik er graag 
voor over. Ook bedankt voor je input in de layout van mijn voorkant, hopelijk vind je hem mooi 
geworden!
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Lieve Sandra, je bent en blijft mijn lieve kleine zusje, maar je bent ook mijn beste vriendin. Ik 
geniet van alle leuke dingen die we samen doen. Helaas woon je niet meer om de hoek, maar ik 
weet dat ik nog steeds altijd bij je terecht kan. En hoe enthousiast jij altijd bent over je werk is fi jn 
om te zien! Blijf zo doorgaan! Ik ben trots op je! 
Lieve papa en mama, bedankt dat jullie er altijd voor mij zijn. Jullie steun en luisterend oor is fi jn. 
Vier jaar lang hebben jullie eigenlijk geen idee gehad wat ik heb gedaan (hopelijk nu wel een beetje 
door de Nederlandse samenvatting); maar als ik zie hoe trots jullie zijn dat ik ga promoveren, ben 
ik weer blij met zulke lieve, meelevende ouders. Blij dat ik altijd bij jullie terecht kan. Ik hou van jullie!
Lieve Mats, mijn vriendje, bedankt dat je er altijd voor mij bent en al je liefde geeft. In de afgelopen 
vier jaar hebben wij ook persoonlijk genoeg beleefd; samen gaan wonen, huis kopen, verhuizen, 
vele rondreisvakanties. Dit had ik met niemand anders willen doen! Dat jij als ZZP’er bent begonnen 
een jaar geleden vind ik heel moedig en gelukkig begint je bedrijfje nu ook te lopen. Ga zo door 
en ik ben er voor je! Ik hou van je!
Liefs,
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